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This project aimed to engineer new T2 MRI contrast agents for cell labeling based on 
formulations containing monodisperse iron oxide magnetic nanoparticles (MNP) coated with 
natural and synthetic polymers. Monodisperse MNP capped with hydrophobic ligands were 
synthesized by a thermal decomposition method, and further stabilized in aqueous media with 
citric acid or meso-2,3-dimercaptosuccinic acid (DMSA) through a ligand exchange reaction. 
Hydrophilic MNP-DMSA, with optimal hydrodynamic size distribution, colloidal stability and 
magnetic properties, were used for further functionalization with different coating materials. A 
covalent coupling strategy was devised to bind the biopolymer gum Arabic (GA) onto MNP-
DMSA and produce an efficient contrast agent, which enhanced cellular uptake in human 
colorectal carcinoma cells (HCT116 cell line) compared to uncoated MNP-DMSA. A similar 
protocol was employed to coat MNP-DMSA with a novel biopolymer produced by a 
biotechnological process, the exopolysaccharide (EPS) Fucopol. Similar to MNP-DMSA-GA, 
MNP-DMSA-EPS improved cellular uptake in HCT116 cells compared to MNP-DMSA. 
However, MNP-DMSA-EPS were particularly efficient towards the neural stem/progenitor cell 
line ReNcell VM, for which a better iron dose-dependent MRI contrast enhancement was 
obtained at low iron concentrations and short incubation times. A combination of synthetic and 
biological coating materials was also explored in this project, to design a dynamic tumor-
targeting nanoprobe activated by the acidic pH of tumors. The pH-dependent affinity pair 
neutravidin/iminobiotin, was combined in a multilayer architecture with the synthetic polymers 
poy-L-lysine and poly(ethylene glycol) and yielded an efficient MRI nanoprobe with ability to 
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O objectivo desta tese consiste na engenharia de novos agentes de contraste T2 para 
marcação celular através de imagiologia por ressonância magnética (MRI), usando formulações 
com nanopartículas magnéticas de óxido de ferro (MNP) revestidas com polímeros naturais e 
com polímeros sintéticos. O método da decomposição térmica foi usado para sintetizar MNP 
monodispersas revestidas com ligandos hidrofóbicos. Para as estabilizar em meio aquoso, os 
ligandos hidrofóbicos foram substituídos por moléculas hidrofílicas, como o ácido cítrico ou o 
ácido meso-2,3,-dimercaptosuccínico (DMSA), através de uma reacção de intercâmbio de 
ligandos. As MNP-DMSA, hidrofílicas, com estabilidade coloidal e propriedades magnéticas 
optimizadas, foram revestidas com diferentes materiais. Para acoplar o biopolímero goma 
arábica às MNP-DMSA, foi usada uma ligação covalente que permitiu obter um agente de 
contraste eficiente e com um nível de captação celular melhorado face às MNP-DMSA em 
células humanas de carcinoma colorectal (linha celular HCT116). Um protocolo experimental 
semelhante foi usado para revestir as MNP-DMSA com um biopolímero novo produzido por via 
biotecnológica, o exopolisacarídeo (EPS) Fucopol. Tal como as MNP-DMSA-GA, as MNP-
DMSA-EPS melhoraram o nível de captação celular nas células HCT116 face às MNP-DMSA. 
No entanto, foram particularmente eficientes numa linha de células estaminais/progenitoras 
neurais (ReNcell VM), nas quais se obteve um melhoramento mais intenso do contraste em 
função da dose de ferro nas imagens por MRI, para doses baixas de ferro e tempos de 
incubação curtos. Neste projecto foi também explorada uma combinação de materiais de 
revestimento sintéticos e biológicos para desenvolver uma nano-sonda dinâmica para 
marcação de tumores, activada pelo pH ácido tumoral. O par de afinidade dependente do pH 
neutravidina/iminobiotina foi combinado com poli-L-lisina e poli(etilenoglicol) através de uma 
arquitectura multi-camada, resultando numa nano-sonda para MRI eficiente e capaz de 
distinguir células cultivadas em condições ácidas de células cultivadas em condições 
fisiológicas. 
 
Palavras-chave: nanopartículas magnéticas de óxido de ferro (MNP), imagiologia por 






Table of Contents 
 
Acknowledgements __________________________________________________________ VII 
Abstract ___________________________________________________________________ IX 
Resumo ___________________________________________________________________ XI 
Index of Figures ___________________________________________________________ XVII 
Index of Tables _____________________________________________________________ XXI 
Abbreviations _____________________________________________________________ XXIII 
Background ______________________________________________________________ XXV 
Chapter 1: Hybrid magnetic-polymeric iron oxide nanoprobes for MRI: from preparation to 
application __________________________________________________________________ 1 
1.1. Physical properties of MNP __________________________________________________ 2 
1.2. MNP synthesis methods ____________________________________________________ 4 
1.3. Biomedical applications of MNP ______________________________________________ 5 
1.4. MNP as MRI contrast agents ________________________________________________ 7 
1.4.1. Structure of MNP-based nanoprobes for MRI ________________________________ 9 
1.4.2. MNP coating materials towards stabilization and functionalization of MRI nanoprobes10 
1.4.2.1. Small organic molecules ____________________________________________ 10 
1.4.2.2. Silica ___________________________________________________________ 11 
1.4.2.3. Polymers ________________________________________________________ 12 
1.4.3. Types of polymers used to coat MNP-based MRI nanoprobes __________________ 13 
1.4.3.1. MNP-polysaccharide hybrid MRI nanoprobes ____________________________ 14 
1.4.3.2. MNP-based MRI nanoprobes assembled with synthetic polymers ____________ 20 
1.5. Concluding Remarks ______________________________________________________ 26 
1.6. References _____________________________________________________________ 27 
Chapter 2: Effects of phase transfer ligands on monodisperse iron oxide nanoparticles _____ 41 
2.1. Introduction _____________________________________________________________ 43 
2.2. Experimental Section _____________________________________________________ 44 
2.2.1. Materials ____________________________________________________________ 44 
2.2.2. Synthesis of hydrophobic magnetic nanoparticles (MNP-OA) ___________________ 44 
2.2.3. Phase transfer by ligand exchange with citric acid (MNP-CA) ___________________ 45 
2.2.4. Phase transfer by ligand exchange with meso-2,3-dimercaptosuccinic acid (MNP-
DMSA) __________________________________________________________________ 45 
XIV 
2.2.5. Preparation of MNP-DMSA-Cyst-GA ______________________________________ 46 
2.2.6. Preparation of MNP-DMSA-GA __________________________________________ 46 
2.2.7. Characterization of magnetic nanoparticles _________________________________ 47 
2.3. Results and Discussion ____________________________________________________ 48 
2.3.1. Size and colloidal stability ______________________________________________ 48 
2.3.2. Surface Chemistry by FTIR _____________________________________________ 50 
2.3.3. Magnetic properties ___________________________________________________ 52 
2.3.4. Comparison of ligand-exchange protocols __________________________________ 53 
2.3.5. Exploring the chemical versatility of MNP-DMSA ____________________________ 55 
2.4. Conclusions _____________________________________________________________ 58 
2.5. References _____________________________________________________________ 58 
Chapter 3: Covalent coupling of gum Arabic onto superparamagnetic iron oxide nanoparticles 
for MRI cell labeling: physiochemical and in vitro characterization ______________________ 63 
3.1. Introduction _____________________________________________________________ 65 
3.2. Experimental Section _____________________________________________________ 66 
3.2.1. Materials ____________________________________________________________ 66 
3.2.2. Synthesis and phase transfer of magnetic nanoparticles ______________________ 66 
3.2.3. Covalent coupling of gum Arabic to MNP-DMSA _____________________________ 66 
3.2.4. Characterization of magnetic nanoparticles _________________________________ 66 
3.2.4.1. Size and structural characterization ___________________________________ 66 
3.2.4.2. Magnetic properties and relaxivities assessment _________________________ 67 
3.2.5. Nanoparticle-cell interactions ____________________________________________ 68 
3.2.5.1. Cell culture_______________________________________________________ 68 
3.2.5.2. Cell viability evaluation _____________________________________________ 68 
3.2.5.3. Iron staining with Prussian blue_______________________________________ 69 
3.2.5.4. Nuclear staining with Hoechst 33258 __________________________________ 69 
3.2.5.5. Cellular staining with Propidium iodide (PI) and nuclear counterstaining with DAPI
 ______________________________________________________________________ 69 
3.2.5.6. GFP labeling of lysosomes and nuclear counterstaining with DAPI ___________ 70 
3.2.5.7. Iron quantification _________________________________________________ 70 
3.2.5.8. Quantification of apoptosis markers by real-time PCR _____________________ 71 
3.2.5.9. In vitro MRI ______________________________________________________ 71 
3.3. Results and Discussion ____________________________________________________ 72 
3.3.1. Morphology, size, colloidal and structural properties of GA coated MNP __________ 72 
3.3.2. Magnetic properties and relaxivities assessment ____________________________ 75 
3.3.3. Cell-nanoparticle interactions ____________________________________________ 77 
XV 
3.4. Conclusions _____________________________________________________________ 84 
3.5. References _____________________________________________________________ 85 
Chapter 4: A value-added exopolysaccharide as a coating agent for MRI nanoprobes ______ 89 
4.1. Introduction _____________________________________________________________ 91 
4.2. Experimental Section _____________________________________________________ 92 
4.2.1. Materials ____________________________________________________________ 92 
4.2.2. Synthesis and phase transfer of iron oxide magnetic nanoparticles (MNP-DMSA) ___ 92 
4.2.3. Preparation of EPS-coated magnetic nanoparticles (MNP-DMSA-EPS) ___________ 93 
4.2.4. Characterization of magnetic nanoparticles _________________________________ 93 
4.2.5. Cell culture and labeling ________________________________________________ 94 
4.2.6. Multi-lineage differentiation of ReNcell VM _________________________________ 95 
4.2.7. Cytotoxicity evaluation _________________________________________________ 95 
4.2.8. Identification of cellular iron by Prussian blue staining ________________________ 96 
4.2.9. Intracellular localization of magnetic nanoparticles ___________________________ 96 
4.2.10. Iron quantification ____________________________________________________ 97 
4.2.11. In vitro MRI of cell phantoms ___________________________________________ 97 
4.3 Results and Discussion ____________________________________________________ 97 
4.3.1. Particle size, composition and surface chemistry ____________________________ 97 
4.3.2 Magnetic properties and relaxivities measurements __________________________ 100 
4.3.3 Cell-nanoparticle interactions ___________________________________________ 103 
4.3.4 Differentiation of MNP labeled neural stem/progenitor cells ____________________ 108 
4.3.5 In vitro MRI of MNP-DMSA-EPS labeled cells ______________________________ 109 
4.4 Conclusion _____________________________________________________________ 111 
4.5 References _____________________________________________________________ 112 
Chapter 5: An affinity-triggered MRI nanoprobe for pH-dependent cell labeling ___________ 117 
5.1. Introduction ____________________________________________________________ 119 
5.2. Experimental Section ____________________________________________________ 121 
5.2.1. Materials ___________________________________________________________ 121 
5.2.2. Production of multi-layer functionalized magnetic nanoparticles ________________ 121 
5.2.2.1. Synthesis and phase transfer of iron oxide magnetic nanoparticles (MNP-DMSA)
 _____________________________________________________________________ 121 
5.2.2.2. Coating MNP-DMSA with iminobiotin-modified poly-L-lysine (PLLib) (MNP-DMSA-
PLLib) ________________________________________________________________ 122 
5.2.2.3. Coating MNP-DMSA-PLLib with Nav-bPEG conjugates (MNP-DMSA-PLLib-Nav-
bPEG) ________________________________________________________________ 122 
5.2.2.4 Characterization of magnetic nanoparticles _____________________________ 123 
XVI 
5.2.2.5. Examination of pH dependent Nav-bPEG release _______________________ 123 
5.2.3. Characterization of in vitro cell-MNP interactions ___________________________ 124 
5.2.3.1. Cell culture and labeling ___________________________________________ 124 
5.2.3.2. Identification of cellular iron by Prussian blue staining ____________________ 125 
5.2.3.3. Intracellular localization of magnetic nanoparticles _______________________ 125 
5.2.3.4. Iron uptake quantification __________________________________________ 125 
5.2.3.5. Determination of cell viability ________________________________________ 125 
5.2.3.6. In vitro MRI of cell phantoms ________________________________________ 126 
5.2.4. Statistical Analysis ___________________________________________________ 126 
5.3. Results and discussion ___________________________________________________ 127 
5.3.1. Multi-layer MNP assembly _____________________________________________ 127 
5.3.2. pH-dependent MNP response __________________________________________ 129 
5.3.3. pH-dependent MNP cellular uptake and MR imaging ________________________ 131 
5.4. Conclusions ____________________________________________________________ 138 
5.5. References ____________________________________________________________ 139 
Chapter 6: Concluding Remarks _______________________________________________ 143 






Index of Figures 
 
Figure 1.1. Schematic representation of the effect of applying an external magnetic field on 
magnetite at different size scales. ________________________________________________ 2 
Figure 1.2. Superparamagnetism features. _________________________________________ 4 
Figure 1.3. Schematic representation of MNP surface modification with biocompatible coating 
and functional moieties. _______________________________________________________ 10 
Figure 2.1. Morphology, size and zeta potential of the hydrophobic and hydrophilic 
nanoparticles. _______________________________________________________________ 49 
Figure 2.2. Surface and magnetic properties of the hydrophobic and hydrophilic nanoparticles. 
 __________________________________________________________________________ 51 
Figure 2.3. MNP-DMSA functionalization possibilities using gum Arabic as model biomolecule.
 __________________________________________________________________________ 55 
Figure 2.4. Surface and magnetic properties of the particles coated with gum Arabic. ______ 56 
Figure 2.5. Determination of the relaxation rates of MNP-DMSA-Cyst-GA and MNP-DMSA-GA 
as a function of iron concentration, respective linear adjustments and r
2 
values. ___________ 57 
Figure 3.1. Size, colloidal stability and composition of the produced particles. ____________ 73 
Figure 3.2. MNP-DMSA-GA colloidal stability over time, in different conditions. ___________ 74 
Figure 3.3. Differential Thermal Analysis (DTA) of MNP-DMSA and MNP-DMSA-GA. ______ 74 
Figure 3.4. FTIR spectra of MNP-DMSA-GA in comparison with MNP-DMSA and free GA. __ 75 
Figure 3.5. Magnetic properties of MNP-DMSA and MNP-DMSA-GA. ___________________ 76 
Figure 3.6. Relaxivities and T2-MRI phantoms of MNP-DMSA-GA. _____________________ 77 
Figure 3.7. Determination of the nanoparticles and GA effects on HCT116 cell viability._____ 78 
Figure 3.8. In vitro interactions of MNPs with HCT116 cells observed by microscopy and iron 
uptake quantification. _________________________________________________________ 79 
Figure 3.9. Effect of particle incubation time on the amount of iron per cell, quantified by ICP. 80 
Figure 3.10. Bright field and fluorescence microscopy images of cells incubated for 48 h with 
MNP-DMSA-GA at IC50. _______________________________________________________ 81 
Figure 3.11. Localization of MNP-DMSA-GA within HCT116 cells after 48h incubation at IC50. 
 __________________________________________________________________________ 81 
Figure 3.12. Hoechst 33258 fluorescent staining of HCT116 cells nuclei. ________________ 82 
XVIII 
Figure 3.13. Fold changes in pro-apoptotic (p21 and BAX) and anti-apoptotic (BCL-2) genes 
expression at 3.5h, 6h, 12h, and 48h after cell incubation with MNP-DMSA-GA at IC50. _____ 83 
Figure 3.14. Evaluation of in vitro MRI cell labeling efficiency with MNP-DMSA and MNP-
DMSA-GA. _________________________________________________________________ 84 
Figure 4.1 Characterization of size and composition of the nanoparticles before and after EPS 
coating. ____________________________________________________________________ 98 
Figure 4.2. Variation of hydrodynamic diameter, polydispersity index and zeta potential of MNP-
DMSA and MNP-DMSA-EPS dispersed in different conditions. ________________________ 99 
Figure 4.3. Evaluation of magnetic and relaxometric properties of MNP-DMSA and MNP-
DMSA-EPS. _______________________________________________________________ 101 
Figure 4.4. Details regarding magnetic properties of MNP-DMSA and MNP-DMSA-EPS.
 _________________________________________________________________________ 102 
Figure 4.5. Cell cytotoxicity assay results for HCT116 and ReNcell VM cells incubated with 
MNPs and EPS. ____________________________________________________________ 104 
Figure 4.6. Representation of cell cytotoxicity assay results in logarithmic form (log10 [Fe] (or 
log10 [EPS])). _______________________________________________________________ 104 
Figure 4.7. Observation and quantification of iron in cell cultures incubated with MNP-DMSA 
and MNP-DMSA-EPS. _______________________________________________________ 105 
Figure 4.8. Contribution of internalized and adsorbed nanoparticles for the cellular iron found in 
cells after labeling with MNP-DMSA or MNP-DMSA-EPS. ___________________________ 106 
Figure 4.9. Tracking the localization of MNP-DMSA-EPS within (A) HCT116 cells and (B) 
ReNcell VM cells by microscopy. _______________________________________________ 108 
Figure 4.10. Immunohistochemistry of post-labeled ReNcell VM cells at day 14 of culture. _ 109 
Figure 4.11. Efficacy of MNP-DMSA-EPS for in vitro MRI cell labeling. _________________ 111 
Figure 5.1. Schematic representation of the multilayer pH-sensitive MNPs and concept for 
achieving preferential interactions with tumoral cells. _______________________________ 121 
Figure 5.2. Multi-layer MNP assembly. __________________________________________ 127 
Figure 5.3. pH-dependent dissociation of Nav-bPEG layer from multilayer nanoparticles as a 
result of 20 h exposition to different pH buffers. ____________________________________ 129 
Figure 5.4. Effect of pH treatment on multilayer nanoparticles surface charge and size. ____ 130 
Figure 5.5. Variation of multilayer nanoparticles size distributions after being exposed to PBS at 
different pHs. ______________________________________________________________ 131 
Figure 5.6. Bright field microscopy images of preparations stained with Prussian blue for iron 
identification, obtained after exposing HCT116 cells to multilayer nanoparticles at 10 µg Fe/ml 
for 5 h. ___________________________________________________________________ 132 
Figure 5.7. Tracking nanoparticles localization after incubation of HCT116 clels for 5 h in acidic 
culture medium at 37°C and 4°C with MNP-DMSA-PLLib, MNP-DMSA-PLLib-Nav-bPEG(A) and 
MNP-DMSA-PLLib-Nav-bPEG(B) at 10 µg Fe/ml. __________________________________ 133 
XIX 
Figure 5.8. pH-dependent cell-nanoparticle interactions after 5 h of incubation with the 
nanoprobes at 10 µg Fe/ml in acidic (pH 6.5) and physiological (pH 7.4) culture medium. __ 135 
Figure 5.9. Contribution of internalized and adsorbed nanoparticles for the proportion of cellular 
iron found in cells after labeling. ________________________________________________ 136 
Figure 6.1. Summary of the average relative iron uptake per cell upon incubation with the MNPs 







Index of Tables 
 
Table 1.1. Applications of superparamagnetic iron oxide nanoparticles in the biomedical field. 6 
Table 1.2. Utilization of biopolymers extracted from natural sources in the development of MNP-
based MRI contrast agents. ____________________________________________________ 16 
 __________________________________________________________________________ 17 
Table 1.3. Utilization of biopolymers obtained by biotechnological processes in the development 
of MNP-based MRI contrast agents. _____________________________________________ 17 
Table 1.4. Utilization of synthetic polymers in the development of MNP-based MRI contrast 
agents.  ____________________________________________________________________ 22 
Table 2.1. Summary of size, zeta potential and magnetic characterization results for the 
hydrophobic (MNP-OA) and hydrophilic (MNP-CA and MNP-DMSA). ___________________ 54 
Table 3.1. Summary of size, magnetic and relaxometric properties of the produced MNP in 
comparison with a commercial MNP-based contrast agent. ___________________________ 77 
Table 3.2. Quantitative characterization of the cell-nanoparticles interactions. ____________ 80 
Table 4.1. Uptake of iron by HCT116 and ReNcell VM after incubation with MNP-DMSA and 
MNP-DMSA-EPS.___________________________________________________________ 105 
Table 4.2. Distribution of cellular iron between internalized and adsorbed fractions _______ 106 
Table 5.1. Average hydrodynamic diameter and zeta potential of multi-layer nanoparticles at 
each assembly step. _________________________________________________________ 128 
Table 5.2. Characterization of Nav-bPEG layer. Nav-bPEG conjugation proportion, Nav-bPEG 
layering conditions and quantification after exposing the multilayer MNPs to different pH 
conditions. ________________________________________________________________ 129 
Table 6.1. Summary of size, colloidal and relaxometric properties of the MNP produced in this 
thesis. ____________________________________________________________________ 144 
Table 6.2. Overall summary of the interactions between the different MNP produced in this 









bPEG Biotin-modified PEG 
CA Citric acid 
Cyst Cysteamine hydrochloride 
DAPI (4',6-diamidino-2-phenylindole) 
DLS Dynamic Light Scattering 
DMEM Dulbecco’s modified Eagle’s medium 
DMSA Meso-2,3-dimercaptosuccinic acid 
DMSO Dimethylsulfoxide 




FBS Fetal bovine serum 
FC Field cooling 
FTIR Fourier transform infrared spectroscopy 
GA Gum Arabic 
ib Iminobiotin 
IC50 Relative half-maximal inhibitory concentration 
ICP-AES Inductively coupled plasma atomic emission spectroscopy 
LbL Layer-by-Layer 
MNP Iron oxide Magnetic Nanoparticles 
MNP-CA Iron oxide magnetic nanoparticles coated with citric acid 




MNP-DMSA coated with Cyst and GA 
MNP-DMSA-EPS MNP-DMSA coated with the exopolysaccharide Fucopol 
MNP-DMSA-GA MNP-DMSA coated with gum Arabic 
MNP-DMSA-PLLib-
Nav-bPEG 
MNP-DMSA coated with iminobiotin-modified Poly-L-lysine, neutravidin 
and biotin-modified poly(ethyleneglycol) 
MNP-OA Iron oxide magnetic nanoparticles coated with oleic acid and 
oleylamine 
MR Magnetic resonance 
MRI Magnetic Resonance Imaging 
MS Saturation Magnetization 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
Nav Neutravidin 
NHS N-hydroxysuccinimide 
NMR Nuclear magnetic resonance 
PBS Phosphate buffered saline 
PdI Polydispersity index 
PEG Poly(ethyleneglycol) 
PLL Poly-L-Lysine 
PLLib Ib-modified PLL 
XXIV 
SPION Superparamagnetic Iron Oxide Nanoparticles 
TE Echo time 
TR Repetition time 
TEM Transmission Electron Microscopy 
TGA Thermogravimetric analysis 
TR Repetition time 
VSM Vibrating sample magnetometry 





Magnetic Resonance Imaging (MRI) is a noninvasive medical imaging technique with a 
wide range of applications in diagnostics which has been used in the clinic for more than 30 
years. Among the currently available clinical imaging techniques, MRI offers important 
advantages, mainly because it does not use harmful radiation and, besides being noninvasive, 
provides excellent spatial resolution (sub-millimeter, the best among X-ray CT, PET, SPECT 
and ultrasound), and anatomical information of deep tissue structures. The major challenge with 
MRI is its relatively low sensitivity (10
-3
 M to 10
-5
 M) compared to other imaging methods, but it 
can be improved with the administration of better contrast agents, which augment the visibility of 
specific body structures by enhancing the contrast of the images. Traditionally, gadolinium-
based paramagnetic compounds are used for this purpose (as T1 contrast agents) and, 
currently, these are the only products approved by health regulatory agencies being used in the 
clinic as MRI contrast agents.
1–3
 
Superparamagnetic iron oxide nanoparticles (MNP) are a different class of MRI contrast 
agents (T2 contrast agents) and potential alternatives to gadolinium-based agents. They 
possess a superior magnetic moment than gadolinium and therefore lower doses of MNP are 
required to provide adequate image contrast.
4
 In addition, iron oxides are biocompatible and 
biodegradable at the doses needed for contrast enhancement.
5
 Since iron is a naturally 
occurring metal in the human body, there are specialized metabolic pathways and clearance 
mechanisms for regulation of iron homeostasis, unlike for gadolinium. The potential for long-
term cytotoxicity of MNP is thus reduced. Some MNP-based MRI contrast agents have been 
approved for clinical use in the past, but were withdrawn from the market due to economical 
rather than safety reasons.
6,7
 Therefore, research continues dedicating large efforts to the 
development of new nanoprobes based on iron oxide nanoparticle formulations with MRI 
applications.  
Due to their nanosize, MNP possess a large and highly reactive surface area, to which 
other chemical compounds or biomolecules can be conjugated. MNPs surface functionalization 
is versatile, which facilitates particle engineering to render MNPs with additional properties 
besides the inherent MRI contrast enhancement ability. Several materials, functionalization 
strategies and nanoprobe architectures have been explored to produce MRI nanoplatforms, and 
in the last years, the enormous interest in these systems has expanded the use of MRI beyond 
disease diagnosis. Currently, several applications of MRI are enabled due to the possibility of 
conjugating MNP with targeting agents, therapeutic agents or even reporter molecules for other 
XXVI 
imaging modalities. Detecting cancer and metastases, monitoring cancer treatment response, 
detecting inflammation or tracking the fate of transplanted stem cells are some of the current 
applications of MNP-based MRI nanoprobes under research.
1,8
 
Natural and synthetic polymers are popular classes of materials used as the basis for 
MNP coating and engineering, with polysaccharides (e.g. dextran) and poly(ethyleneglycol) 
(PEG) among the most employed materials. While polymeric coatings aim primarily at stabilizing 
the MNP in biological fluids, they can also modulate the particles magnetic properties and be 
modified with biologically active molecules or responsive chemical groups towards the design of 
multifunctional nanoprobes, namely tissue or cell-targeted and stimuli-responsive nanoprobes.
9
 
Continuous advances in polysaccharide production by biotechnological means are 
leading to greener and more sustainable processes which isolate new biocompatible and 
biodegradable materials. However, the exploitation of new polysaccharides for the design of 
MNP-based MRI nanoprobes is limited and the commercially available polymers are still 
preferred.
10–12
 On the other hand, a number of polymer-coated nanoprobes have been 
developed based on engineered synthetic polymers bearing environment-sensitive bonds or 
chemical groups that make them change properties as a response to changes in environmental 
characteristics.
13
 Yet, some biological interactions found in Nature could be used instead to 
provide the same type of responsiveness. 
 
The project presented in this thesis aimed to engineer new T2 MRI contrast agents 
based on formulations containing monodisperse iron oxide MNP coated with natural and 
synthetic polymers. The novelty of the work relies on: 
 The development of a new strategy to couple natural polymers onto 
monodisperse superparamagnetic iron oxide nanoparticles; 
 The demonstration of the feasibility of a new exopolysaccharide, produced 
through a biotechnological process, as a coating material in a MNP-based MRI 
nanoprobe; 
 The development of an affinity triggered magnetic nanoprobe for selective 
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Chapter 1 
Hybrid magnetic-polymeric iron oxide nanoprobes for 
MRI: from preparation to application 
In the last decades, the advent of nanotechnology has driven the study and application 
of nanoscale (~ 1 - 200 nm) versions of magnetic materials. The enormous interest in 
nanomaterials is understood as on the nanoscale magnetic materials display properties different 
from the respective bulk materials. Among the various nanoparticles under research, iron oxide 
magnetic nanoparticles (MNP), mostly the iron oxides magnetite (Fe3O4) and maghemite (γ-
Fe2O3), have attracted particular interest due to their superparamagnetism, biocompatibility and 
biodegradability. MNP are thus ideal platforms to work on a cellular and molecular level in 
several biomedical applications. Favored by their unique magnetic properties, iron oxide 
nanoparticles have been widely used in the development of engineered nanoplatforms for 
imaging through magnetic resonance imaging (MRI). Polymers are among the most explored 
materials to coat MNPs towards versatile MRI nanoprobes This chapter introduces the 
properties and applications of MNP and reviews the recent applications of MRI nanoprobes with 
polymeric coatings.  
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1.1. Physical properties of MNP 
At the macroscale, bulk magnetite (Fe3O4) and maghemite (γ-Fe2O3) are ferrimagnetic, 
meaning that they exhibit permanent magnetic moment at room temperature even in the 
absence of an external magnetic field. Ferrimagnetic behavior arises from the combination of 





, which possess unpaired electrons. As a consequence, the sum of the magnetic moments 
generated by the unpaired electrons creates a net magnetic moment for each atom. Due to 
strong magnetic coupling interactions and to the organization of the atoms in the metal 
crystalline structure, net magnetic moments of adjacent atoms align with each other (either in 
parallel or antiparallel direction), thus creating a permanent magnetization within the solid, even 
in the absence of an external magnetic field. Due to energetic requirements, a ferrimagnetic 
solid is organized in regions called magnetic domains, where there is a mutual alignment of all 
atomic magnetic moments in the same direction. Between domains, magnetic moments are 
oriented in random directions. In a macroscopic piece of iron oxide there are a large number of 
domains, and all may have different magnetization orientations (Figure 1.1 A).  
 
Figure 1.1. Schematic representation of the effect of applying an external magnetic field on magnetite at 
different size scales. (A) bulk magnetite; (B) single domain magnetite nanoparticles; (C) 
superparamagnetic iron oxide nanoparticles (SPIONs); (D) iron ions. Adapted from Stephen et al.
1
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When the volume of the solid iron oxides is reduced until a critical diameter, as in the 
case of MNP, each particle will consist of a single magnetic domain with ferromagnetic behavior 
(Figure 1.1 B). The critical diameter corresponds to the size at which domain boundaries are no 
longer energetically favorable and varies for differing materials.
2
 In the case of spherical 
magnetite (Fe3O4) the critical diameter is between 70 – 100 nm.
2,3
 If the size of spherical 
magnetite nanoparticles is further reduced to below approximately 20 nm,
2
 the nanoparticles 
become superparamagnetic (Figure 1.1 C): in the absence of an external magnetic field, the 
thermal energy available at room temperature is sufficient to make the magnetization of the 
particle as a whole to change, despite the individual atomic moments maintaining their ordered 
state relative to each other (Figure 1.2 A). Therefore, in a system containing superparamagnetic 
nanoparticles, due to the random fluctuations of the magnetic moment of each particle, the net 
magnetization of the system will be zero. However, when a magnetic field is applied, there will 
be a net statistical alignment of particles’ magnetic moments. This behavior is similar to what 
happens with paramagnetic materials except that the magnetic moment is not that of a single 
atom but of the MNP containing various atoms (can be up to 10
4
 times larger than for a 
paramagnetic material);
1,3
 this being the reason for the designation of superparamagnetism. 
(Figure 1.1)  
At a high enough magnetic field all the MNP magnetic moments in the system will be 
aligned and a maximum magnetization will be reached (the saturation magnetization), which 
can be very close to the bulk Ms. The evolution of the magnetization with the intensity of the 
externally applied magnetic field in superparamagnetic nanoparticles is described by a non-
hysteretic sigmoidal M-H curve (Figure 1.2 B) proportional to the Langevin function, which takes 
into account a Boltzman distribution of the energy levels corresponding to all of the possible 
orientations of the particle magnetization moment:
4
 
 𝑚(𝐵0) = 𝑚(∞)𝐿(𝑥) (1.1) 
where m(B0) is the magnetization of the suspension at a field B0, m() is the magnetization at 
saturation and L(x) is the Langevin function: 






where MS(T) is the saturation magnetization of the bulk at temperature T, V is the volume of the 
MNP core, B0 is the applied magnetic field and kB is the Boltzman constant. 
In order to flip the magnetic moment of a nanoparticle there is an energy barrier that 
needs to be overcome, the magnetic anisotropy energy (Ea). Ea is proportional to the product of 
the magnetic anisotropy constant (K) and the volume of the magnet (V). When the nanoparticle 
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volume is small enough at a given temperature, Ea is equal or inferior to the thermal energy 
available (kBT, where kB is the Boltzman constant and T is the temperature) and therefore, the 
magnetic moment is able to fluctuate just by thermal effect. This relation shows that 
superparamagnetism itself depends on the size of the MNP. In general, the smaller the MNP, 
the lower the transition temperature from ferrimagnetic to superparamagnetic behavior.
2,3
 
Another effect of size reduction is the enhancement of the relative contribution of surface effects 
to the saturation magnetization of the particles, due to surface disorder.
3
 Besides size, shape 
also affects the magnetic properties of superparamagnetic MNP since it is known to strongly 
affect the magnetic anisotropy constant K and consequently the anisotropy energy barrier. 
 
Figure 1.2. Superparamagnetism features. (A) Schematic representation of a superparamagnetic 
nanoparticle in the absence of an external magnetic field. (B) Magnetization curve of a superparamagnetic 
fluid. 
1.2. MNP synthesis methods 
In general, biological applications require magnetic particle cores with a number of well-
defined and reproducible structural, physio-chemical and toxicity properties. While some 
intrinsic properties, such as MNP core size, shape, surface chemistry and core magnetic 
properties can be tuned through the choice of appropriate synthesis procedures, the application 
of appropriate surface coatings tailors other features like colloidal stability, functionality and 
biocompatibility. 
There are several methods available to synthesize iron oxide magnetic nanoparticles, 
ranging between physical, chemical and biological procedures.
2,4
 Chemical synthesis methods 
are the most popular and can be divided in hydrolytic and non-hydrolytic methods. While 
hydrolytic methods produce MNP with surface chemistries that make them dispersible in 
aqueous media, non-hydrolytic methods involve the use of organic solvents and the resultant 
MNP are hydrophobic. Both categories of syntheses have advantages and drawbacks 
depending on the intended application of the resultant nanoparticles. The most commonly 
employed hydrolytic method is the co-precipitation method, also known as Massart method, 
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firstly described in 1981.
5
 It consists in the co-precipitation of a stoichiometric mixture (2:1) of 
ferrous (Fe
2+
) and ferric ions (Fe
3+
) salts (usually chlorides) in alkaline conditions. Although the 
co-precipitation method produces large amounts of MNP and permits in situ functionalization of 
the particles using additives (e.g. polymers), it usually yields a mixture of magnetite and 
maghemite, due to uncontrolled oxidation, which minimizes the magnetic properties of the 
ferrofluid. Tight control over synthesis parameters such as pH, ionic strength, concentration of 
the growth solution and nature of the base is needed in order to control MNP core size and 
shape, ensure the formation of mostly magnetite, and make the method reproducible.
3,6
 Other 
hydrolytic methods include hydrothermal routes,
7
 developed in order to improve the magnetic 
properties of co-precipitation MNP, or microemulsion techniques, which intend to overcome the 
drawback of limited control over MNP size distribution in co-precipitation by confining the space 
for MNP growth inside emulsions or reverse micelles.
8
 
However, none of these methods offers such control over crystallinity, core size and 
monodispersity as the thermal decomposition method, which is the most popular non-hydrolytic 
MNP synthesis method. Organic precursors of iron like Fe(Cup)3, Fe(CO)5 and Fe(acac)3 or iron 
oleate complexes decomposed at elevated temperatures using organic solvents (including 
polyols) and surfactants result in highly monodisperse and crystalline nanoparticles of magnetite 
coated with hydrophobic ligands.
9–13
 Therefore a phase transfer step is needed in order to 
solubilize the MNP for biological applications. The success of this synthetic strategy relies in the 
separate occurrence of crystal nucleation and crystal growth. Control over particle size and 
shape is provided by adjusting the reaction times and the temperature but also the 




Details about these and other synthesis methods are addressed extensively in the 
literature
2,4
 and reveal the efforts made in the last years towards the development of methods to 
produce biocompatible MNP with controllable physiochemical characteristics. 
1.3. Biomedical applications of MNP 
Iron oxide MNP are appealing platforms for biological applications as they are 
biocompatible and biodegradable and possess sizes in the range of macromolecules. Their 
superparamagnetic character is advantageous since, after introduction of MNP in living 
systems, it enables MNP magnetization to be activated only in the presence of an external 
magnetic field while at zero field the dispersions of MNP behave like colloids (ferrofluids), 
avoiding magnetic aggregation. Superparamagnetism can be exploited in a range of biomedical 
applications, summarized in Table 1.1.  
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Through the application of a magnetic field gradient in the proximity of the ferrofluid, a 
magnetic force is generated and MNP can be manipulated to exert control over their 
biodistribution in order to deliver therapeutic agents to specific organs or tissues;
14–16
 to 




Another interesting property is the capability of MNP to generate heat when subjected 
to an alternating magnetic field (AMF). Under an appropriate AMF, the magnetic moments of the 
MNP reorient themselves and then release energy in the form of heat during the 




Table 1.1. Applications of superparamagnetic iron oxide nanoparticles in the biomedical field. 
Application Function Ref. 
Magnetic focusing Cell/Drug delivery 
14–16
 
Contrast Agents for MRI 
Disease diagnosis / treatment monitoring 
22–29
 















Magnetic-Mechano actuation Stem cell differentiation; tissue engineering 
17–19
 




The most remarkable and explored property of MNP ferrofluids is, however, their ability 
to generate small local magnetic fields that shorten the relaxation times T1 and T2 of the 
surrounding water protons. The shorter relaxation times lead to a change in the nuclear 
magnetic resonance signal intensity in that region and MRI contrast is improved due to the 
presence of MNP acting as contrast agents.
22–29
 The local magnetic field generated by MNP can 
be a source for imaging itself if it can to be detected by external devices. This is the concept of 
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1.4. MNP as MRI contrast agents 
Magnetic Resonance Imaging (MRI) was first reported back in 1973,
44
 with the first 
contrast agent for in vivo MRI (based in manganese) being demonstrated in 1978.
45
 In the same 
year, through nuclear magnetic resonance (NMR) studies, Ohgushi et al.
46
 discovered the ability 
of iron oxide nanoparticles (crosslinked with dextran) to shorten the T2 relaxation time of water 
and showed that they were more efficient (by one or more orders of magnitude) than the 
paramagnetic ions or free radical contrast agents in relaxing neighboring nuclei.
46
 During the 
1980’s iron oxide MNP were then demonstrated to produce contrast in in vivo MRI.
47,48,49
 From 
then on, iron oxides have been extensively used as MRI contrast agents and, in 1995, the first 
iron oxide MNP-based MRI contrast agent (Ferumoxides, from Guerbet, Advanced Magnetics) 
was approved by the American Food and Drug Administration (FDA) for human use in liver 
imaging.
50
 While many other iron oxide MNP commercial agents have appeared in the last 
years, some have been withdrawn from market. By now, the only approved iron oxide MNP for 
pharmaceutical use is Ferumoxytol,
51
 for the treatment of anemia, although this MNP also has 
properties as MRI contrast agent. In the meanwhile numerous research studies continue being 
reported in the literature seeking for improved MNP towards MRI applications. 
MRI makes use of a strong permanent magnetic field, B0, which causes the magnetic 
moments of water protons in a tissue to align in its direction, precessing around B0 (at the 
Larmor frequency) and producing an equilibrium magnetization along the z-axis, Mz (with 
amplitude M0). By applying a radiofrequency (RF) magnetic field at the same frequency of the 
hydrogen protons precession and perpendicular to B0 (in the xy plane), the protons resonate 
(absorb energy form the RF pulse) and their magnetic moments start precessing coherently, 
such that the net magnetic moment is rotated to the transverse plate (Mxy) and precesses at the 
Larmor frequency. In practice, the RF transverse field is applied in a pulsed sequence. From the 
instant that the RF pulse is turned off, the magnetic moments of the protons relax back to 
equilibrium and this response is measured via induced currents in pick-up coils in the MRI 
scanner.
1,52,53
 The time required for the magnetic moments to relax to the equilibrium state 
(relaxation time), and therefore, MRI contrast, is tissue dependent. 
MRI contrast is due to differences in proton density, spin-lattice relaxation time (T1, 
longitudinal relaxation time) and spin-spin relaxation time (T2, transversal relaxation time) of 
protons.  
T1 is the time constant of the exponential recovery process of longitudinal magnetization 
M0 along the z-axis after a RF pulse. T1 reflects an exchange of energy, as heat, from the 
system to its surrounding, which is related to the dipolar coupling of the proton moments to their 
surrounding; therefore isolated protons show negligible rates of T1 relaxation.
1,3
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T2 is time constant of the exponential decay of transverse magnetization Mxy after a RF 
pulse, which corresponds to the amount of time for precessing magnetic moments to become 
randomly aligned (dephased) in the xy-plane after a RF pulse, eventually resulting in a net 
magnetic moment of zero in the xy plane. Dephasing of the magnetization of the precessing 




Since the natural variations of T1 and T2 in tissues are small, sometimes exogenous 
materials are used to enhance the contrast between tissues – contrast agents. Most contrast 
agents influence both T1 and T2 but usually their effect is more pronounced in either T1 or T2. 
T1 contrast agents increase the MRI signal intensity, providing positive contrast 
enhancement in T1-weighted MR images (lighter image regions), while T2 contrast agents 
decrease signal intensity resulting in negative contrast in T2-weighted images (darker image 
regions). The current clinical contrast agents are based on paramagnetic chelates of lanthanide 
metals such as gadolinium, which is a T1 agent.
51
 The presence of paramagnetic ions near 
water protons shortens their T1 relaxation time through coordination with water molecules 
providing increased contrast. The short blood circulation times, poor detection sensitivity and 
toxicity concerns of gadolinium chelates had led to the continued development of 
superparamagnetic iron oxide-based T2 MRI contrast agents.
54
 Due to their larger magnetic 
moments, MNP-based MRI contrast agents produce higher relaxation rates at lower doses than 




 The low toxicity of iron, which is normally processed through 
various metabolic pathways, makes these agents very attractive.
55
 
Iron oxide MNP are mainly T2 contrast agents, enhancing contrast by inducing a 
pronounced decrease in T2 along with a less pronounced decrease in T1. When MNP are 
present in the tissues and are subjected to an external magnetic field, their large magnetic 
moments align with it, consequently creating gradients of magnetic fields in the tissues, i.e., 
local inhomogeneities in the net magnetic field, through which the water protons diffuse. The 
dipolar coupling between magnetic moments of water protons and the magnetic moments of 
MNP causes dephasing of the protons magnetic moments, thereby shortening their T2 
relaxation time. Due to localized differences in the uptake of the MNP by tissues, there will be 
regions of different MRI signal intensity, with less intensity (darkening) in the vicinity of MNP. 
The addition of a MNP contrast agent causes an increase in the longitudinal (1/T1) and 
transversal (1/T2) relaxation rates of the water protons. The relaxation rate in the presence of 
MNP depends linearly on the concentration of the MNP and is given by 
 (1 𝑇𝑖⁄ )𝑜𝑏𝑠 = (1 𝑇𝑖⁄ )𝑑𝑖𝑎 + 𝑟𝑖[MNP]         𝑖 = 1,2 (1.4) 
where (1/Ti)obs is the observed relaxation rate in the presence of the MNP contrast agent, 




) is the relaxivity. 
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Relaxivity is defined as the slope of the above linear relation and is a measure of the efficacy of 
the MNP as MRI contrast agent since it defines the ability of a fixed concentration of MNP to 
increase the relaxation rate of the protons.  
Although MNP have been used mainly as T2 contrast agents, it is possible to model 
their characteristics so that they have an effect on T1. For example, reduction of MNP core size 
to diameters of less than 10 nm, are capable of producing positive contrast in T1-weighted 
images. However, under these conditions their T2 effects are reduced.
56,57
 Nonetheless, MNP-
based T1-contrast agents could be an alternative to gadolinium chelates to produce contrast 
enhancement in tissue regions where MR signal is naturally low. 
1.4.1. Structure of MNP-based nanoprobes for MRI 
The quality of a MNP MRI contrast agent in vivo depends on the physiochemical 
properties of magnetic core but also on the MNP ability to be stealth and escape from the 
reticuloendothelial system so that they can circulate in blood for sufficient time to reach the 
target tissues and be taken up by target cells. The stability of the MNP in biological fluids (like 
blood) is therefore of uttermost importance.  
Bare iron oxide nanoparticles do not present colloidal stability at physiological pH due to 
the proximity of their isoelectric point (pH 6.8),
58
 tending to agglomerate and flocculate rapidly. 
Besides having neutral pH, biological fluids are complex and contain various macromolecules 
that readily interact with iron oxide surface and can cause colloidal instability of the 
nanoparticles. Also, the high surface–to-volume ratio of nanoparticles yields high surface 
energies which make the surface prone to oxidation, with consequences on the magnetic and 
relaxometric properties.
1
 To overcome these limitations, MNP-based MRI contrast agents are 
usually composed of magnetic core(s) involved in biocompatible and hydrophilic coating 
materials (Figure 1.3) that prevent MNP agglomeration through electrostatic and/or steric 
interparticle repulsions and enhance biocompatibility of the system in biological media.  
MNP coatings also play significant roles in tuning MNP physiochemical properties like 
hydrodynamic size, magnetic core aggregation, surface charge and surface chemistry and, in 
particular, the magnetic
59,60
 and relaxometric properties
61–65
 of the nanoprobes. Importantly, free 
functional groups on the MNP wrapping molecules can be used to bind other compounds to the 
MNPs, such as reporter molecules for different imaging modalities,
32
 therapeutic agents (such 




 and targeting moieties 
specific for certain cell types
23
 (Figure 1.3 and Table 1.1).  
Taking advantage of the myriad of available biocompatible hydrophilic materials, 
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Figure 1.3. Schematic representation of MNP surface modification with biocompatible coating and 
functional moieties. 
1.4.2. MNP coating materials towards stabilization and functionalization of MRI 
nanoprobes 
Depending on the chemistry of the ligand molecules present at the surface of particles 
after synthesis and on the purpose intended for the final particles, different coating materials 
and methods can be chosen. For example, it may be necessary to add new coating layers, to 
exchange the ligand, crosslink it or modify it with functional groups to provide particles’ 
stabilization and/or functionality. The most common for MNP include small organic molecules 
(e.g. citric acid, phosphonic acid), inorganic materials (e.g. silica) and natural/synthetic polymers 
natural and synthetic (e.g. dextran, poly(ethylene glycol)). 
1.4.2.1. Small organic molecules 
Small organic molecules bearing functionalities with affinity for iron oxide Fe-OH surface 
groups adsorb onto the MNPs by coordination processes, similar to covalent bonds with the Fe 
ions at the surface of the iron oxide crystals.
70
 These functionalities can be carboxylic acid, 
phosphonic acid, amines or cathecol groups.
3,4,6
 The chemical structure of the coating 
molecules usually contains multiple functional groups (of the same type or not), so that (at least) 
one of them coordinates with the nanoparticles surface while the other(s) are left exposed to the 
solvent, being responsible by stabilizing the particles at physiological pH, for example by 
electrostatic interactions. This coating method was employed to stabilize MNPs with citric acid, 
either in situ (during the synthesis), such as the case of the commercial VSOP C148 iron oxide 
MRI contrast agent,
71–73
 or post-synthesis, as it was employed recently to produce MNPs for 
stem cell labeling and tracking by MRI.
74
 Other coating molecules such as 2,3-




 or methylene diphosphonic acid,
76
 were also used to provide 
increased stability to MNP synthesized in aqueous medium. Another example of the utilization 
of organic small molecules is the phase transfer of MNP synthesized in organic solvents. The 
carboxylic acid group functionality (in oleic acid) is first employed for MNP synthesis and 
stabilization in hydrophobic medium. Then, to render the resulting particles hydrophilic, the oleic 
moieties are replaced by hydrophilic small molecules with higher affinity towards iron oxide due 





 are commonly employed for this purpose, leaving free 
carboxylic acid (and thiol groups, in the case of DMSA) at the surface of the particles to provide 
stability in aqueous media. The free functional groups are also useful as reactive groups for 




 or more complex 
polymeric constructs to engineer hybrid efficient MRI nanoprobes.
82
 Finally, these small organic 
molecules with affinity for iron oxide surfaces can be conjugated first with other molecules (e.g. 
PEG) to serve as anchoring moieties onto MNP. This strategy was employed to PEGylate 





One of the most commonly used inorganic coating materials is silica. Organosilane 
compounds attach onto MNP surfaces through stable covalent Fe-O-Si bonds between the 
surface Fe-OH and the Si-OCH3 moieties, similar to the coordination mechanism of 
carboxylates or phosphates.
6
 The silica shell introduces negative charges on the particles 
surface, thereby stabilizing them through electrostatic interactions. MNP coating with 
organofunctional silane shells is interesting because of these properties, but also because 
silica-based coatings improve particles biocompatibility,
84
 protect the iron oxide cores from 
chemical degradation,
84–86
 and are optically transparent, which allows to conjugate molecules 
with optical properties in the silica matrix and build multimodal nanoprobes.
87,88
 Different routes 
can be followed to obtain MNPs with silica shells. Among them are the in situ formation of silica 
around iron oxide seeds through hydrolysis and condensation of a sol-gel precursor such as 
tetraethyl orthosilicate (TEOS)
89,90
 (known as Stöber process), the microemulsion method,
84
 the 
water-in-oil microemulsion (or inverse microemulsion),
85,91





 The functionalization of MNP using silane chemistry is versatile, as 







) and pre-functionalized organosilanes are also available 
commercially, ready to couple with biofunctional molecules. In addition, engineering of 
alternative synthesis and coating assembly methods allows producing alternative 
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nanoparticulate structures, such as mesopourous silica-coated MNP
96,97
 useful to combine 
imaging and drug delivery; and ultrasmall core-shell MNP with T1-weighted MRI contrast agent 
properties.
56
 Also, exploitation of the photoacoustic properties of core-shell silica-coated MNP 




Along with silica-based coatings, hydrophilic polymeric coatings are preferred over 
small organic molecules for MNP functionalization. The main reasons for this preference are 
their colloidal and chemical stabilization properties and higher versatility for chemical 
modifications. Polymers provide colloidal stability through steric interactions established 
between the polymeric chains or through a combination of steric and electrostatic interactions, 
when charged moieties are present in the polymer. Importantly, polymeric shells also offer 
protection to iron oxide magnetic cores at physiological pH, which contributes for the chemical 
stability of the constructs. In biological terms, the polymer coating mediates the interface 
between the iron oxide surface and the biological medium. Therefore it dictates the way the 
cells “see” the nanoprobes (overall size, surface chemistry) and contributes to biodistribution 
and pharmacokinetics of MNP upon administration. Polymers provide MNPs with surface 
functionality, making possible to tailor their biological and physio-chemical properties, namely to 
design hybrid nanoprobes with ability to provide multimodal imaging, specific targeting, delivery 
and stimulated release of therapeutic agents. The MRI properties of the hybrid nanoparticles are 
intrinsically dependent on the interactions between the magnetic dipole created by the iron 
oxide core and the water protons in the vicinity. In particular, the magnitude of MRI relaxivity 
depends on the number of water molecules disturbed by the magnetic field generated by the 
MNPs. The presence of a hydrophilic polymer is of uttermost importance as it mediates the 
access of water molecules to the magnetic core. Manipulation of parameters such as the 
hydrophilicity
65
 and the thickness
99
 of the coating and the aggregation degree of magnetic cores 
surrounded by the polymer
100
 can affect the MRI properties of a hybrid MNP. 
Due to the high reactivity of MNP surface, there is a range of strategies for the coating 
of MNP with polymers, which can be carried out either in situ during the MNP synthesis, or post-
synthesis. Basically, polymers can be directly conjugated to the “naked” MNP through chemical 
groups in their native structure which are able to coordinate with iron oxide surface or indirectly, 
through interaction with small ligands previously coupled onto the MNP. Electrostatic 
interactions, hydrophobic interactions and hydrogen bonding are involved in the adsorption 
mechanism of polymers onto MNP but the establishment of covalent bonds is also an important 
alternative because it is more permanent. Most in situ coating strategies rely on coordination of 
the polymer onto iron oxide surface while post-synthesis coating strategies generally involve (a) 
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using a linker ligand between the MNP surface and the polymer or (b) replacement of the 
ligands initially at the MNP surface by a polymer bearing iron oxide anchoring ligands. The later 
strategy can be employed when the MNP as-synthesized are hydrophobic and solubilization into 
aqueous medium is performed by ligand-exchange reaction.
65
 
1.4.3. Types of polymers used to coat MNP-based MRI nanoprobes 
From the large number of polymeric materials described in the literature to produce 
hybrid MRI nanoprobes, two main groups can be identified: polymers with biological origin 
(biopolymers, in particular polysaccharides) and synthetic polymers. Table 1.2, Table 1.3 and 
Table 1.4 present examples of the utilization of polysaccharides and synthetic polymers to 
produce MNP-based MRI nanoprobes. 
Polysaccharides are one of the three types of biopolymers found in Nature 
(polynucleotides, polypeptides and polysaccharides). The abundance of polysaccharides in 
Nature allied with the advances towards low cost and greener extraction/production processes 
have increased the interest in exploitation of polysaccharide materials for a range of 
applications, including nanotechnology. These biopolymers present favorable characteristics 
and biological properties that make them versatile materials to employ as coating materials for 
MNP to be used in biomedical applications. Polysaccharides are water soluble, biocompatible 
and biodegradable, which is crucial for clinical application in humans because health regulatory 
agencies demand that, besides being biocompatible, materials shall be biodegradable upon 
administration.
50
 In addition to these advantages, polysaccharides generally have biological 
activity, as most of them are present in structural tissues of living organisms, and can be 
involved in molecular recognition mechanisms.
101–104
 Also, they naturally present a large 
number of functional groups in their chains, which can serve as anchoring points onto MNP and 
as reactive groups for modification. 
However, polysaccharides can have high degradation rates and sometimes need to be 
combined with other polymers or crosslinked to reduce degradation rates and enhance stability 
in biological environment.
105
 That is the case of CLIOs (cross-linked iron oxide particles), for 
which carboxymethyl groups were added to the dextran coating and cross-linked to 
epichlorohydrin to increase stability of the MNP.
106
 Optimal performance of polysaccharides is a 
challenge because synthesis of natural polymers is carried out in living organisms and thus is 
not strictly controlled. The alteration in structural properties of the polymers during production is 
difficult as well as the strict reproducibility of the polymer structure from batch to batch. 
Synthetic polymers, on the other hand, can be tailored to meet specific properties (e.g. 
degradation rates, responsiveness to certain stimuli
67,107
). This class of materials is attractive to 
engineer biocompatible materials to stabilize and functionalize MNP because of its controllable 
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synthesis and modifiable properties, which potentially facilitates reproducibility and production 
scale-up. Indeed, polymer synthesis methodologies are well studied and are controllable, 
making possible to systematically add chemical modifications and functionalities on the polymer 
during its synthesis or to combine different polymers to obtain new materials (e.g. block 
copolymers) with tailor-made properties.
108–113
 Synthetic methods such as living radical 
polymerization (atom-transfer radical-polymerization (ATRP) and reversible addition–
fragmentation chain-transfer polymerization (RAFT)),
110
 ring opening polymerization (ROP)
111
 
and polymerization induced self-assembled approach (PISA)
114
 can be used to produce a 
virtually infinite number of tailor-made polymers with specific properties, including well defined 
molecular weights, polydispersity, and engineered modes of attachment to the MNPs
115
 that 
may facilitate the control of iron oxide cores aggregation to form single or multi-core MNPs. With 
these strategies, innovative hybrid multifunctional nanoprobes are emerging but there is still lack 
of in vitro and in vivo studies compared to polysaccharide-coated MNPs. 
To get the best of both worlds, there is also the possibility to employ mixed coatings that 
combine natural and synthetic polymers, for example by covalent coupling
116




1.4.3.1. MNP-polysaccharide hybrid MRI nanoprobes 
Polysaccharides consist of repeating units of mono or disaccharides linked by glycosidic 
bonds to form linear or branched chain structures. Due to the high variability of building block 
composition, type of branching, molecular weight of the polymer and eventual combination with 
proteins (peptidoglycans) or lipids (glycolypids), polysaccharides have diverse biological and 
physico-chemical properties that are interesting from a biomedical perspective.  
The polysaccharides most commonly used to coat MNP for use as MRI contrast agents 
include dextran and modified versions of dextran (e.g. carboxymethyl dextran, diethylamino 
ethyl dextran), hyaluronan, chitosan, pullulan, heparin, gum arabic, starch, fucoidan, cellulose, 
alginate and mannan. They can be obtained either by extraction from natural sources (e.g., 
plants, algae, animal tissues, shells) or by microbial production via biotechnological processes 
(e.g., bacterial exopolysaccharydes), as summarized in Table 1.2 and Table 1.3, where some 
examples of polysaccharide-coated MNP for MRI are presented. Polysaccharides usually 
contain multiple hydroxyl groups and part of them are neutral (dextran, pullulan, starch, 
cellulose and mannan), but in in some cases, also contain charged groups such as amine (in 
chitosan), carboxylate (in alginate, hyaluronan and gum arabic) and sulfate (in heparin and 
fucoidan).
117
 Therefore they can establish strong bonding interactions with the surface of iron 
oxide MNP. Co-precipitation method is the most commonly used for preparation of 
polysaccharide-coated MNP. The coating may be performed in situ, during the synthesis of the 
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magnetic iron oxide nanoparticles, or after the particles are synthesized, through addition of the 
polymer and conjugation to the MNP by adsorption or chemical bonding.  
Dextran is undoubtedly the most popular natural polymer used as MNP coating for MRI 
application. It is synthesized from sucrose by several lactic acid bacteria and is a branched 
polysaccharide that can be found with varying molecular weights and branching degrees. It is 
composed of glucose molecules with a linear backbone of repeating units of an α-linked D-
glucopyranosyl.
117,118
 Dextran has anti-coagulant properties and is FDA-approved for clinical 
application as blood-thinning agent.
115
 The iron oxide MNP-based MRI T2 contrast agent 
Ferumoxides (Endorem/Feridex), with a hydrodynamic diameter of 50 – 150 nm, possesses a 
dextran coating. In addition, charged versions of dextran were employed to produce other 
commercial iron oxide MNP based MRI T2 contrast agents with smaller hydrodynamic 
diameters. Carboxydextran was used to produce Resovist (20 nm, blood pool agent) and 
Ferocarbotran (60 nm, liver imaging) while Ferumoxytol (30 nm, blood pool agent and 
macrophage imaging) has a carboxylmethyl-dextran coating.
4
 Transfection agents can be 
administered in combination with the MNP to increase cellular uptake. For example, a 
nanomaterial consisting of a mixture of ferumoxytol, heparin sulfate and protamine sulfate is 
presently undergoing a clinical trial for neural stem cell-mediated enzyme/prodrug therapy for 
glioma.
119,120
 The literature reports other approaches for cell-targeted MRI labeling using 
dextran-coated MNPs where targeting moieties are bond to the dextran coating to enhance 
specific cellular MNP uptake. In the recent work of Jafari et al.
121
, SPIONs coated with dextran 
(DSPIONs) were conjugated with bombesin (BBN) to produce a targeted contrast agent for 
detection of breast cancer using MRI. Through binding studies, DSPIONs-BBN were shown to 
bind to T47D breast cancer cells overexpressing gastrin-releasing peptide (GRP) receptors. In 
vivo MRI T2
*
-weighted of mice bearing breast tumors after administration of the particles showed 
increased contrast. Dai et al.
28
 functionalized glucose-dextran-MNP with folic acid by covalent 
conjugation onto the polysaccharide coating to produce a MRI nanoprobe to detect 
inflammation sites of arthritis. In addition to specific detection of inflammation in mice, treatment 
efficacy was able to be monitored because there was a lack of contrast enhancement in the 
injured site after treatment compared to the images of non-treated mice. Optimization of core 
and particle size and magnetic properties of these MNPs was carried out by adding glucose to 
the synthesis reactor besides dextran. Glucose served as a chelating agent that controlled the 
iron oxide core size and could reduce the thickness of dextran coating. A different study 
122
 
focused on the utilization of dextran-coated MNP for mesenchymal stem cell labeling and 
tracking by tailoring the surface charge of the particles to promote cellular uptake. In vitro MRI of 
cells labeled with the produced nanoparticles confirmed the increased cellular uptake through 







































































Biopolymer or MNP modification / 
functionalization 


















targeting and in vivo imaging 
of brain tumor cells  
124
 
Post synthesis covalent 
conjugation 
- 











coated MNP  
Fucoidan amination with 
diaminopropane 
In vivo imaging of activated 
platelets for detection of 











Carboxymethylation of chitosan; 
rhodamine isothiocyanate (RITC); 
folic acid 
Cancer-specific targeting, 
detection and imaging 






MNPs mixed with Poly-L-Lysine 
solution prior to administration. 
In vivo tracking of human 












Fluorescein isothiocyanate (FITC) 
In vivo imaging of human 








(PheoA) covalently conjugated to 
heparin 
Simultaneous in vitro 
photodynamic therapy and 
dual-mode fluorescence/MRI 
imaging of cancer cells 
66
 








Red fluorescent dye DY-555–N-
hydroxysuccinimide ester covalently 
attached to the MNP’s starch 
coating followed by  poly-D-lysine 
adsorption 





Co-precipitation In situ coating  
Human hepatocellular carcinoma 
cell line homing peptide (A54) 
labeled with 5-carboxyl-fluorescein  
Biomolecular-targeted 
diagnostics and therapeutics 










































































Biopolymer or MNP modification / 
functionalization 
Intended purpose Ref. 
Cellulose Green plants 
Thermal 
decomposition of 
iron oleate in 
organic solvent 
Encapsulation of several 
oleic acid stabilized 
Fe3O4 nanocrystals 





Long-term, noninvasive cell 









Carboxymethyl cellulose (CMC); 
folic acid and 5-FU anticancer drug 
conjugated to CMC; fluorescein 
isothyocyanate (FITC) adsorbed 
onto the final CMC-MNP. 
Folate receptor targeted drug 






Table 1.3. Utilization of biopolymers obtained by biotechnological processes in the development of MNP-based MRI contrast agents. (continued)         





Biopolymer or MNP modification 
/ functionalization 
Intended purpose Ref. 
Dextran 
Lactic acid 
bacteria, such as 
L. mesenteroides, 
L. brevis and       
S. mutants 
Co-precipitation 
In situ coating  
Carboxylmethylation of dextran on 
MNP; bombesin peptide covalently 
conjugated onto carboxymethyl 
dextran-coated MNP 
Targeting and imaging of 




in presence of 
glucose 
Folic acid covalently bond to glu-
dex-MNP 
Diagnosis and monitoring of 
treatment response of 





dextran was employed to tune 
MNPs charge; FITC 









































































Table 1.3. Utilization of biopolymers obtained by biotechnological processes in the development of MNP-based MRI contrast agents. (continued)         





Biopolymer or MNP modification 
/ functionalization 
Intended purpose Ref. 
Co-precipitation 
In situ coating; 
alginate was cross-




oxidized to iron oxide 
- 
Tracking of implanted alginate 
microcapsules with 
encapsulated rat myoblast 






Co-precipitation In situ coating  
Ethylenediamine and succinic 
anhydride. 
In vitro magnetic labeling of 
bone marrow-derived rat 





coating by adsorption 
Cross-linked pullulan chains, with 
glutaraldehyde 




















onto aminated MNP 
Dextran coating was cross-linked 
and aminated with NH4OH; 
Doxorubicin bound to hyaluronan-
coated MNP through hydrazone 
linkage 
Targeted drug delivery and 
bimodal imaging (MRI and 
fluorescence) of ovarian 
cancer cells expressing CD44 















Acylation (oleil-modification) of 
hyaluronan 
Selective in-vitro cytotoxicity 
towards cancer cells and 





synthesis in the 





PEI stabilized-MNP previously 
labeled with FITC. 
Imaging of surgically induced 





in of iron 
precursor in 
organic solvent  
Post-synthesis 
electrostatic 
interactions with the 
ligand a t the surface 
of the MNP and 
coordination with 
MNP surface 
Hyaluronan conjugated with 
dopamine; MNP solubilized with 
cetyltrimethylammonium bromide 
(CTAB) 




































































Table 1.3. Utilization of biopolymers obtained by biotechnological processes in the development of MNP-based MRI contrast agents. (continued)         





Biopolymer or MNP modification 
/ functionalization 








In vitro and in vivo mannose-






Carboxylation of mannan 
Imaging of lymph node 
through MNP targeting to 
immune cells.  
144,145
 
In situ coating - 
Imaging of rabbit 




can also be extracted from brown algae 
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1.4.3.2. MNP-based MRI nanoprobes assembled with synthetic polymers 
Hydrophilic, biodegradable, nontoxic synthetic polymers have been widely explored and 
well developed by biomaterials and nanotechnology research fields in the last decades. Some 
popular synthetic polymers that have been described to produce MRI contrast agents include 
poly(ethylene glycol) (PEG), poly(lactic acid) (PLA) and poly(lactic-co-glycolic acid) (PLGA), 
which present the advantage of being FDA approved materials for clinical use, but polyacrylic 
acid (PAA), polyethyleneimine (PEI), poly-L-lysine (PLL), poly(styrene sulfonate) (PSS), 
polyvinyl alcohol (PVA) and polyvinylpyrrolidone (PVP) are also frequently reported as part of 
MNP-polymer assemblies, as summarized in Table 1.4. 
Methods for iron oxide MNP assembly with synthetic polymers are generically divided in 
two groups: (a) coating, when the polymer chains wrap around the magnetic core(s) to form a 
network of MNP and polymer; and (b) encapsulation, when many magnetic cores are within a 
polymer matrix in a core-shell fashion. Coating MNP cores with polymeric materials is usually 
performed during the synthesis of hydrophilic particles, or post-synthesis by adsorption onto the 
naked hydrophilic MNP or in ligand-exchange process when the initial MNP are hydrophobic. 
Encapsulation is a popular strategy to assemble hydrophobic MNP by making use of 
amphiphilic tailor-made synthetic block co-polymers. Two preparation methods can be 
employed: single emulsion method (oil-in-water emulsion – w/o) or double emulsion method 
(water-in-oil-in-water emulsion - w/o/w),
50
 depending on the desired particle structure and 
intended purpose. Polymeric micelles with encapsulated MNP have been studied widely as 
nanoplatforms for drug delivery and imaging applications. The micelles are intended to prolong 
the drug blood circulation time and prevent direct contact between the drug and healthy tissues 
or organs. At the same time, aggregation of MNP inside the micelle core results in high T2 
relaxivity MRI contrast agents.
50,147
 
Poly(ethylene glycol) (PEG) is a synthetic polymer recognized for its biocompatibility 
and “stealth” properties, forming anti-fouling surfaces that prevent adsorption of proteins and 
recognition of the pegylated materials by the macrophage – monocytic system, thereby 
increasing materials blood circulation time. Several pharmaceuticals currently in the market 
have FDA-approved PEG coatings in order to enhance their blood circulation times.
148
 Due to 
these properties, PEG has been also widely used as coating agent for magnetic nanoparticles. 
Inclusively there was a commercial MRI contrast agent (which commercialization is currently 
abandoned) – Clariscan – that had a pegylated starch coating to avoid recognition by the 
monocytic system.
4
 Various strategies for coating were developed to attach PEG to MNPs, 
either by in situ
110
 or post-synthesis methods.
80,109,116
 They rely on the use of PEG polymers 
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functionalized with iron oxide grafting groups or tailor made PEG-based co-polymers where one 
of the blocks can have multiple grafting groups.  
Other synthetic polymers are charged due to the presence of many amine or carboxylic 
acid groups on their structure. Positively charged polymers are widely used to deliver material 
into cells, namely genetic material, because they can establish electrostatic interactions with the 
negatively charged cell membrane that facilitate the internalization. Poly-L-lysine (PLL) and 
polyetileneimine (PEI) are positively charged at physiological pH and are commonly used as 
non-viral transfection agents for gene delivery. Some authors report the utilization of PLL as 
transfection agent also for MNP
129,149,150
 but is common to use it as MNPs’ coatings for 
stabilization and enhancing cellular uptake in view of MRI cell labeling.
151–154
 PEI-coated MNPs 
are commonly employed for DNA and RNA delivery by magnetofection
42,43
 but also for gene 
delivery and simultaneous cell tracking.
155–157
 However, utilization of MNP coated with PLL or 
PEI in vivo is controversial because these polymers (specially PEI) interact strongly with 
proteins and cell membranes due to their high density of positive charges and have cytotoxic 
effects.
7,158,159




The charged nature of polyelectrolytes can also be exploited to assemble them into 
multilayers for MNP surface modification via layer-by-layer (LbL) technique. LbL consists in the 
alternate adsorption of polyanions and polycations around the MNP core(s), allowing the 
engineering of surface attributes like charge, particle size and shell chemistry. It is also a means 
of engrafting biologically active macromolecules for further functionalization. For example, 
poly(sodium styrene sulfonate) (PSS) was reported as part of LbL magnetic nanosystems for 










































































Table 1.4. Utilization of synthetic polymers in the development of MNP-based MRI contrast agents. (continued) 





Polymer or MNP 
modification / 
functionalization 










coordination of PAA 
carboxylic groups 
onto the MNP surface 
Block copolymer with PEO 
(PEO-b-PAA); controlled 
clustering of MNP-PEO-b-
PAA through reaction with 
PEO diacrylate oligomer; 
loaded with cationic drug 
Maximization of r2 for 
sensitive MRI and 





In situ coating - 
Preparation of hydrophilic 
ultra-small Fe3O4 MNP 
as contrast agents for T1 











Co-precipitation In situ coating 
Diblock copolymers of 
poly(oligoethylene glycol 
acrylate) with incorporated 
phosphonic acid, carboxylic 
acid or glycerol groups 
Tailoring of crystallinity 
and colloidal stability of 
MNP in aqueous medium 





decomposition of iron 




Commercial PEG derivatives 
with OH, SH, COOH and 
NH2 groups; hyaluronan 
covalently conjugated to 
MNP-PEG-NH2 
In vitro and in vivo 
mesenchymal stem cell-










MNP conjugated with 
antibodies against mouse 
VEGF receptor-1 
Optimization of MRI 
contrast enhancement 
properties of MNP, 
stabilization in aqueous 
medium and cell-targeted 




decomposition of iron 






Aminated PEG derivatives; 
ligand-exchange between 
OA and DMSA for MNP 
phase transfer  
Stabilization and increase 
blood circulation time of 









ligands with imidazole, 
Tumor pH-targeted 


































































Table 1.4. Utilization of synthetic polymers in the development of MNP-based MRI contrast agents. (continued) 





Polymer or MNP 
modification / 
functionalization 
Intended purpose Ref. 
oleate in the 




cathecol and phenyl groups, 
and conjugated with a 
photosensitizer (chlorin 6) 








Fe(acac)3 in organic 









siRNA conjugation onto PEI-
coated MNP through 
electrostatic interactions 
Gene delivery and 




Hydrothermal  In situ coating 
PEI-MNP functionalized with 
PEG, acetic anhydride or 
succinic anhydride 
One pot synthesis of PEI-











PEG was grafted to PEI to 
form PEG-g-PEI; siRNA was 
coupled to PEG-g-PEI 
coated MNP through 
electrostatic interactions 
Simultaneous siRNA 
delivery and MRI cell 
tracking in vitro and in 








Fe(acac)3 in organic 








PLA copolymers mixture 
;cRGD and DOX were 
loaded in the micelles  
Tumor-targeted 
controlled drug delivery 





Fe(acac)3 in organic 
solvent 
Post-synthesis; single 
emulsion method and 
solvent evaporation 
Co-polymer of PLA and 
mPEG (PLA-mPEG-OH); 
magnetic micelles coated 
with PEI and chitosan; 
Chitosan-PEI-magnetic 
micelle conjugation with DNA 
by electrostatic interactions 
Theranostic system for 






Fe(acac)3 in organic 
solvent 
Single emulsion 
method and solvent 
evaporation; 
nanoprecipitation 
Co-polymer of PLA and 
TPGS 
In vivo MRI imaging of 






































































Table 1.4. Utilization of synthetic polymers in the development of MNP-based MRI contrast agents. (continued) 





Polymer or MNP 
modification / 
functionalization 










decomposition of iron 
oleate in organic 
solvent 
Encapsulation of 
multiple oleic acid 
stabilized 
nanocrystals within 
















PGLA functionalized with 
antibodies for the dendritic 
cell receptor DC-SIGN; MNP 
functionalized with a FITC-
labelled peptide antigen  
Targeted delivery of 
nanovaccine and 
multimodal  imaging of 
nanocarrier-dendritic 





commercial MNP (10 
nm, Ocean nanotech, 






enhancement of the 
effects of high-intensity 
focused ultrasound 




(EMG 304, Ferrotec, 




Microspheres loaded with 
hydrophobic drug sorafenib 
in the PLGA oil phase 
MRI-monitored local 
delivery of sorafenib to 
limit proangiogenic 






decomposition of  







particles for MR imaging 










Magnetite MNP oxidized to 
maghemite and coated with 
citrate  
Stem cell labeling and 
tracking by MRI post-






































































Table 1.4. Utilization of synthetic polymers in the development of MNP-based MRI contrast agents. (continued) 





Polymer or MNP 
modification / 
functionalization 




through adsorption  oxidized to maghemite of MNP labeling on the 
biological properties of 





Magnetite MNP oxidized to 
maghemite and coated with 
citrate 
In vivo stem cell tracking 
post transplantation to 







Magnetite MNP were 
oxidized to maghemite 
In vitro labeling of human 
umbilical cord 











interactions (Layer by 
Layer) 
- 










Native PVA, Amine-PVA; 
carboxyl-PVA and thiol-PVA 
In vitro study of 
interactions of the MNP 
with brain-derived 
endothelial cells, 










In vivo MRI contrast 









In situ coating - 
Investigation of  the effect 
of nanoparticle size on 
MRI of normal liver and 




hydrolysis of chelate 
metal alkoxide 
complexes in liquid 
polyol 
In situ coating 
PLL was administered 
together with the MNP-PVP 
Labeling of mice β-cells 
for in vivo visualization of 
islet grafts by MRI in a 
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1.5. Concluding Remarks 
Colloidal iron oxide MNPs possess unique properties that make them useful for 
biomedical applications. They have received particular attention as T2 contrast agents for MRI 
due to their superparamagnetism, biocompatibility and biodegradability. Polymeric coatings, 
popularized by dextran and PEG, had initially the main goal of stabilizing the nanoprobes in 
biological fluids and enhancing their blood circulation times for use as diagnostic devices. As a 
result of the excellent chemical reactivity of MNP surface, availability of innumerous natural and 
synthetic polymers and functionalization chemistries, research in the last decades has 
extensively explored the combination of these materials to engineer more complex 
nanosystems: hybrid polymeric/MNP MRI nanoprobes with additional properties such as 
targeted drug and gene delivery, stimuli-responsiveness and/or multimodality imaging 
capabilities. Biopolymers, in particular polysaccharides, are appealing materials due to their 
biocompatibility, biodegradability and biological function but also from the point of view of 
availability, as nowadays production by means of biotechnological processes using genetically 
modified microorganisms is more and more common, less expensive and greener. However 
they lack the synthetic control and the possibility of introducing chemical modifications during 
synthesis, characteristic of synthetic polymers. These offer practically infinite possibilities of 
design making use of the available chemistry synthesis methods to conjugate different 
monomers, oligomers and adding chemical and biological functionalities. Given the potentialities 
of polymers, their combination with MNP is promising. There is a large number of studies 
published regarding this combination but general the studies involving nanosystems with 
polysaccharide coatings have been more extensive with the characterization of biological 
interactions of MNP both in vitro and in vivo than the ones employing complex synthetic polymer 
assemblies, which focus more on the physiochemical characterization of the nanoprobes 
themselves.  
Some challenges remain, however, in the full development of such hybrid 
polymeric/MNP MRI nanoprobes. While problems with strict control of particle size distribution, 
stability of colloidal ferrofluids and respective magnetic properties are being researched, there is 
still lack of knowledge regarding large scale production, long-term stability in storage and 
production cost. Importantly, studies regarding the clinical effectiveness of the developed 
nanosystems of are still scarce and in vivo long term biodistribution and toxicity of MNP 
unknown. Besides nanoprobe development, research is needed in order to understand the fate 
of MNP and their coatings after administration into the human body in order to enable the 
transference from the bench to bedside and effective use in medicine. 
Overall, the hybrid polymeric/MNP nanoprobes currently available in the form of 
research platforms and presented in this review show the potential of superparamagnetic iron 
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oxide nanoparticles in molecular imaging and therapeutics, enlightening their importance in 
nanomedicine as a form of levering the future of Medicine. 
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Chapter 2 
Effects of phase transfer ligands on monodisperse 
iron oxide magnetic nanoparticles  
Oleic acid coated iron oxide nanoparticles synthesized by thermal decomposition in 
organic medium are highly monodisperse but at the same time are unsuitable for biological 
applications. Ligand-exchange reactions are useful to make their surface hydrophilic. However, 
these could alter some structural and magnetic properties of the modified particles. Here we 
present a comprehensive study and comparison of the effects of employing either citric acid 
(CA) or meso-2,3-dimercaptosuccinic acid (DMSA) ligand-exchange protocols for phase transfer 
of monodisperse hydrophobic iron oxide nanoparticles produced by thermal decomposition of 
Fe(acac)3 in benzyl ether. We show the excellent hydrodynamic size distribution and colloidal 
stability of the hydrophilic particles obtained by the two protocols and confirm that there is a 
certain degree of oxidation caused by the ligand-exchange. CA revealed to be more aggressive 
towards the iron oxide surface than DMSA and greatly reduced the saturation magnetization 
values and initial susceptibility of the resulting particles compared to the native ones. Besides 
being milder and more straightforward to perform, the DMSA ligand exchange protocol 
produces more chemically versatile MNP for further functionalization possibilities. This versatility 
is shown through the covalent linkage of gum Arabic onto MNP-DMSA using carboxyl and thiol 
based chemical routes and yielding particles with comparable properties. 
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2.1. Introduction 
Superparamagnetic iron oxide nanoparticles (SPION) have been gaining increased 
attention in the last decades due to their applications in environmental sciences, memory 
storage and, mainly, in biomedical and pharmaceutical sciences.
1,2
 Superparamagnetism, large 
surface to volume ratio and biocompatibility are unique physical properties of iron oxide at the 
nanoscale that make it one of the most studied nanomaterials nowadays. There are several 
forms of iron oxide but the more explored ones are magnetite (Fe3O4) and maghemite (-Fe2O3) 
due to their improved magnetic properties and biocompatibility.
3
 The different crystal structure of 
these two iron oxides influences the net spontaneous magnetization of the particles: at 300 K, 
92-98 emu/g for magnetite, and 76-84 emu/g for maghemite.
4–6  
There are several methods to synthesize SPION, ranging between physical, chemical 
and biological methods. The most common are chemical methods and among those, co-
precipitation is widely used to obtain larger amounts of hydrophilic nanoparticles. However, 
SPION produced by this method have a broad size distribution and tend to easily aggregate and 
become colloidally unstable.
7
 This behavior is not desirable for most applications, as it is 
associated with wide size distributions, increased average hydrodynamic diameters and 
decreased surface to volume ratio. For example, regarding biomedical applications, the 
increase in size of the aggregates reduces the area available for grafting of bioactive molecules 
and compromises the biocompatibility and biodistribution of the administered particles.
2
 
Similarly, in the case of environmental remediation applications (e.g.  removal of heavy metals 
from water), the formation of large agglomerates reduces the adsorbing area and particle 
transport becomes hampered, limiting the system efficiency.
8
  
Up to now, the synthesis method that allows better control of sizes and produces the 
narrowest size distributions is the thermal decomposition of organometallic precursors of iron in 
organic solvents. The magnetic properties of SPION obtained by this route are enhanced in 
comparison with other methods due to their more crystalline structure. However, there is a 
limitation: the precursors and solvents are not biocompatible, and the resulting ferrofluids are 
only stable in hydrophobic media. Therefore, an intermediate step of phase transfer to aqueous 
media is required before any biological application.
3,7
 There are two approaches for the phase 
transfer: adding an amphiphilic molecule that binds through hydrophobic interactions to the 
original surfactant layer and forms a micellar structure that encapsulates the magnetic cores,
9
 or 
replacing the native hydrophobic surfactants by hydrophilic molecules that have higher affinity 
for iron.
10,11
 This last process is called ligand-exchange and has been widely used
10,12–17
 
because it is a simple and effective method. The used ligands consist of an anchoring chemical 
group that binds to the surface of the SPION (e.g., carboxylic acid, phosphonic acid, dopamine) 
and a hydrophilic region that becomes exposed to the surrounding water molecules, affording 
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physiological stability and conjugation capability.
18
 The anchoring group of the ligand is 
important as it is responsible for the stability of the new coating and also because it can 
influence the magnetic properties of the hydrophilic MNP.
19
 Due to their small size and presence 





 are two frequently used molecules in ligand-
exchange procedures. Good colloidal stability is generally obtained in both cases but the overall 
effects of the process on structural and magnetic properties of the resulting particles, to our 
knowledge, have never been directly compared. Some studies claim no alteration of the 
saturation magnetization value (MS) compared to the precursor hydrophobic particles
23
 and 
others show consequences on the magnetization characteristics
11,24
 but this comparison is often 
neglected.
10,13,16,22,25
 Therefore, the benefits of using one ligand instead of the other are not 
clear. In this work, we present a comprehensive comparison between two ligand-exchange 
protocols that employ either citric acid or DMSA, discussing the effects of these two ligands on 
the colloidal and magnetic properties of SPION intended for biological and biomedical 
applications. We analyze hydrophobic SPION synthesized by the thermal decomposition 
method and the hydrophilic SPION resulting from the ligand exchange regarding their core size, 
hydrodynamic diameter and colloidal stability along with surface characterization by FTIR and 
evaluation of the magnetic properties by VSM. DMSA-modified MNP were finally coated with 
gum Arabic to show their chemical versatility, taking advantage of the carboxyl and thiol groups 
available at the particles surface. 
2.2. Experimental Section 
2.2.1. Materials 
All chemicals were purchased from Sigma-Aldrich and used without ulterior purification. 
2.2.2. Synthesis of hydrophobic magnetic nanoparticles (MNP-OA) 
Hydrophobic magnetic nanoparticles were synthesized following Sun’s method
9
 with 
slight modifications. Briefly, iron tri(acetylacetonate) (2 mmol), 1,2-tetradecanediol (10 mmol), 
oleic acid (6 mmol), oleylamine (6 mmol), and benzyl ether (10 ml) were mixed and stirred 
magnetically under a constant flow of nitrogen. The mixture was heated to 200 °C at a rate of 
3ºC/min and kept at 200°C for 2 h. Then, under a blanket of nitrogen, the mixture was heated to 
reflux (300°C) at a rate of 4.5ºC/min and kept in reflux for 1 h. The resultant black-colored 
mixture was cooled to room temperature by removing the heat source. Ethanol (about 20 ml) 
was added to the mixture, to precipitate the particles after which they were separated via 
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centrifugation (9000 rcf, 15 min). The supernatant was discarded and the pellet was re-
dispersed in hexane (10 ml) in the presence of oleic acid (50 µl) and oleylamine (50 µl) with the 
aid of vortexing and sonication. Centrifugation (7000 rcf, 10 min) was then applied to remove 
any undispersed material. The pellet was discarded and the supernatant was precipitated with 
ethanol (about 20 ml), centrifuged (9000 rcf, 10 min) to remove the solvent and redispersed into 
hexane. 
2.2.3. Phase transfer by ligand exchange with citric acid (MNP-CA) 
Ligand-exchange using citric acid was performed following the protocol described by 
Lattuada et al.
10
 MNP-OA (120 mg) were previously dried, and dispersed in a 50/50 mixture of 
1,2-dichlorobenzene and N,N′-dimethylformamide (15 ml of total volume), to which 0.1 g of citric 
acid was added. The mixture was incubated in a rotating agitator at 100ºC for approximately 18 
h. MNP-CA were precipitated by the addition of diethyl ether (about 40 ml) and recovered by 
magnetic separation. The particles were redispersed in acetone and reprecipitated by means of 
a permanent magnet three times to remove all traces of free citric acid. After the final magnetic 
precipitation, traces of acetone were removed with a nitrogen flow and the particles were re-
dispersed in milliQ water and filtered through a 0.1 µm pore membrane. 
2.2.4. Phase transfer by ligand exchange with meso-2,3-dimercaptosuccinic acid (MNP-
DMSA) 
A standard ligand-exchange protocol
15
 was used to replace oleic moieties by DMSA. 
MNP-OA (50 mg Fe3O4) were precipitated from the hexane suspension by adding ethanol and 
applying a permanent magnet several times. The supernatant was discarded. After the final 
precipitation, the MNP-OA were re-dispersed in toluene (20 ml), added to a solution of DMSA 
(90 mg) in DMSO (5 ml) and mixed with sonication. The mixture was incubated at room 
temperature for 48 h in a rotating agitator. After the reaction, the translucent solvent containing 
the oleic acid and oleylamine was discarded and the black particles (MNP-DMSA) attached to 
the walls of the flasks were re-dispersed in ethanol with sonication and vortexing. This mixture 
was centrifuged and re-dispersed in ethanol several times to clean the particles. Finally, the 
MNP-DMSA were re-dispersed in milliQ water, basified to pH 10 with sodium hydroxide and 
dialyzed against milliQ water for about 48 h. Filtration through a 0.1 µm pore membrane and 
adjustment of the pH to 7 was carried out as a final step. 
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2.2.5. Preparation of MNP-DMSA-Cyst-GA 
MNP-DMSA were first aminated with cysteamine hydrochloride (Cyst) and then 
covalently bond to carboxylic groups of GA. For that, MNP-DMSA thiol groups were activated 
with 2,2’-dithiodipyridine (DTDP) as follows. MNP-DMSA (15 mg of Fe3O4) were precipitated 
from the stock solution by centrifugation and re-dispersed in a previously filtered saturated 
solution of DTDP (15 ml) in phosphate buffer (10 mM, pH 8). The activation reaction continued 
overnight in a rotating agitator at room temperature. The suspension was then centrifuged (9000 
rcf, 20 min) and the unreacted DTDP in the supernatant removed. The precipitated particles 
were redispersed in a solution of cysteamine (15 ml, 120 mM) in phosphate buffer (10 mM, pH 
8) with sonication and vortex and incubated for approximately 5 h in a rotating agitator at room 
temperature. To remove unreacted cysteamine, dialysis was performed (48 h). Finally, the 
MNP-DMSA-Cyst were precipitated by centrifugation (9000 rcf, 10 min) and redispersed in 1 ml 
of phosphate buffer (10 mM, pH 8). Covalent coupling of GA to MNP-DMSA-Cyst was 
performed using N-hydroxysuccinimide (NHS) / N-(3-dimethylaminopropyl)-N’-ethyl-
carbodiimide hydrochloride (EDC) chemistry. In order to activate the carboxyl groups of GA, 
NHS and EDC were added to an aqueous solution of GA (45 ml, 10 mg/ml) at concentrations of 
100 mM and 20 mM, respectively. The pH was adjusted to 4.5 and the mixture was left to 
incubate for 1.5 h under magnetic stirring. After this, MNP-DMSA-Cyst were added dropwise to 
the activated GA with sonication using an ultra-sound bath and the pH was adjusted to 7.5 to 
promote the covalent coupling. This mixture was incubated overnight in rotating agitator at room 
temperature and finally MNP-DMSA-Cyst-GA were washed by several centrifugations (9000 rcf, 
10 min) and re-dispersed in milliQ water with sonication and vortexing. 
2.2.6. Preparation of MNP-DMSA-GA 
MNP-DMSA were coated with GA by covalent bond formation between GA amine 
groups with MNP-DMSA carboxylic groups. NHS and EDC were added to 8 ml of an aqueous 
solution of MNP-DMSA (~1 mg/ml Fe3O4, pH 4.5) at the concentration of 100 mM and 20 mM 
respectively to activate DMSA carboxylic acid groups. The pH was carefully monitored to be 
around 4.5 and the activation reaction continued for 1.5 h in a rotating agitator at room 
temperature. The activated MNP-DMSA were, then, added dropwise to a solution of GA (36 ml, 
10 mg/ml) in phosphate buffer (5 mM, pH 8), with sonication. The pH of the mixture was 
adjusted to 8 and the reaction continued in a rotating agitator overnight at room temperature. 
MNP-DMSA-GA were recovered by applying several centrifugations (9000 rcf, 20 min) and 
replacing the supernatant with milliQ water. 
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2.2.7. Characterization of magnetic nanoparticles 
Particle size and shape were characterized by Transmission Electron Microscopy 
(TEM) using a 100-kV JEOL JEM1010 microscope equipped with a Gatan Orius 200 SC digital 
camera. A drop of dilute particle suspension in hexane (MNP-OA) or in water (MNP-CA, MNP-
DMSA, MNP-DMSA-Cyst-GA and MNP-DMSA-GA) was placed on a carbon-coated copper grid 
and dried at 50ºC before observation. The average particle core diameter was calculated by 
measuring about 200 particles for each sample, using ImageJ Software (National Institutes of 
Health, USA). Hydrodynamic size and zeta potential of the particles were characterized by 
Dynamic Light Scattering (DLS) using a Nanosizer ZS (Malvern) and diluted water dispersions 
of particles (about 0.5 mg/ml) at pH 7. The mean value of the volume-weighted size distribution 
was used as hydrodynamic diameter (dh). The zeta potential (-potential) variation with pH was 
measured in a 0.01 M KNO3 solution, whereas HNO3 or KOH solutions were used for pH 
adjustment. Inductively coupled plasma atomic emission spectroscopy (ICP-AES) (Horiba 
Jobin-Yvon, Ultima) was used to determine the iron and sulfur content of the MNP samples. 
Fourier transform infrared (FTIR) spectra were acquired using a Nicolet 20 SXC FTIR to confirm 
the iron oxide phase and the nature of the coating. IR spectra of the MNP were recorded 
between 4000 cm
-1
 and 250 cm
-1
. Samples were prepared by diluting 2% iron oxide powder in 
KBr (w/w) and pressing it into a pellet.  
The magnetic properties of the samples were evaluated using a vibrating sample 
magnetometer (VSM) (MagLab VSM, Oxford Instruments). The samples were analyzed 
dispersed in hexane (MNP-OA) or water (all the other samples), in frozen state. Magnetization 
loops were measured at 200 K (for MNP-OA) and 250 K (for the other samples) and corrected 
by subtracting the diamagnetic contribution of the dispersants and the sample holder. The 
saturation magnetization at the maximum field was normalized to the gram of iron oxide (Fe3O4 
for MNP-OA and Fe2O3 for the remaining particles, as supported by FTIR analysis). The 
apparent particle magnetic diameter (dMag) was obtained using the magnetization loops (M(H)) 
and Chantrell’s equation (eq. 2.1), derived for non-interacting magnetic nanoparticles and a log-
normal distribution of particle sizes:
26
 









where mS and MS are the saturation magnetization of the nanoparticles and the bulk phase of 
magnetite (or maghemite), respectively, χini is the initial susceptibility, calculated at low field, in 
the region where the magnetization varies linearly with the applied field, and 1/H0 is obtained by 
extrapolating M to zero at high fields, in the region where the relationship between M and 1/H is 
a straight line. 
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Temperature dependent zero-field cooling (ZFC) and field cooling (FC) magnetization 
measurements were performed by cooling the samples to 5 K under a zero or a 100 Oe 
magnetic field, respectively. Then, the magnetization was measured while the samples were 
heated (3 K/min) to 250 K under a 100 Oe field.  
The efficiency of MNP-DMSA-Cyst-GA and MNP-DMSA-GA as MRI contrast agents 
was evaluated in a 7 T NMR Brucker Avance III Spectrometer at 25ºC. Samples were prepared 
with milliQ water at different iron concentrations (0, 0.1, 0.2, 0.4, 0.5, 0.6, 0.8 and 1 mM), placed 
in standard 5 mm glass tubes and sonicated for 30 min before the measurements of longitudinal 
and transverse relaxation rates (R1=1/T1 and R2=1/T2) T1 was measured using an inversion 
recovery sequence with TR ranging from 3 to 10 s. T2 was measured using a Call-Purcell-
Meiboom-Gill sequence with TE of 1 ms and the number of echoes needed to cover a time 
interval of about 10 times T2. R1 and R2 were plotted against iron concentration and a linear 
fitting of the data was performed. The slopes of lines are the longitudinal (r1) and transverse (r2) 
relaxivities.  
2.3. Results and Discussion 
2.3.1. Size and colloidal stability 
Monodisperse magnetic nanoparticles with cores of 7.9  1.1 nm were obtained through 
the thermal decomposition of iron acetylacetonate in benzyl ether at 300ºC in the presence of 
oleylamine and oleic acid. These particles (MNP-OA) are hydrophobic and therefore, very stable 
in non-polar organic media, such as hexane. However, for biomedical applications, dispersion in 
aqueous media is of uttermost importance. Ligand-exchange method was successful to stabilize 
the prepared MNP in water, using either citric acid (CA) or meso-2,3-dimercaptosuccinic acid 
(DMSA). TEM images (Figure 2.1 A-C) show that in both cases MNPs keep their shape and 
individuality after ligand exchange reaction. No evident aggregation is observed although 
distribution in the TEM grid changes with the solvent, from non-polar to polar, showing an 
increase in assembling disorder. Core diameters of 7.6  1.1 nm and 7.1  1.4 nm were 
obtained for MNP-CA, and MNP-DMSA, respectively, showing that the change of ligand at the 
surface causes a slight decrease on the average size of the nanoparticle cores (4% for MNP-CA 
and 10% for MNP-DMSA). This decrease may be explained by the release of ferrous ions from 
the iron oxide surface to solution which leads to partial nanoparticle dissolution during the ligand 
exchange reaction. Particle dissolution is a result of the chelating effect of CA and DMSA 
towards iron oxide and was reported previously in the literature.
21,25,27
 Nevertheless, the 
diameters remain inside the range of sizes of the native MNP-OA. In terms of effective size, the 
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exchange of ligand at the surface of MNP-OA (dh = 10.5  0.8 nm) increases the hydrodynamic 
diameter of the particles, being the increase larger for MNP-CA (dh = 18.5  4.2) than for MNP-
DMSA (dh = 14.9  3.4 nm) (Figure 2.1 D). In general, the reproducibility of the protocols is 
similar, since the variability of the resultant dh around the average is comparable (26% for MNP-
CA and 22% for MNP-DMSA). Polydispersity is also identical for both protocols (pdI = 0.27  
0.08 for MNP-CA and pdI = 0.31  0.06 for MNP-DMSA) and their values fall inside the error bar 
of each other.  
  
Figure 2.1. Morphology, size and zeta potential of the hydrophobic and hydrophilic nanoparticles. 
Representative TEM images and core size distribution for (A) MNP-OA, (B) MNP-CA and (C) MNP-DMSA 
(full line represents the log-normal fitting). Inter-batch variability of (D) hydrodynamic diameter (bars) and 
polydispersity index (dots) and (E) zeta potential. (n = 8 batches, for figures D and E) 
Both citric acid and DMSA are hydrophilic small molecules with high affinity for iron 
oxide surfaces. The presence of multiple carboxyl groups in these molecules (three in citric acid 
and two in DMSA) makes them very reactive towards the MNP surface due to the strong 
interactions that the carboxyl groups are known to form with the iron groups at the MNP 
surface.
10,28
 This property allows the replacement of the oleic hydrophobic moieties on MNP-OA 
through ligand-exchange reaction. Carboxyl (and thiol) groups not involved in the adsorption 
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colloidal stability in aqueous phase.
24
 Therefore, after the ligand-exchange reaction, the 
average zeta potential of the particles is negative, with a value of -30 mV and around 20% 
variability when measured in water milliQ, at pH between 6 and 7 (Figure 2.1 E). This 
observation supports the presence of negatively charged groups at the surface of MNP-CA and 
MNP-DMSA (free carboxylic acid and thiol groups). As a visible consequence, both kinds of 
particles are very stable in water dispersion for months. They form a translucent colloid, for 
which is difficult to magnetically isolate the particles. In fact, the colloid moves as a whole when 
in presence of a permanent magnet. Noteworthy, when the variation of zeta potential with pH is 
measured under a 0.01 M ionic strength (Figure 2.2 A), MNP-DMSA proved to be more stable 
than MNP-CA. In fact MNP-CA zeta potential value decreased to around -20 mV, while for 
MNP-DMSA this value remained close to -30 mV in the pH range from 3 to 10, probably due to 
the net negative charge of undissociated thiols groups. Further stabilization of the ligand shells 
is attained through intermolecular disulfide cross-linkages between the ligands under ambient 
conditions.
20,21
 This characteristic may be important for maintenance of the stability over a large 
range of pH. 
2.3.2. Surface Chemistry by FTIR 
To get further insight on MNP surface chemistry, samples were characterized by FTIR 
spectroscopy. Figure 2.2 B shows the spectra of free citric acid and DMSA together with the 
spectra of the prepared MNP, confirming the interchange of the MNP capping molecules. Before 
the ligand-exchange (MNP-OA), the IR spectrum presents a strong absorption band around 
3000 cm
-1
 (C-H stretching modes) due to oleic acid and oleylamine chains.
24
 It is also visible a 
strong and broad peak around 3400 cm
-1
 due to –OH and –NH2 vibrations.
10
 After the ligand-
exchange, these bands (in particular the C-H band) become much weaker and new well defined 




, typical from asymmetric and symmetric stretching of 
carbonyl groups, respectively, appear in both MNP-CA and MNP-DMSA. In other words, the 
sharp carbonyl absorption bands present around 1700 cm
-1





 in citric acid shifted to lower frequencies because the ligands are bound to the 
particles and their carboxyl group is dissociated and coordinated with the iron oxide surface. 
Given the large splitting between the COO
-
 bands, the carboxylate group appears to be bound 
to iron through a monodentate interaction.
29
 The IR bands characteristic of thiol (2250 – 2600 
cm
-1
) or disulfide groups (500-540 cm
-1
) are not evident in the MNP-DMSA FTIR spectrum. 
However, by ICP it was possible to identify sulfur and quantify the S/Fe ratio in the samples of 
MNP-DMSA and confirm the presence of 0.2  0.05 mg (DMSA) / mg (Fe)  in MNP-DMSA.  
The bands in the region of 400 cm
-1
 and 600 cm
-1
, that correspond to the vibrations of 
Fe-O bonds in the spinel structure of magnetite,
24
 present sharper peaks in the spectra of the 
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hydrophilic particles than in the spectra of MNP-OA. The appearance of doublets and shoulders 
is attributed to the higher number of modes of vibration of Fe-O bonds associated to a higher 
degree of oxidation of the iron oxide in MNP-CA and MNP-DMSA as compared to MNP-OA, i.e., 
presence of maghemite besides magnetite. The presence of a doublet in the 600 cm
-1
 region for 
MNP-CA is in accordance with the observed reddish color of the MNP-CA aqueous suspensions 
and washing supernatants, indicative of oxidation. This finding was also reported by other 
groups
10,16
 and attributed to the strong reactivity of citric acid towards iron oxide, due to its three 
carboxyl groups, and to the high temperature (100ºC) at which the ligand exchange with citric 
acid is performed. These two factors promote the removal of iron ions from the surface of the 
particles when the native ligands are replaced by the citrate. The oxidation reported by FTIR is 
in accordance with the core size decrease observed for MNP-CA and MNP-DMSA.  
 
Figure 2.2. Surface and magnetic properties of the hydrophobic and hydrophilic nanoparticles. (A) 
variation of zeta potential with pH; (B) FTIR spectra; (C) Magnetization loops at RT (250 K for MNP-CA 
and MNP-DMSA and 200 K for MNP-OA); (D) ZFC/FC curves (dashed line: ZFC; solid line: FC); a: MNP-
OA, b: MNP-DMSA, c: MNP-CA, d: CA, e: DMSA. 
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2.3.3. Magnetic properties 
Figure 2.2 C and Figure 2.2 D show that the prepared nanoparticles are 
superparamagnetic at room temperature (RT). The magnetization curves, in Figure 2.2 C, are 
described by the Langevin function and do not present hysteresis for the three samples, as it is 
characteristic of superparamagnetic nanoparticles;
2,7
 only a negligible value (less than 25 Oe) is 
observable, that is attributed to the remanent field of the VSM coils. 
Besides this, the blocking temperature (TB), which coincides with the maximum of the 
ZFC curves (Figure 2.2 D) and represents the threshold between ferromagnetic and 
superparamagnetic regime for particles presenting a monodisperse size distribution,
30
 is far 
below RT for both hydrophobic and hydrophilic MNP (TB = 29 K for MNP-OA and MNP-CA; TB = 
65 K for MNP-DMSA). Therefore, at RT, the particles are already in the superparamagnetic 
regime, as corroborated by the magnetization curves. 
The narrow width of the ZFC curve indicates that the “magnetic volume” distribution of 
MNP-OA and MNP-CA is narrow,
31
 in accordance to what is seen from TEM images (Figure 2.1 
A and Figure 2.1 B). The rapidly increasing FC curve for temperatures below TB in MNP-OA and 
MNP-CA is typical of a sample constituted by non-magnetically interacting particles, which, in 
the case of MNP-OA may be due to the oleic surfactant layer, that keeps particles sufficiently 
apart and prevents magnetic interactions between them.
31,32
 In the case of MNP-CA, the 
particles present a larger hydrodynamic diameter associated to the formation of aggregates but 
citric acid seems to reduce interactions between particles within the aggregates. In contrast, the 
ZFC curve of MNP-DMSA presents a slightly wider peak anticipating a wider distribution of 
particle sizes, which is corroborated by the core size distributions obtained from TEM pictures. 
Also, the flat FC curve below TB for MNP-DMSA, indicates the existence of magnetic dipole 
inter-particle interactions within the aggregates.
33
 A possible justification may be the 
establishment of inter-particle disulfide bonds, which contributes to a shortening of the distance 
between the particles’ magnetic cores and thus, increased magnetic interactions. 
Magnetization loops show that there is a reduction of the saturation magnetization (MS) 
values from MNP-OA (MS = 54 emu/g) to MNP-DMSA (MS = 38 emu/g) and MNP-CA (MS = 33 
emu/g). The lower MS of MNP-OA compared to bulk magnetite value (MS magnetite = 92-98 
emu/g) 
4–6
 was expected due to the well-known nanoscale size effects: the magnetic behavior of 
the magnetic moments at the surface is different from those in the core, leading to an overall 
reduction of the net particle magnetic moment.
34
 A much higher disorder of spins is present at 
the surface than in the core. Several factors may contribute to justify the decrease in saturation 
magnetization after the ligand-exchange reaction. First, core size reduction (4% for MNP-CA 
and 10% for MNP-DMSA) implies larger surface canting. Secondly, oxidation of magnetite to the 
less magnetic maghemite (MS, maghemite = 76-84 emu/g)
4–6
 also contributes negatively to the 
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net magnetic moment. The literature reports MS post-oxidation decreases (at RT) of between 
5% and 33%.
6,11,24
 In addition, the removal of surface iron ions that takes place during ligand 
exchange and the formation of new bonds with the ligands may further contribute to decrease 
the overall magnetic moment of the particle.
35,36
 In this work, we have observed a MS reduction 
of 39% for MNP-CA and 30% for MNP-DMSA. To understand this change, all the previously 
mentioned factors have to be taken in account. Thus, it is clear that MS reduction does not relate 
only with core size variation. For MNP-CA, besides particle dissolution, a larger degree of 
oxidation of the material (supported by FTIR and nanoparticle color) and higher surface 
magnetic disorder also contribute to the lower MS value compared to the precursor particles 
(MNP-OA) and MNP-DMSA. As expected for SPION produced by the thermal decomposition 
method, the magnetic diameters estimated from Chantrell’s equation (Table 2.1) approach the 
physical diameter measured in TEM images.
24
 The slightly lower values of dMag compared to 
dcore in MNP-OA and MNP-CA suggest a core-shell structure, where the magnetic core is 
surrounded by a layer of less magnetic (or nonmagnetic) material, showing typical spin canting 
phenomenon. In contrast, for MNP-DMSA sample dMag is identical to dcore, in accordance with its 
superior MS. DMSA coordination with iron oxide seems to prevent surface disorganization. 
Regarding the initial susceptibility χini, which is the slope of the magnetization curve at low field, 
MNP-CA present the lowest value (Table 2.1), meaning that are more resistant to magnetization 
directionalization,
6
 i.e. a larger field needs to be applied in order to promote magnetic moment 
reversal inside the particle until saturation is attained.  
2.3.4. Comparison of ligand-exchange protocols 
The ligand-exchange is a crucial step for the stabilization of monodisperse MNP in 
aqueous media. It is one of the most employed methods to obtain monodisperse MNPs for 
biomedical applications and its advantages are related to the ability to maintain the size 
distribution and the magnetic properties of the precursor hydrophobic particles, preventing 
aggregation through repulsive electrostatic interactions between particles. 
Regarding size and colloidal stability, when compared to MNP-CA, MNP-DMSA present 
lower hydrodynamic size and better colloidal stability in low salt conditions (Figure 2.2 and Table 
2.1). It was observed that the harsher reaction conditions (higher temperature and prolonged 
reaction time) needed for the CA ligand-exchange cause a larger degree of oxidation in the 
resultant particles, which leads to lower magnetic saturation magnetization than in MNP-DMSA. 
In accordance with this observation, Song et al.
25
 showed that in a temperature driven ligand-
exchange reaction, prolonging the reaction time was sufficient to decrease the MS by 24%. CA, 
by itself, is a stronger iron chelating agent than DMSA due to the presence of three carboxylate 
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groups against the two in DMSA. On top of that, the higher temperature further enhances CA 
aggressivity towards iron oxide surface.  
Table 2.1. Summary of size, zeta potential and magnetic characterization results for the hydrophobic 
(MNP-OA) and hydrophilic (MNP-CA and MNP-DMSA). 
 































MNP-OA 7.9 (1.1) 10.5 (0.8) 




MNP-CA 7.6 (1.1) 18.5 (4.8) 




MNP-DMSA 7.1 (1.4) 14.9 (3.4) 




standard deviation is represented within brackets;
 a
 average and standard deviation of the core size distribution for one 
representative measurement; 
b
 average value of 8 batches; 
c 
value of one representative measurement. 
Although MNP-DMSA present a higher blocking temperature and a wider magnetic size 
distribution compared to MNP-CA, the compromise between better saturation magnetization, 
lower effective size and improved colloidal stability makes the DMSA ligand-exchange method a 
more promising technique regarding the size and magnetic properties. Besides these, there are 
extra advantages of using DMSA. For surface characterization, the DMSA coating offers the 
possibility of being readily quantified by ICP-AES, though the determination of the S/Fe ratio in 
the samples. Typically TGA is used for this purpose but requires a lot more sample and is more 
time consuming. For example, in this work we have obtained 2  0.6 µmol(S)/mg(Fe), that 
corresponds to 0.7  0.2 µmol(DMSA)/mg(Fe2O3). With this data, and taking in account that the 
particles are spherical with 7 nm diameter (Figure 2.1 A) and the density of Fe2O3 is 4.89 g/cm
3
, 
a ratio of 370 (120) molecules of DMSA per particle was estimated. Concerning particle 
functionalization, the carboxyl and thiol groups remaining free at the surface of MNP-DMSA 
provide versatility to use different chemistries to graft molecules bearing complementary groups, 
while MNP-CA only has the carboxylic group available. Finally, the DMSA ligand-exchange 
protocol is more straightforward and ambient/economy-friendly, as it does not require heating at 
100ºC. The advantages here reported for DMSA ligand-exchange protocol, are in accordance 
with the fact that research works based on DMSA ligand-exchange are more frequent than citric 
acid based ones. In addition, the protocols that employ citric acid are more complex than the 
one here explored, involving 2-step reactions.
13,22
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2.3.5. Exploring the chemical versatility of MNP-DMSA 
To test the possibilities of chemical binding to MNP-DMSA, a proof-of-concept 
experiment was carried out where two chemical routes were employed to covalently bind the 
biopolymer gum Arabic (GA) onto the MNP-DMSA. Gum Arabic was used due to its proven 
properties as a coating agent for SPIONs
37,38
 and also due to its composition which renders 
more than one chemical group for surface functionalization. One route uses cysteamine as a 
linker between MNP-DMSA and GA while the other directly couples GA to MNP-DMSA (Figure 
2.3 A). Cysteamine has both thiol and amine groups, therefore, the strategy consisted in using 
DTDP to promote the formation of disulfide bonds with the thiol groups of DMSA and afterwards 
employing EDC/NHS chemistry to promote the formation of an amide bond between the amine 
groups of cysteamine and the carboxylate groups of GA. The second strategy makes use of the 
carboxylate groups from DMSA and the amines of GA where the formation of amide bond 
between these groups is promoted also using EDC and NHS. 
 
Figure 2.3. MNP-DMSA functionalization possibilities using gum Arabic as model biomolecule. (A) 
schematic representation of the two chemical approaches tested; (B) distribution of hydrodynamic 
diameters at pH 7 in water; (C) TEM image of MNP-DMSA-Cyst-GA; (D) TEM image of MNP-DMSA-GA. 
Both chemical routes proved to be successful to coat MNP-DMSA with GA via covalent 
bonds and the resultant particle aggregates are very similar in their morphology, size, surface 
chemistry, colloidal and magnetic properties. The high molecular weight and highly branched 
character of GA promotes the formation of aggregates of around 250 nm (Figure 2.3 B and 
Table 2.1), composed by multiple magnetic cores of MNP-DMSA involved in a shell of GA, 
which is visible in the TEM images (Figure 2.3 C and Figure 2.3 D). 
Figure 2.4 A shows that amination of MNP-DMSA with cysteamine was successful as 
the isoelectric point changes from very acid in MNP-DMSA (less than 2) to close to 6 in MNP-
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DMSA-Cyst, indicating the presence of free amine groups at the surface of the particles. 
Afterwards, by coupling GA through EDC/NHS chemistry, it was possible to re-stabilize the 
particles at physiological pH. It is interesting to note that the zeta potential profile vs pH of MNP-
DMSA-Cyst-GA is practically the same as for MNP-DMSA-GA, which means that the coating of 
MNP-DMSA with GA through the carboxylate moieties of the MNP-DMSA was also successful. 
The success of the coupling is confirmed by FTIR analysis (Figure 2.4 B) as the 
characteristic band of GA, located at 1036-1071 cm
-1 
and due to C-O stretching vibrations,
39
 is 
present in both MNP-DMSA-Cyst-GA and MNP-DMSA-GA spectra. An absorption band 
resembling amide I band, attributed to C=O bond stretching vibrations,
40
 is present at around 
1635 cm
-1
 in MNP-DMSA-Cyst-GA and MNP-DMSA-GA spectra. There is also a shoulder-like 
band at 1530-1540 cm
-1
 that resembles the amide II band, is associated with the N-H bond 
bending, C-N and C-C stretching vibrations. This suggests the presence of amide bonds 
resultant from the covalent bond between the ligands at the surface of the particles (Cysteamine 
or DMSA) and GA, although a contribution from chemical crosslinking of GA chains between 
themselves may also be present. 
 
Figure 2.4. Surface and magnetic properties of the particles coated with gum Arabic. (A) Evolution of the 
zeta potential with pH (B) FITR spectra; (C) Magnetization loops at T=250K; (D) ZFC/FC curves. A: MNP-
DMSA, B: MNP-DMSA-Cyst-GA, C: MNP-DMSA-GA, D: GA. 
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Regarding the magnetic properties (Figure 2.4 C and Table 2.1), the saturation 
magnetization values of MNP-DMSA-GA (39 emu/g) and MNP-DMSA-Cyst-GA (36 emu/g), are 
similar to MNP-DMSA (MS = 38 emu/g) (Figure 2.2 C and Table 2.1). For MNP-DMSA-Cyst-GA 
more reaction steps were involved, which may justify the slight decrease of MS. FTIR spectrum 
for these particles (Figure 2.4 B) shows extra bands in the Fe-O vibrations region, confirming a 
more oxidized state for MNP-DMSA-Cyst-GA. The two GA coated MNP samples have a 
blocking temperature (TB) of around 85 K (Figure 2.4 D and Table 2.1), which is higher than the 
65 K from MNP-DMSA (Figure 2.2 and Table 2.1), probably due to the enhanced inter-particle 
magnetic interactions promoted by the aggregation. Like for MNP-DMSA, the FC curve is flat 
below TB, thus confirming the presence of inter-particle dipolar interactions. The width of ZFC 
curve is also similar to the observed for MNP-DMSA, which means that the “magnetic sizes” 
distribution is maintained after coupling with GA, as expected.  
 
Figure 2.5. Determination of the relaxation rates of MNP-DMSA-Cyst-GA and MNP-DMSA-GA as a 
function of iron concentration, respective linear adjustments and r
2 
values. (A) Longitudinal relaxation 
rates, R1; (B) transverse relaxation rates, R2. 
The efficiency of gum Arabic coated nanoparticles as magnetic resonance imaging 
(MRI) contrast agents is also similar. They have low longitudinal (r1) and high transverse (r2) 









 were obtained for MNP-DMSA-Cyst-GA and MNP-
DMSA-GA, respectively (Figure 2.5). These results are very promising for their use in MRI 




Endorem/Feridex, at the same magnetic field). Though their hydrodynamic diameter (250 nm) 
may be large for in vivo applications that require long circulation times, these particles could be 
an alternative for passive targeting , the extravasation of particles within tumors that depends on 
particle size and nature of the coating. Particles interact with the innate property of the tumors in 
order to accumulate preferentially via an enhanced permeability and retention (EPR) effect.
41
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2.4. Conclusions 
Colloidal stability in aqueous media is a key point in the production of MNP for 
biomedical applications. Most synthesis methods based on aqueous chemical precipitation of 
iron oxide yield particles that are hydrophilic but tend to aggregate and that have a polydisperse 
size distribution that does not suit the needs. Therefore, the generally accepted alternative to 
obtain monodispersity is the synthesis by thermal decomposition of organic precursors of iron in 
organic solvents followed by a phase transfer method that makes the nanoparticles hydrophilic 
while keeping the monodispersity. Ligand-exchange reaction is usually employed for this 
purpose and DMSA and citric acid (CA) have been used extensively as exchange ligands. In 
this work, the effect of CA and DMSA ligand-exchange reactions in the surface chemistry and 
magnetic characteristics of the particles were compared in detail. Both methods yield stable 
dispersions of MNP in aqueous environment. Although the core size, the hydrodynamic 
diameter and colloidal stability of the resulting particles are similar, the magnetic properties are 
altered. DMSA coated particles present superior magnetic properties. CA is more aggressive 
towards iron oxide surface than DMSA and, catalyzed by high temperature (100ºC), promotes a 
larger extent of oxidation and spin canting than DMSA, which translates in a larger decline 
(39%) in the magnetization saturation as compared to MNP-DMSA (30%). DMSA coated MNP 
present better initial susceptibility, making them more easily magnetizable. Considering that 
these particles are intended to be functionalized with bioactive molecules for biomedical 
applications, MNP-DMSA are more versatile. The thiol and carboxylic groups at the surface of 
MNP-DMSA serve as chemical anchors for grafting other molecules. As a proof-of-concept, the 
biopolymer gum Arabic, already known to be useful as a stabilizing agent for contrast agents, 
has proven to be successfully grafted onto the MNP-DMSA through either free thiol or 
carboxylic groups leading to aggregates of MNP with similar colloidal properties that maintain 
the magnetization saturation of MNP-DMSA and show enhanced interparticle magnetic 
interactions. These results contribute to the understanding of the effects of CA and DMSA in the 
surface and magnetic properties of MNP and show the functional versatility of MNP-DMSA. 
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(35)  Daou, T. J.; Grenèche, J. M.; Pourroy, G.; Buathong, S.; Derory, A.; Ulhaq-Bouillet, C.; Donnio, 
B.; Guillon, D.; Begin-Colin, S. Coupling Agent Effect on Magnetic Properties of Functionalized Magnetite-
Based Nanoparticles. Chem. Mater. 2008, 20, 5869–5875, DOI:10.1021/cm801405n. 
(36)  Morales, M. P.; Veintemillas-Verdaguer, S.; Montero, M. I.; Serna, C. J.; Roig, A.; Casas, L.; 
Martínez, B.; Sandiumenge, F. Surface and Internal Spin Canting in Γ-Fe 2 O 3 Nanoparticles. Chem. 
Mater. 1999, 11, 3058–3064, DOI:10.1021/cm991018f. 
(37)  Roque, A. C. A.; Bicho, A.; Batalha, I. L.; Cardoso, A. S.; Hussain, A. Biocompatible and Bioactive 
Gum Arabic Coated Iron Oxide Magnetic Nanoparticles. J. Biotechnol. 2009, 144, 313–320, 
DOI:10.1016/j.jbiotec.2009.08.020. 
(38)  Zhang, L.; Yu, F.; Cole, A. J.; Chertok, B.; David, A. E.; Wang, J.; Yang, V. C. Gum Arabic-
Coated Magnetic Nanoparticles for Potential Application in Simultaneous Magnetic Targeting and Tumor 
Imaging. AAPS J. 2009, 11, 693–699, DOI:10.1208/s12248-009-9151-y. 
(39)  Batalha, I. L.; Hussain, A.; Roque, A. C. A. Gum Arabic Coated Magnetic Nanoparticles with 
Affinity Ligands Specific for Antibodies. J. Mol. Recognit. 2010, 23, 462–471, DOI:10.1002/jmr.1013. 
(40)  Kong, J.; Yu, S. Fourier Transform Infrared Spectroscopic Analysis of Protein Secondary 
Structures. Acta Biochim. Biophys. Sin. (Shanghai). 2007, 39, 549–559, DOI:10.1111/j.1745-
7270.2007.00320.x. 
(41)  Nanomaterials for the Life Science: Magnetic Nanomaterials; Kumar, C. S. S. R., Ed.; 1st ed.; 








Chapter 3: Covalent coupling of gum Arabic onto superparamagnetic iron oxide nanoparticles for MRI cell 
 labeling: physiochemical and in vitro characterization 
63 
Chapter 3 
Covalent coupling of gum Arabic onto 
superparamagnetic iron oxide nanoparticles for MRI 
cell labeling: physiochemical and in vitro 
characterization 
Gum arabic (GA) is a hydrophilic composite polysaccharide derived from exudates of 
Acacia senegal and Acacia seyal trees. It is biocompatible, possesses emulsifying and 
stabilizing properties and has been explored as a coating agent on nanomaterials for biomedical 
applications, namely magnetic nanoparticles (MNPs). Previous studies focused on the 
adsorption of GA onto MNPs produced by co-precipitation methods. In this work, MNPs 
produced by thermal decomposition method, known to produce uniform particles with better 
crystalline properties, were employed for the covalent coupling of GA through its free amine 
groups, which increases the stability of the coating layer. MNPs were produced by thermal 
decomposition of Fe(acac)3 in organic solvent and, after ligand-exchange with meso-2,3-
dimercaptosuccinic acid (DMSA), GA coating was achieved by the establishment of a covalent 
bond between DMSA and GA moieties. Clusters of several magnetic cores entrapped in a shell 
of GA were obtained, with good colloidal stability and promising magnetic relaxation properties 
(r2/r1 ratio of 350). HCT116 colorectal carcinoma cell line was used for in vitro cytotoxicity 
evaluation and cell labeling efficiency studies. We show that, upon administration at the 
respective IC50, GA coating enhances MNP cellular uptake by 19 times compared to particles 
only bearing DMSA moieties. Accordingly, in vitro MR images of cells incubated with increasing 
concentrations of GA-coated MNP present dose-dependent contrast enhancement. The 
obtained results suggest that the GA magnetic nanosystem could be used as MRI contrast 
agent for cell labeling applications. 
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3.1. Introduction 
The unique physiochemical properties of iron oxide magnetic nanoparticles (MNP), 
namely large surface to volume ratio, superparamagnetism and biocompatibility, make them 
useful for biomedical applications such as magnetic resonance imaging (MRI), magnetic particle 
imaging (MPI), hyperthermia, targeted drug and gene delivery, cell labeling, among others.
1
 The 
effective size, shape and surface charge determine the successful function of a magnetic 
nanosystem in biological environments. Here, particle coating plays an important role because it 
is the interface between the magnetic core and the cellular medium. The coating mediates 
interactions with cells, namely by contributing to the active (via attachment of cell-specific 
ligands) or passive (via tumor enhanced permeation and retention effect) targeting of the 
particles to the tissues. Hydrophilic coatings, usually composed by polysaccharides (e.g. 
dextran) or synthetic polymers (e.g. polyethylene glycol (PEG)), provide colloidal stability 
through steric stabilization and can enhance blood circulation times upon particles 
administration in vivo.
1–3
 Gum Arabic (GA) is a hydrophilic composite polysaccharide derived 
from exudates of Acacia senegal and Acacia seyal trees, characterized by excellent emulsifying 
and long-term stabilizing properties. It is also biocompatible thus having its main applications in 
food, pharmaceutical and cosmetic industries.
3–5
 This biopolymer comprises three main 
components: low-protein content arabinogalactan (90%) high-protein content arabinogalactan 
(10%) and high-protein content glycoproteins (<1%).
4,5
 MNP coated with GA were previously 
shown to be stable in aqueous media,
6,7
 functionalized with drugs for targeted drug delivery
8–10
 
and used as magnetically targeted MRI contrast agents.
11
 For example, in vitro tests showed 
cellular uptake of GA coated MNP in mammalian cell lines
11,12
 and, by MRI, it was possible to 
observe their accumulation at tumor sites in mice bearing 9L glioma tumors after intravenous 
injection and under magnetic targeting with an external magnetic field.
11
 In these studies, 
coating was achieved by physical adsorption but the GA charged groups (carboxyl and amine) 
can also be employed for covalent bonding via carbodiimide activation.
6
 Unlike physical 
adsorption, covalent bonding provides a more permanent attachment of the polymer to the 
particles, avoiding its detachment and the disorganization of the MNP clusters, which may 
compromise temporal stability of the material.
13
 Also, in the previous studies,
8–12
 the MNP were 
synthesized by co-precipitation methods, which are known to produce less crystalline MNP with 
heterogeneous distribution of sizes and shapes.
14,15
 The thermal decomposition method is an 
alternative to obtain monodisperse MNP with enhanced magnetic properties.  
In this work we present a route for covalent binding of GA onto MNPs derived from the 
thermal decomposition of an oganometallic precursor. We show, for the first time, a 
comprehensive characterization of MNP coated with gum Arabic in human cells. The particles 
were characterized regarding their size, colloidal stability, magnetic properties and efficacy as 
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MRI contrast agents (longitudinal, r1, and transverse, r2, relaxivities). A promising r2/r1 ratio was 
found, superior to that of the commercial agent Endorem/Feridex. In vitro evaluation of cell-
particle interactions was performed using the HCT116 human colorectal carcinoma cell line. We 
found that GA coating promotes a 19-fold increase in MNP uptake compared to the uncoated 
precursor only bearing DMSA at its surface and that in vitro T2-weighted MRI of cells incubated 
with GA coated MNP present a dose-dependent signal decrease. 
3.2. Experimental Section 
3.2.1. Materials 
All chemicals were purchased from Sigma-Aldrich and used without ulterior purification. 
Reagents for cell culture and analysis were purchased from Invitrogen. 
3.2.2. Synthesis and phase transfer of magnetic nanoparticles 
Hydrophobic magnetic nanoparticles were synthesized following Sun’s method
16
 with 
slight modifications. For the phase transfer to aqueous media, a ligand-exchange reaction using 
DMSA was performed as described previously
13
 (See details in Chapter 2: Section 2.2.2 and 
Section 2.2.4). Following this procedure, MNP-DMSA were obtained. 
3.2.3. Covalent coupling of gum Arabic to MNP-DMSA 
GA was bound to the MNP-DMSA, via carbodiimide chemistry, through the formation of 
an amide bond between the free carboxyl groups of DMSA and the free amines of GA. (See 
details in Chapter 2: Section 2.2.6) 
3.2.4. Characterization of magnetic nanoparticles 
3.2.4.1. Size and structural characterization 
Particle size and shape were characterized by Transmission Electron Microscopy 
(TEM) using a 100-kV JEOL JEM1010 microscope equipped with a Gatan Orius 200 SC digital 
camera. The average particle core diameter was calculated using ImageJ software (National 
Institutes of Health, USA). Hydrodynamic size (dh) and zeta potential (-potential) of the 
particles were determined using a Nanosizer ZS (Malvern) at pH 7. The mean value of the 
volume-weighted size distribution was used as dh. -potential variation with pH was measured in 
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a 0.01 M KNO3 solution (HNO3 or KOH solutions were used for pH adjustment). Colloidal 
stability of MNP-DMSA-GA over time was studied by evaluating the percent change in 
hydrodynamic diameter (Z-average) during one week for not autoclaved particles diluted in 
water, and for autoclaved particles diluted in water and in cell culture medium. These three 
conditions were chosen in order to evaluate the effect of sterilization by autoclaving and to 
mimic the environment found by the particles when put in contact with cells in the in vitro 
assays. To study stability, samples were placed in a DLS cuvette and hydrodynamic diameter 
measurements were taken in the course of one week without agitation. In the last day, samples 
were homogenized by pipetting up and down several times and measured again. Inductively 
coupled plasma (ICP) atomic emission spectroscopy (Horiba Jobin-Yvon, Ultima) was used to 
determine the iron content of the MNP samples. Fourier transform infrared (FTIR) spectra were 
acquired using a Nicolet 20 SXC FTIR. Simultaneous thermogravimetric analysis (TGA) and 
differential thermal analysis (DTA) of MNP-DMSA-GA powder was carried out in a Seiko 
TG/DTA 320 U, SSC 5200 thermobalance. 
3.2.4.2. Magnetic properties and relaxivities assessment 
Magnetization measurements were performed using a vibrating sample magnetometer 
(VSM) (MagLab VSM, Oxford Instruments). Magnetization loops were measured at 250 K and 
corrected by subtracting the diamagnetic contribution of the dispersants and the sample holder. 
The saturation magnetization at maximum field was normalized to grams of Fe2O3. Temperature 
dependent zero-field cooling (ZFC) and field cooling (FC) magnetization measurements were 
performed by cooling the samples to 5 K under a zero or a 100 Oe magnetic field, respectively. 
Then, the magnetization was measured while the samples were heated (3 K/min) to 250 K 
under a 100 Oe magnetic field. The relaxometric properties of MNP-DMSA-GA were evaluated 
in a 7 T NMR Brucker Avance III Spectrometer at 25ºC. T1 was measured using an inversion 
recovery sequence (TR between 3 and 10 s). T2 was measured using a Call-Purcell-Meiboom-
Gill sequence (TE of 1 ms and the number of echoes needed to cover a time interval of about 
10 times T2). R1 (1/T1) and R2 (1/T2) were plotted against iron concentration and a linear 
behavior was found. The lines slopes are the longitudinal (r1) and transverse (r2) relaxivities, that 
measure the efficiency of the nanoparticles as MRI contrast agents. T2-weighted MRI phantom 
images of MNP-DMSA-GA water suspensions at 0.1, 0.4, 0.8 and 1 mM (Fe) were obtained with 
a multi-echo image sequence (TR = 5 s; Tt = 8 ms). 
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3.2.5. Nanoparticle-cell interactions 
3.2.5.1. Cell culture 
Human colorectal carcinoma cell line (HCT116) was cultured in Dulbecco’s modified 
Eagle’s medium supplemented with 10% (v/v) fetal bovine serum and 1% (v/v) of penicillin-
streptomycin at 37 ºC with 99% relative humidity and 5% CO2. For experiments, cells were 
incubated with fresh medium for 24h to allow cell adhesion. Then, the culture medium was 
replaced by fresh medium containing the nanoparticles and cells were incubated for the 
required time, after which the nanoparticle-cell interaction experiments described in the 
following sections were carried out. Nanoparticles were sterilized prior to the addition to culture 
medium by filtration with a sterile membrane filter of 0.45 µm pore diameter. 
3.2.5.2. Cell viability evaluation 
HCT116 cells were incubated with MNP-DMSA and MNP-DMSA-GA at iron 
concentrations of 5, 15, 25, 40, 55, 75, 100 and 150 µg/ml and with GA at concentrations of 3, 
9, 15, 24, 33, 44, 59 and 89 µg/ml. GA concentrations correspond to the GA content in MNP-
DMSA-GA at the chosen iron concentrations and were calculated from TGA results (GA 
constitutes 21% weight of MNP-DMSA-GA). 
After 48 h incubation with MNPs and GA in a 96-well plate, at 7.5⨯10
3
 cells/well, culture 
media was removed and the wells were washed twice with PBS. Cell viability was evaluated 
using a standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay and 
a previously defined protocol
17
 with slight modifications, described in the following lines. MTT 
was dissolved in PBS at 5 mg/ml and diluted to 0.45 mg/ml in culture media. 110 µl of the 
resultant MTT solution was added to each well, followed by 2.5 h incubation at 37 ºC. After this 
period, the solution was removed from the wells, without disturbing the cells, and replaced by 
100 µl of DMSO to dissolve the formazan crystals obtained as a result of MTT metabolization. 
The plate was gently shaken for 10 min at room temperature and the absorbance of the wells at 
540 and 630 nm was measured in a microplate reader (Microplate Titre Infinite F200, TECAN 
Spectra). Cell viability was calculated using the following equation: 
 𝑐𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (%) =  
(𝑎𝑏𝑠@540𝑛𝑚 − 𝑎𝑏𝑠@630𝑛𝑚)𝑠𝑎𝑚𝑝𝑙𝑒
(𝑎𝑏𝑠@540𝑛𝑚 − 𝑎𝑏𝑠@630𝑛𝑚)𝑐𝑜𝑛𝑡𝑟𝑜𝑙
× 100 (3.1) 
where sample refers to cells incubated with particles or GA and control refers to cells without 
particles or GA.  
Three independent MTT assays were performed. The relative IC50 for each particle type 
was determined by fitting the viability results to a logistic dose-response curve
18
 using Origin 8 
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software. In the following experiments, cells were incubated with the relative IC50 of MNP-DMSA 
and MNP-DMSA-GA. 
3.2.5.3. Iron staining with Prussian blue 
After 48 h incubation (24-well plate with 10 mm
2
 coverslips on the bottom of each well; 
1⨯10
5
 cells/well) with nanoparticles at their IC50 values (55 g/ml for MNP-DMSA and 43 g/ml 
for MNP-DMSA-GA), cells were washed three times with 0.5 ml of PBS and fixed with 0.3 ml of 
cold paraformaldehyde (4% v/v in PBS) for 15 min. The paraformaldehyde was removed, cells 
were washed three times with PBS and, when the coverslips were dry, 0.5 ml of Prussian blue 
solution (equal volumes of HCl (2% v/v) and potassium ferrocyanide trihydrate 2% (m/v)) was 
added and incubated for 15 min at room temperature. After removal of the staining solution, 
cells were washed three times with PBS and counterstained for 2 min with 0.5 ml of neutral red 
0.5% (m/v). Preparations were then washed three times with PBS, air-dried and mounted on the 
microscope slide using 1 drop of glycerol 1:3 (v/v in PBS). Slides were observed under bright-
light illumination using a Olympus BX51 microscope equipped with a Olympus DP50 camera 
and the AnalySIS Soft Imaging software. 
3.2.5.4. Nuclear staining with Hoechst 33258 
After 48 h incubation (24-well plate with 10 mm
2
 coverslips on the bottom of each well; 
1⨯10
5
 cells/well) with nanoparticles at their IC50 values (55 g/ml for MNP-DMSA and 43 g/ml 
for MNP-DMSA-GA), cells were washed three times with 0.5 ml of PBS and fixed with 0.3 ml of 
ice-cold paraformaldehyde (4% v/v in PBS) for 15 min in the dark, at 4ºC. The 
paraformaldehyde was removed, cells were washed three times with PBS and, when the 
coverslips were dry, 0.3 ml of Hoechst solution (containing 0.6 µl of 5mg/ml Hoechst stock 
solution in 0.3 ml of PBS) was added and incubated for 15 min in the dark at room temperature. 
After removing the Hoechst solution, preparations were then washed three times with PBS, air-
dried and mounted in the microscope slide using 1 drop of glycerol 1:3 (v/v in PBS). Slides were 
observed by fluorescence microscopy using a Olympus BX51 microscope equipped with a 
Olympus DP50 camera and the AnalySIS Soft Imaging software 
3.2.5.5. Cellular staining with Propidium iodide (PI) and nuclear counterstaining with 
DAPI 
After 48 h incubation (35 mm
2
 petri dish with 10 mm
2
 coverslip on the bottom; 1⨯10
5
 
cells) with MNP-DMSA-GA at their IC50 (43 g/ml), cells were washed three times with 1 ml of 
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PBS and fixed with 1 ml of ice-cold paraformaldehyde (4% v/v in PBS) for 15 min in the dark, at 
4ºC. After removing the paraformaldehyde, cells were washed three times with 1 ml of PBS and 
incubated for 5 min with 1 ml of Triton 0.1% (v/v) for permeabilization. After this incubation, cells 
were washed three times with PBS to remove triton, the coverslips were dried and 1 ml of a 
Propidium Iodide (PI) solution (in PBS, 10 µg/ml) was added and incubated for 30 min in the 
dark at room temperature. PI solution was removed and the preparation was washed three 
times with PBS, air dried and mounted in the microscope slide using 5 µl of DAPI solution. 
Slides were observed by fluorescence microscopy using a Olympus BX51 microscope equipped 
with a Olympus DP50 camera and the Cell F View Image System Software. 
3.2.5.6. GFP labeling of lysosomes and nuclear counterstaining with DAPI 
Cells were incubated (35 mm
2
 petri dish with 10 mm
2
 coverslip on the bottom; 1⨯10
5
 
cells) for 48 h with MNP-DMSA-GA at their IC50 (43 g/ml). CellLight® Lysosomes-GFP, 
BacMam 2.0 reagent (Life Technologies, USA) (25 particles per cell, assuming 2⨯10
5
 cells) was 
added directly to the cells 20 h before the end of the incubation time and left incubating 




After 48h of incubation, cells were washed three times with 1 ml of PBS and fixed with 1 ml of 
ice-cold paraformaldehyde (4% v/v in PBS) for 15 min in the dark, at 4ºC. The 
paraformaldehyde was removed, and cells were washed three times with 1 ml of PBS. At this 
point, the preparation was air dried and mounted in the microscope slide using 5 µl of DAPI 
solution. Slides were observed by fluorescence microscopy using a Olympus BX51 microscope 
equipped with a Olympus DP50 camera and the Cell F View Image System Software. 
3.2.5.7. Iron quantification 
Cells were incubated for 12 h, 24 h and 48 h in a 24-well plate (1⨯10
5
 cells/well) with 
nanoparticles at their IC50 values (55 g/ml for MNP-DMSA and 43 g/ml for MNP-DMSA-GA). 
The iron content in three cell culture fractions was quantified by ICP. 
Well supernatant (fraction 1) contains mainly culture media, dead cells and particles 
that remained in the extracellular space. Cells remaining in the wells were trypsinized, 
resuspended in medium and counted using a hemocytometer. These cell suspensions were 
centrifuged at 5000 rpm for 10 min to separate cell pellet (fraction 2) and cell supernatant 
(fraction 3). The three fractions were digested separately with 100 µl of aqua regia 
(concentrated HCl/HNO3 3:1 (v/v)) for 30 min at 90ºC, left cool down to room temperature, 
diluted to a final volume of 1 ml with milliQ water and analyzed separately by ICP.  
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The iron in the cellular fraction (sum of fraction 2 and fraction 3) was normalized to the 
number of cells counted previously. To compare the interaction of each particle type with cells, 
the iron content in cellular fraction and well supernatant was normalized to the total amount of 
iron quantified (sum of cellular and supernatant iron). A control sample containing only cells was 
also quantified to provide a calibration for the native iron content of cells. 
3.2.5.8. Quantification of apoptosis markers by real-time PCR 
Cells were incubated for 3.5h, 6h, 12h and 48h (T-25 flask, 2⨯10
5
 cells/ml) with MNP-
DMSA-GA at its relative IC50. Control cell cultures without MNPs were also prepared for all time 
points. At the end of these exposure periods, total mRNA was extracted using TRIZol Reagent 
kit (Life Technologies, USA) according to manufacturer’s instructions. Concentration of the 
extracted RNA was determined using Nanodrop1000-ND. 100 ng of RNA was reverse 
transcribed using the NZY M-MuLV First-Strand cDNA Synthesis Kit (Nzytech, Portugal) 
according to the supplier’s instructions. The produced first-strand cDNA was quantified using 
Nanodrop 1000-ND and amplified (100 ng) by real-time PCR (Corbett Rotor Gene 6000 – 
QUIAGEN) using the kit 5x HOT FIREPol EvaGreen qPCR Mix Plus (ROX) (Solis BioDyne, 
Estonia), and specific primers for p21, BAX, BCL-2 and rRNA18S5 (Metabion GmbH, 
Germany).Real-time PCR program parameters included 15 minutes at 95ºC, followed by 40 
cycles involving denaturation at 95ºC for 15 seconds, annealing at Tmelting (59ºC for p21 and 
rRNA18S5, 62ºC for BAX and 75ºC for BCL-2) for 20 seconds and elongation at 72ºC for 20 
seconds. The expression level of each gene was normalized to the internal control (rRNA18S5 
gene). The fold changes of target genes expression relative to the control samples were 





3.2.5.9. In vitro MRI 
Prior to be imaged, cells were dispersed in agarose gel. The agarose dispersions of 
cells were prepared as follows.
21
 Cells were incubated for 48h (24-well plate, 1.25⨯10
5
 
cells/well) with MNP-DMSA and MNP-DMSA-GA at three iron concentrations: C1 = IC50 – 0.25 ⨯ 
IC50; C2 = IC50; and C3 = IC50 + 0.25 ⨯ IC50. (relative IC50). Two wells per condition were 
prepared in order to have enough cells for the assay. After incubation, cells were washed 3 
times with 0.3 ml of PBS and trypsinized (0.2 ml of trypsin per well and 5 min incubation at room 
temperature). After neutralizing trypsin with 0.2 ml of culture medium, the content of the wells 
was transferred to 1.5 ml centrifuge tubes, centrifuged at 1500 rpm for 5 min and the 
supernatant was discarded. The pellet was re-suspended in 0.5 ml of cold paraformaldehyde 
(4% v/v in PBS) for 15 min at room temperature. The paraformaldehyde was then removed by 
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centrifugation (1500 rpm, 5 min), the pellet was re-dispersed in 0.2 ml of PBS and cells were 
counted. At this point, for each condition, samples with the same number of cells (3.125 ⨯ 10
5 
cells) were prepared in 0.1 ml of PBS. These cell dispersions were added to 0.2 ml aliquots of 
fresh 0.75% (w/v) agarose (at around 40 ºC), mixed well and transferred to 5 mm diameter NMR 
tubes for imaging after solidifying. The final concentration of agarose in the dispersions was 0.5 
mg/ml and the final concentration of cells was 1⨯10
6
 cells/ml. 
T2-weighted MR images were obtained under a magnetic field of 7 T, at 25 ºC, using a 
Bruker Avance III Spectrometer (160 G/cm imaging gradient) and a flash sequence (TR = 110 
ms, TE = 1.7 ms, 20º excitation angle). MRI signal was quantified using ImageJ (National 
Institutes of Health, USA) to calculate the histogram, the average pixel value and the integrated 
density (sum of all pixel values divided by the average pixel value) over a 6 mm
2 
circular region 
of interest placed in the center of each image. 
3.3. Results and Discussion 
3.3.1. Morphology, size, colloidal and structural properties of GA coated MNP 
We have synthesized MNP by the thermal decomposition method and obtained 
monodisperse particles. After their phase transfer to aqueous media by ligand exchange with 
DMSA, GA was bound to particles. Chemical bonds provide stronger binding than adsorption 
and contribute for the structural stability of the system. Therefore, we took advantage of the 
presence of free amine groups in GA and free carboxyl groups at the surface of DMSA coated 
MNP (MNP-DMSA) to establish a covalent bond through carbodiimide chemistry. We have 
obtained a brownish colloid stable in aqueous media. TEM pictures and hydrodynamic diameter 
measurements in Figure 3.1 A and 3.1 B show the morphology and size of the particles after 
conjugation with GA. The high molecular weight and highly branched character of GA promotes 
the formation of monodisperse aggregates (dh = 344  87 nm, pdI = 0.2  0.05) with multiple 
magnetic cores of MNP-DMSA (dh = 14.9  3.4 nm, dcore = 7  1 nm) densely packed in a shell 
of GA which is visible surrounding the magnetic cores in the TEM images. Assuming that the 
aggregates are spherical, and taking in account the average hydrodynamic diameter of the 
clusters and the average core diameter of MNP-DMSA, each cluster is estimated to contain a 
maximum of 120 000 iron cores. 
MNP-DMSA-GA show colloidal stability despite their tendency for zeta potential higher 
than -30 mV (Figure 3.1 C). In average, at pH~ 7, zeta potential is -21  6 mV and precipitation 
is observed at around pH 2.5. This indicates that, as expected, the stabilization has both 
contributions from GA chains steric repulsions and from electrostatic interactions due to 
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negative charges of GA and to the presence of some free carboxyl groups from the DMSA at 
the surface. Autoclaved particles also showed stability when dispersed in culture medium 
(Figure 3.2). 
 
Figure 3.1. Size, colloidal stability and composition of the produced particles. Representative TEM image 
(A), hydrodynamic diameters distribution at pH 7 in water (B), variation of zeta potential with pH (C) and 
TGA data for MNP-DMSA and MNP-DMSA-GA (D). 
In order to access the amount of GA attached to the particles, TGA and DTA were 
performed. The TGA curve of MNP-DMSA reveals a weight loss of ~ 11% due to the removal of 
DMSA molecules (second and third steps of weight loss, between 150ºC and 800ºC, in Figure 
3.1 D), which are lost mainly at ~219ºC, corresponding to the exothermic peak in the DTA curve 
(Figure 3.3). On the other hand, between 145ºC and 400-450ºC, there is a ~32% loss of weight 
in the TGA curve of MNP-DMSA-GA (Figure 3.1 D), with maximum loss rate at 290ºC, 
represented by the exothermic peak of the DTA curve at this temperature (Figure 3.3). The 
observed weight loss can be attributed to GA decomposition (burning).
22,23 
This information 
allows deducing that GA represents approximately 21% of the particles total weight. Taking into 
account that the average hydrodynamic diameter is 344 nm, the density of Fe2O3 is 4.89 g/cm
3
, 
the molecular weight of GA is about 2.5 ⨯ 10
5 22
 and the iron oxide cores are spherical, with 
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approximately 7 nm diameter, the magnetic clusters are composed of approximately 0.7 
molecules of GA per iron oxide core.  
 
Figure 3.2. MNP-DMSA-GA colloidal stability over time, in different conditions. (A) Hydrodynamic diameter 
(Z-Average) variation versus settling time. (B) Hydrodynamic diameter (Z-Average) variation upon re-
suspension after one week of settling.  
 
Figure 3.3. Differential Thermal Analysis (DTA) of MNP-DMSA and MNP-DMSA-GA. 
The presence of the GA shell was also confirmed by FTIR spectroscopy (Figure 2 -3.4) as the 
GA characteristic peak, located at 1036-1071 cm
-1 
and due to C-O stretching vibrations,
24
 is 
present in MNP-DMSA-GA spectrum. A typical amide absorption band, attributed to C=O bond 
stretching vibrations is present at around 1635 cm
-1
 in MNP-DMSA-GA spectrum. In addition, 
there is also a shoulder-like band at 1530-1540 cm
-1
 that resembles the amide II band, being 
associated with the N-H bond bending, C-N and C-C stretching vibrations. This suggests the 
presence of amide bonds resultant from the covalent bond between the DMSA at the surface of 
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the particles and GA, although a contribution from chemical crosslinking of GA chains between 
themselves may also be present. 
 
Figure 3.4. FTIR spectra of MNP-DMSA-GA in comparison with MNP-DMSA and free GA. 
3.3.2. Magnetic properties and relaxivities assessment 
For applications such as MRI cell labeling or magnetic drug targeting, 
superparamagnetic behavior and good induced relaxation properties are of paramount 
importance. As expected, negligible hysteresis was observed in the magnetization experiments 
(Figure 3.5 A), showing that the MNP-DMSA superparamagnetic behavior is maintained after 
the coating with GA. The saturation magnetization of the particles (MS = 39 emu/g(Fe2O3)) is 
also maintained as seen in Figure 3.5 A and Table 3.1. This indicates that the covalent coupling 
protocol did not change the crystalline structure of the magnetic cores. However, the blocking 
temperature (TB) increased from 65 K to 85 K (Figure 3.5 B and Table 3.1) as a result of the 
aggregation of several magnetic cores. The dipolar field created by a MNP is approximately 
proportional to its magnetic moment (and thus to its volume) and decreases with the third power 
of the distance.
25
 Since the magnetic cores maintain their sizes compared to MNP-DMSA, the 
increase in TB can be attributed to enhanced inter-particle magnetic interactions promoted by 
the aggregation. The GA network that surrounds the magnetic cores brings them close together 
in such a way that the inter-particle distance is not enough to reduce dipolar interactions and 
therefore, the magnetic spins couple.
26
 This enhances the mean energy barrier for 
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Figure 3.5. Magnetic properties of MNP-DMSA and MNP-DMSA-GA. (A) Magnetization loops at 250 K; 
(B) Zero Field Cooling (ZFC, dotted line) and Field Cooling (FC, solid line) curves. 
Typically, superparamagnetic iron oxide nanoparticles contribute to the decrease of T2, 
causing a decrease of the MRI image signal (negative contrast), which is visible as a darkening 
effect in the image.
14
 Figure 3.6 A shows the linear relation found between the longitudinal 
(1/T1) and transverse (1/T2) relaxation rates and iron concentration for MNP-DMSA-GA. From 
these lines, it is concluded that, as expected, MNP-DMSA-GA have low longitudinal (0.9 mMs
-1
) 
and high transverse (314.7 mMs
-1
) relaxivities (Table 3.1). The r2/r1 ratio characterizes the 
efficiency of the particles as MRI negative contrast agents. For MNP-DMSA-GA a r2/r1 ratio of 
350 was obtained. Besides depending on the saturation magnetization of the particles, MNP’s 
ability to influence water protons’ relaxation times depend also on the proximity of water 
molecules to the MNP. Here, the type of coating plays an important role.
13,27
 Hydration is a 
relevant factor to enhance r2 relaxivity values, especially for small core particles.
28
 In the case of 
MNP-DMSA-GA, the large r2 is probably aided by the hydration effect produced by the polymer 
chains network entrapping the small magnetic cores. Water molecules enter the network of GA 
surrounding the particle cores and are held there for long periods of time, increasing the water 
concentration closer to the high-field region, created by the magnetic cores inside the 
agglomerate. The obtained r2/r1 value is much higher than that of commercial Endorem/Feridex 
(r2/r1 of 83) at the same magnetic field strength.
29
 This contrast agent also has a polysaccharide 
coating (dextran). We, thus, anticipate that GA-coated MNP would be expected to increase the 
efficacy of MRI contrast in comparison with Endorem/Feridex. High r2/r1 ratios imply that low 
concentration of particles is sufficient to obtain the darkening effect in a T2-weighted MRI image, 
increasing the sensitivity of the technique. As seen in the T2-weighted phantom MRI images of 
MNP-DMSA-GA water dispersions (Figure 3.6 B), MRI signal intensity lowers with the increase 
Chapter 3: Covalent coupling of gum Arabic onto superparamagnetic iron oxide nanoparticles for MRI cell 
 labeling: physiochemical and in vitro characterization 
77 
of particles’ concentration (image contrast increases). Even for the lowest concentration of 
particles, there is a signal difference between the MNP sample and water. 
 
Figure 3.6. Relaxivities and T2-MRI phantoms of MNP-DMSA-GA. (A) Linear adjustment of the plots of R1 
(1/T1) and R2 (1/T2) as a function of iron concentration in MNP-DMSA-GA. (B) T2-weighted MRI phantom 
images of water dispersions of MNP-DMSA-GA at different iron concentrations, obtained under a magnetic 
field of 7 T and using a multi-echo image sequence (TR = 5 s; Tt = 8 ms). 
Table 3.1. Summary of size, magnetic and relaxometric properties of the produced MNP in comparison 



























11 14.9 (3.4) 0.31 -30 (6.0) 38 65 2.6 110 42.3 
MNP-
DMSA-GA 
















Standard deviation is represented within brackets, when applicable. 
3.3.3. Cell-nanoparticle interactions 
The effects of GA coated particles and their precursor MNP-DMSA on the metabolic 
activity of HCT116 cells was evaluated using the MTT assay after 48 h of exposition (Figure 3.7 
A). This epithelial cell line was chosen as model to test the particles due to its high proliferation 
(doubling time ~ 21.2 h).
30
 At the lower iron concentrations (5 and 15 µg/ml) the average viability 
is still higher than 80% for both particle types, but it decreases with the increase in particles 
concentration in the culture medium. The decrease is more pronounced for MNP-DMSA-GA and 
for the same iron concentration, average viability is lower for cells treated with MNP-DMSA-GA. 
Interestingly, free GA (Figure 3.7 A) and MNP-DMSA are less cytotoxic than their combination 
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in MNP-DMSA-GA. The cytotoxicity of GA coated particles may be related with alterations in the 
structure of GA due to intramolecular reactions during the covalent binding process. Another 
possible reason is the presence of residual amount of chemicals (NHS and EDC) in the particles 
after the chemical linkage of GA to MNP-DMSA. A previous study
11
 reported lower cytotoxicity 
of gum arabic coated MNP up to 20 mg(Fe)/ml. However, comparison with our results is difficult 
due to differences in particle mean hydrodynamic diameter, cell type and incubation times with 
particles. Namely, in the referred study, cells were incubated only for 4 h with particles and were 
allowed to recover for 24 h in fresh culture medium prior to the MTT assay. Lower incubation 
times would probably cause less cytotoxicity to the cells tested in our work, even incubating with 
a higher concentration of MNP.
11,12
 The adjustment of viability data (extended up to particle 
concentration of 150 g/ml) to a dose-response curve (Figure 3.7 B) provided relative IC50 
values (particle concentration that induces a cell viability corresponding to the point halfway 
between 100% and the baseline)
18
 of 43 µg(Fe)/ml and 55 µg(Fe)/ml for MNP-DMSA-GA and 
MNP-DMSA, respectively, confirming the higher toxicity of MNP-DMSA-GA. 
 
Figure 3.7. Determination of the nanoparticles and GA effects on HCT116 cell viability. (A) Cell viability 
evaluation by the metabolic MTT assay for HCT116 cells exposed to MNP-DMSA, MNP-DMSA-GA and 
free GA. (B) Determination of the IC50 for MNP-DMSA and MNP-DMSA-GA. Viability results are presented 
as the average and standard deviation of three independent assays. 
Prussian blue and neutral red staining (Figure 3.8) show that after incubation with MNP-
DMSA and MNP-DMSA-GA at the respective IC50 for 48 h (Figure 3.8 B and 3.8 C), cell 
morphology and size is identical to control cells, incubated without particles (Figure 3.8 A). It is 
also visible that, compared to MNP-DMSA, much more MNP-DMSA-GA were uptaken by cells 
and that particles appear to be localized in the cell cytoplasm. Quantification of the iron content 
found in the well supernatants and cellular fraction after 48 h incubation with MNP-DMSA-GA 
and MNP-DMSA shows that these particles distribute differently in the cell culture (Figure 3.8 
D). In accordance with the Prussian blue images, a much larger percentage of the total iron is 
found in the cellular fraction (internalized and adsorbed particles) after exposure to MNP-DMSA-
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GA (74%) than after exposure to MNP-DMSA (4%) (Figure 3.8 D and Table 3.2). This 
corresponds to 17 pg(Fe)/cell (11.4×10
-5 
% of total iron per cell) after incubation with MNP-
DMSA-GA against 1 pg(Fe)/cell (0.6×10
-5 
% of total iron per cell) after incubation with MNP-
DMSA. We conclude that GA coating promotes a 19-fold increase in the percent of iron 
internalized per cell. This tendency maintains for shorter incubation periods with particles 
(Figure 3.9) and the amount of iron bound per cell due to MNP-DMSA-GA is maintained 
approximately constant, indicating that the interaction kinetics is fast (less than 12h). 
 
Figure 3.8. In vitro interactions of MNPs with HCT116 cells observed by microscopy and iron uptake 
quantification. Prussian blue and neutral red staining of cells incubated for 48h (A) without MNP, (B) with 
MNP-DMSA at the IC50 (55 g/ml) and (C) with MNP-DMSA-GA at the IC50 (43 g/ml). (D) Proportion of 
iron found in cellular and supernatant fractions, quantified by ICP. (E) Detail of the Prussian blue staining 
of cells incubated with MNP-DMSA-GA. (F) Same region stained with the fluorescent Hoeschst 33258 and 
(G) superimposition of E and F. Scale bar: 10 µm. 
Several factors may contribute to justify the higher affinity of MNP-DMSA-GA to 
HCT116 cells than MNP-DMSA, namely the differences in hydrodynamic size and surface 
chemistry. It is documented that the nature of the protein corona that forms upon dispersion of 
the nanoparticles in complete culture medium depends on the MNPs physiochemical properties 
and influences the interaction with cells.
31,32
 Also, uptake of MNP with more negative surface 
charge is lower than uptake of positively or less negatively charged particles and the increase of 
the agglomerate size also promotes internalization.
33
 Although the expression of the gene 
coding for asialoglycoprotein receptor in HCT116 cell line is not documented, it is known that 
other colorectal carcinoma cell lines express this membrane receptor,
34,35
 responsible by cell 
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membrane interactions with galactose residues of polysaccharides. Given the high content of 
galactose in gum arabic,
5
 further studies to access the presence of asialoglycoprotein receptor 
in HCT116 cell line could help to understand the uptake mechanism of MNP-DMSA-GA. 
 
Figure 3.9. Effect of particle incubation time on the amount of iron per cell, quantified by ICP. 
Table 3.2. Quantitative characterization of the cell-nanoparticles interactions. 
 
% mt (Fe) 
%mt (Fe) uptaken per 
cell (⨯10-5) 
m (Fe) uptaken per cell 
(pg) 
cellular supernatant 
Time point 12h 24h 48h 12h 24h 48h 12h 24h 48h 12h 24h 48h 
MNP-
DMSA 
7.1 5.9 3.7 92.9 94.1 96.3 1.9 0.7 0.6 4.0 1.5 1.3 
MNP-
DMSA-GA 
56.9 69.5 74.3 43.1 30.5 25.7 12 11 11.4 18.2 19.3 17.3 
 
The comparison of neutral red and Hoechst 33258 staining images (Figure 3.8 E, F and 
G) confirms that the internalized MNP-DMSA-GA accumulate in the cytoplasm and do not enter 
the nucleus, as expected, due to their large size. Superimposition of bright field and 
fluorescence images of cells stained with propidium iodide and DAPI better evidences the 
preferential accumulation in regions surrounding the nucleus (Figure 3.10) in structures that 
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Figure 3.10. Bright field and fluorescence microscopy images of cells incubated for 48 h with MNP-DMSA-
GA at IC50. (A) Bright field; (B) Cellular staining with propidium iodide; (C) nuclear staining with DAPI. 
Agglomerates of nanoparticles are detected as black dots and are indicated by the red arrows in A, B and 
C. Scale bar: 10 µm. 
 
Figure 3.11. Localization of MNP-DMSA-GA within HCT116 cells after 48h incubation at IC50. (A) Bright 
field, (B) GFP labeling of lysosomes, (C) nuclei counterstained with DAPI and (D) merged images. Scale 
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Nuclear staining with Hoechst 33258 was also used to evaluate the effects of particles 
in nuclear morphology (Figure 3.12). The majority of non-treated cells (Figure 3.12 A) presented 
nuclei with homogeneous distribution of fluorescence, indicating the presence of uncondensed 
chromatin dispersed through the whole nucleus, which is representative of viable interphase 
cells. Cells treated with particles at the respective IC50 values show some evidence of apoptotic 
nuclei, namely chromatin condensation and nuclear fragmentation, as indicated by the bright 
non-homogeneous fluorescence (Figures 3.12 B and 3.12 C). Cell division is apparently not 
compromised, as some mitotic nuclei are also highlighted by Hoechst fluorescence.  
 
Figure 3.12. Hoechst 33258 fluorescent staining of HCT116 cells nuclei. (A) control cells (no MNPs); (B) 
cells incubated with MNP-DMSA at its IC50 (55 µg/ml) and (C) cells incubated with MNP-DMSA-GA at its 
IC50 (43g/ml). Scale bar: 10 µm. 
To understand whether the decrease of cell viability caused by MNP-DMSA-GA at IC50 
is related with an increased apoptotic response, a time course real-time PCR analysis of mRNA 
levels of apoptotic (p21 and BAX) and anti-apoptotic (BCL-2) genes was performed (Figure 
3.13). The quantification revealed that 3.5h after addition of MNP-DMSA-GA, the pro-apoptosis 
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genes p21 and BAX were overexpressed compared to untreated control cells while the anti-
apoptotic gene BCL-2 had approximately the same expression as in control cells (Figure 3.13). 
This behavior suggests an almost immediate trigger of an apoptotic response upon cell-MNP 
contact (ratio BAX/BCL-2 of 3.6). However, the response is suppressed after 6h and 12h of 
incubation, as the expression levels of the pro- and anti-apoptotic genes is reversed (ratio 
BAX/BCL-2 of 0.5) (Figure 3.13). This result suggests that there is an adaptation to the 
presence of nanoparticles in the culture medium. Nevertheless, at 48h of incubation the ratio 
BAX/BCL2 slightly increases (1.3) indicating that cells may be triggering an apoptotic response 
due to prolonged exposition to MNP-DMSA-GA (Figure 3.13). Therefore, the reduction of 
viability quantified by the MTT assay at 48h incubation with MNP-DMSA-GA (administered at 
the IC50) may in part be associated with an apoptotic response. Since MTT assay is a metabolic 
test based on mitochondrial activity, loss of mitochondrial metabolism without loss of cell 
viability may also contribute to explain the observed MTT results. 
 
Figure 3.13. Fold changes in pro-apoptotic (p21 and BAX) and anti-apoptotic (BCL-2) genes expression at 
3.5h, 6h, 12h, and 48h after cell incubation with MNP-DMSA-GA at IC50 (43g/ml). 
Given the high relaxivity of MNP-DMSA-GA and enhanced cellular uptake compared to 
MNP-DMSA, their efficacy for cell labeling by MRI was evaluated (Figure 3.14). Hypointense 
regions indicating the presence of particles inside (or strongly bound to the surface) of cells are 
clearly visible in the images of cells incubated with MNP-DMSA-GA in contrast to untreated 
control cells or cells incubated with MNP-DMSA for all concentrations (Figure 3.14 A). This 
behavior indicates that GA coating contributes for the efficacy of the particles as MRI contrast 
agent and is in accordance with other study, where a different cell line was used.
11
 In addition, 
for MNP-DMSA-GA, hypointensity increases (grey density decreases) with increasing 
concentration of incubated particles, as shown by the histograms of the images (Figure 3.14 B) 
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and respective grey density quantification (Figure 3.14 C). In other words, for the same number 
of HCT116 cells, MNP-DMSA-GA give dose-dependent MRI signal, indicating that particle 
uptake increases with the administered dose. 
 
Figure 3.14. Evaluation of in vitro MRI cell labeling efficiency with MNP-DMSA and MNP-DMSA-GA. (A) In 
vitro MRI images of HCT116 cells incubated with increasing concentrations of MNP-DMSA and MNP-
DMSA-GA, from C1 to C3, compared with untreated control cells;(B) histograms of in vitro MRI images of 
cells incubated with MNP-DMSA-GA and (C) quantification of grey density of images in (A). C1 = IC50-
0.25⨯IC50; C2 = IC50; C3 = IC50+0.25⨯IC50. 
3.4. Conclusions 
We have obtained very stable dispersions of monodisperse superparamagnetic 
particles (PdI = 0.2) composed by several magnetic cores entrapped in a shell of GA, with 
hydrodynamic diameter of 344  87 nm. GA was shown to contribute to high transverse and low 
longitudinal MR relaxivity values (r2/r1 ratio of 350), resulting in good MRI contrast enhancement 
properties, observed both in phantom images of water dispersion of MNP-DMS-GA and in in 
vitro MRI images of HCT116 cells incubated with different concentrations of particles. By 
quantification of the cellular iron after incubation for 48h with particles, we showed that GA 
coating on MNP-DMSA enhances MNP cellular uptake by 19 times compared to MNP-DMSA 
alone. Incubation for different periods revealed that the iron uptake kinetics for MNP-DMSA-GA 
is fast (less than 12h) and cellular uptake is always enhanced compared to uncoated 
nanoparticles. After 48h of incubation, MNP-DMSA-GA localize in the lysosomes, which 
suggests uptake by endocytosis but the evaluation of the presence of asialoglycoprotein 
receptors in the HCT116 cell line could give new insights on MNP-DMSA-GA cellular uptake 
mechanism. We also found out that HCT116 cell line is very sensitive to MNPs, given the 
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observed dose-dependent cell viability decrease in MTT assay at the tested iron concentrations 
(IC50 values of 55 µg/ml for MNP-DMSA and 43 µg/ml for MNP-DMSA-GA). Apoptotic response 
was detected by up-regulation of pro-apoptotic genes p21 and BAX and down-regulation of anti-
apoptotic gene BCL-2 after 3.5h and also at 48h of incubation with the MNP-DMSA-GA 
nanoparticles (but to a lesser extend in this last time point). Nonetheless, given the large 
hydrodynamic diameter and the good MRI contrast enhancement properties, MNP-DMSA-GA 
present potential for in vitro MRI cell labeling applications. Further modification of GA (for 
example with a fluorophore or radionuclide) would contribute for a multimodal contrast agent, 
allowing to follow the labeled cells by MRI and other imaging technique(s). 
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Chapter 4 
A value-added exopolysaccharide as a coating agent 
for MRI nanoprobes 
Fucopol, a fucose-containing exopolysaccharide (EPS) produced by the bacterium 
Enterobacter A47 DSM 23139 using glycerol as a carbon source, was employed as a new 
coating material for iron oxide magnetic nanoparticles (MNP). The coated particles were 
assessed as nanoprobes for cell labeling by Magnetic Resonance Imaging (MRI). The MNP 
were synthesized by a thermal decomposition method and transferred to aqueous medium by 
ligand-exchange reaction with meso-2,3-dimercaptosuccinic acid (DMSA). Covalent binding of 
EPS to DMSA-stabilized nanoparticles (MNP-DMSA) resulted in a hybrid magnetic-biopolymeric 
nanosystem (MNP-DMSA-EPS) with a hydrodynamic size of 170 nm, negative surface charge 
at physiological conditions and transverse to longitudinal relaxivities ratio, r2/r1, of 148. In vitro 
studies with two human cell lines (colorectal carcinoma - HCT116 - and neural stem/progenitor 
cells - ReNcell VM) showed that EPS promotes internalization of nanoparticles in both cell lines. 
In vitro MRI cell phantoms also showed superior performance of MNP-DMSA-EPS in ReNcell 
VM, for which iron dose-dependent MRI signal drop was obtained at relatively low iron 
concentrations (12 - 20 µg Fe/ml) and short incubation time. Furthermore, ReNcell VM 
multipotency was not affected by culture in the presence of MNP-DMSA or MNP-DMSA-EPS for 
14 days. Our study suggests that Fucopol-coated MNP represent useful cell labeling 
nanoprobes for MRI.  
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4.1. Introduction  
Iron oxide magnetic nanoparticles (MNP) represent an interesting platform with 
application in several areas, particularly in the biotechnological and biomedical fields, due to 
their biocompatibility and superparamagnetic properties. In the last two decades, a large 
number of research studies evaluated the use of MNPs in magnetic resonance imaging (MRI), 
in hyperthermia, as multimodal imaging agents, as nanovectors for drug and gene delivery, or in 
a combination of these imaging and therapeutic functions to build theranostic nanosystems.
1–3
 
Interactions between biological environment and MNPs are mediated by the coating material 
and functionalization, which allow to tailor the MNPs in terms of specific cell-type targeting, drug 
release, cellular uptake, multifunctionality or in vivo stealth properties. Hydrophilic coatings, 
usually composed of small molecules (e.g. meso-2,3-dimercaptosuccinic acid (DMSA)) or 
polymers, either synthetic (e.g. polyethyleneglycol (PEG)) or natural (e.g. dextran), are preferred 
due the compatibility with biological media and the ability to provide colloidal stabilization to the 
nanosystem.  
Clinical application of MNPs is subjected to approval by health regulatory agencies (eg. 
Food and Drug Administration - FDA), which require the particles to be biodegradable following 
their administration.
4
 Since inert synthetic coatings or encapsulation matrices are mostly not 
biodegradable, polysaccharides are appealing alternative materials. They are abundant in 
nature, hydrophilic, biodegradable and generally accepted as biocompatible. In addition, 
availability of functional groups for chemical modification
5
 make polysaccharide-coated MNPs 
versatile nanoplatforms. Indeed, iron oxide based commercial MRI contrast agents are typically 
coated with dextran or chemically modified versions of this bacterial polysaccharide (e.g. 
Ferumoxides (Feridex/Endorem) from Advanced Magnetics (USA) and Ferucarbotran 
(Resovist), from Bayer Shering Pharma AG (Germany)).
6
 Exopolysaccharides (EPSs) are 
polysaccharides secreted to the extracellular environment by many microorganisms. The 
extracellular nature of EPS simplifies their extraction process. EPS are mostly composed of 
neutral monosaccharides but in some cases amino-sugars and/or acidic sugars are also part of 
the composition. Some non-carbohydrate substituents (such as acetate, pyruvate, succinate, 
and phosphate) are also found in many microbial EPS.
7
 Although dextran is still the most used 
microbial polysaccharide to coat MNPs for imaging, diagnosis and treatment,
8
 other EPSs have 
been studied and reviewed in the literature.
5
 For example, multifunctional MNP bearing a 
targeting moiety and an anticancer drug were developed based on EPS (mauran and gellan) 
coatings  and showed potential for imaging and magnetic hyperthermia.
9
 Similarly, pullulan 
derived coatings originated MNPs with potential for magnetic hyperthermia in human 
nasopharyngeal epidermal carcinoma cell line
10
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Fucopol is an EPS produced by Enterobacter A47 DSM 23139 using glycerol as the 
sole carbon source.
7
 It is composed of fucose, galactose, glucose, pyruvate, succinate and 
acetate in the molar ratios 1.6:1.3:1.1:1.2:0.7:1.5. The polymer possesses a residual protein 
fraction of 5 wt.%.
7
 This environmentally-friendly, sustainable EPS is considered a high added 
value product because, in addition to good flocculating and emulsion stabilizing properties, it is 
rich in fucose, which is one of the rare sugars, difficult to obtain but with many applications, from 
pharmaceutical to cosmetics.
7
 Preparations containing fucose, fucose-containing oligomers or 
polymers were shown to have biological properties such as anti-carcinogenic, anti-inflammatory 
and induction of neuronal growth.
7,12
 Our research group has previously shown the good 
performance of Fucopol as a coating material of magnetic particles employed in human 
antibody purification.
13
 Due to the biological importance of fucose and the properties of the EPS, 
it was explored as a coating material for magnetic nanoparticles intended for biomedical 
applications, in particular, as MRI contrast agents. 
Fucopol was covalently bound to meso-2,3-dimercaptosuccinic acid-functionalized MNP 
and the resulting nanosystem (MNP-DMSA-EPS) was characterized regarding its composition, 
size, magnetic and relaxometric properties. After evaluation of MNP-DMSA-EPS in vitro 
cytotoxic potential, the respective cell labeling efficacy was studied in two human cell lines (a 
colorectal cell line and a neural stem/progenitor cell line). Prussian blue staining, fluorescence 
microscopy, chemical quantification of iron internalization and in vitro MRI of cell phantoms were 
employed to assess the efficacy of the nanoprobes. 




 was produced by cultivation of the bacterium 
Enterobacter A47 DSM 23139, using glycerol as the sole carbon source, under controlled 
bioreactor conditions, as previously described.
11
 The polymer was recovered from the culture 
broth by dialysis of the cell-free supernatant and freeze-dried. 
4.2.2. Synthesis and phase transfer of iron oxide magnetic nanoparticles (MNP-DMSA) 
Hydrophobic iron oxide magnetic nanoparticles were synthesized by the thermal 
decomposition of iron tri(acetylacetonate) in benzyl ether using 1,2-tetradecanediol as reducing 
agent, and oleic acid and oleylamine as surfactants.
14
 To render these MNP hydrophilic a 
ligand-exchange reaction with DMSA was employed.
15
 Briefly, a toluene dispersion of 
hydrophobic MNP was mixed with a solution of DMSA in dimethylsulfoxide (DMSO). After 48 h 
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incubation at room temperature, the solvent containing the oleic acid and oleylamine was 
discarded and the black hydrophilic nanoparticles were re-dispersed in ethanol. After several 
washes by centrifugation the nanoparticles were re-dispersed in milliQ water, basified to pH 10 
and dialyzed against milliQ to provide the final DMSA coated MNP (MNP-DMSA). 
4.2.3. Preparation of EPS-coated magnetic nanoparticles (MNP-DMSA-EPS) 
Fucopol was covalently coupled onto the hydrophilic MNP-DMSA using carbodiimide 
chemistry. A Fucopol solution (5 mg/ml, in phosphate buffer, 0.1 M, pH 7.6) was prepared and 
centrifuged to remove any unsolubilized polymer fraction. Only the supernatant (3.7 ± 0.7 mg 
Fucopol/ml, quantified through the anthrone test
16
) was used for the coating reaction. To 
activate the carboxylic acid groups of DMSA, N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide 
(EDC) and N-Hydroxysuccinimide (NHS) were added to 2 ml of MNP-DMSA (2 mg/ml, in MES 
buffer, 0.1 M, pH 6) at the concentration of 2 mM and 50 mM, respectively, followed by 15 min 
of incubation in a rotating agitator (Stuart, SB3) (20 rpm) at room temperature. Then, the pH 
was adjusted to 7.6 and the activated MNP-DMSA were added dropwise to the polymer solution 
under vigorous (700 – 1000 rpm) magnetic agitation. The reaction continued in a rotating 
agitator (20 rpm) overnight at room temperature. MNP-DMSA-EPS were recovered by several 
cycles of centrifugation (9000 rcf, 15 min) and replacement of the supernatant by milliQ water. 
The larger aggregates were magnetically removed using a magnetic separator for 
microcentrifuge tubes (Bilatest M12+12, Sigma Aldrich). 
4.2.4. Characterization of magnetic nanoparticles 
Particle size and shape were characterized by Transmission Electron Microscopy 
(TEM) using a 100-kV JEOL JEM1010 microscope equipped with a Gatan Orius 200 SC digital 
camera. Hydrodynamic size (dh) and zeta potential of the particles were determined using a 
Nanosizer ZS (Malvern). The mean value of the intensity-weighted size distribution, measured 
at pH 7, was used as dh. Zeta potential variation with pH was measured in a 0.01 M KNO3 
solution (HNO3 or KOH solutions were used for pH adjustment). To evaluate the particles’ 
hydrodynamic diameter stability in physiological conditions, we have analyzed the Z-Average 
value of samples dispersed in both Phosphate Buffered Saline (0.01 M; with 0.15 M NaCl, pH 
7.4) (PBS) and Dulbecco’s Modified Eagle’s culture medium supplemented with bovine serum. 
Two time points were studied: t = 0 h (at the moment of the nanoparticles dispersion) and t = 2 h 
(2 h after the preparation of the nanoparticles dispersion. Inductively coupled plasma - atomic 
emission spectroscopy (ICP-AES) (Horiba Jobin-Yvon, Ultima) was used to determine the iron 
content of the MNP samples. Fourier transform infrared (FTIR) spectra were acquired using a 
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Nicolet 20 SXC FTIR. Thermogravimetric analysis (TGA) of MNP-DMSA and MNP-DMSA-EPS 
powder was carried out in a Seiko TG/DTA 320 U, SSC 5200 thermobalance. 
Magnetization measurements were performed using a vibrating sample magnetometer 
(VSM) (MagLab VSM, Oxford Instruments). Magnetization loops were measured at 250 K, 
corrected by subtracting the diamagnetic contribution of the dispersants (50 l) and the sample 
holder, and normalized to the saturation magnetization value (mmax) of each sample.  
Temperature dependent zero-field cooling (ZFC) and field cooling (FC) magnetization 
measurements were performed by cooling the samples to 5 K under a zero or a 0.01 T 
magnetic field, respectively. Then, the magnetization was measured while the samples were 
heated (3 K/min) to 250 K under a 0.01 T field.  
The relaxometric properties of MNP-DMSA-EPS were evaluated in a 7 T NMR Brucker 
Avance III Spectrometer at 25ºC. Water suspensions of MNP-DMSA-EPS at different iron 
concentrations were prepared. Longitudinal relaxation time T1 was measured using an inversion 
recovery pulse sequence with TR between 3 and 10 s. Transverse relaxation time T2 was 
measured using a Call-Purcell-Meiboom-Gill pulse sequence with TE of 1 ms and the number of 
echoes needed to cover a time interval of about 10 times T2. Longitudinal (R1 = 1/T1) and 
transversal (R2 = 1/T2) relaxation rates were plotted against iron concentration and a linear 
behavior was found. The lines slopes are the longitudinal (r1) and transverse (r2) relaxivities, that 
measure the efficiency of the nanoparticles as MRI contrast agents. T2-weighted MRI phantom 
images of MNP-DMSA-EPS water suspensions at 0.1, 0.4, 0.8 and 1 mM (Fe) were obtained 
with a multi-echo image sequence (TR = 5 s; Tt = 8 ms). 
4.2.5. Cell culture and labeling 
Two adherent human cell lines were used in this work: a colorectal carcinoma cell line 
(HCT116) and a neural stem/progenitor cell line (ReNcell VM). HCT116 cells were cultured in 
Dulbecco’s modified Eagle’s medium (DMEM, Life Technologies) supplemented with 10% (v/v) 
fetal bovine serum (Life Technologies) and 1% (v/v) of penicillin-streptomycin (Life 
Technologies) at 37 ºC with 99% relative humidity and 5% CO2. ReNcell VM cells were seeded 
in tissue culture plates or glass coverslips sequentially coated with poly-L-ornithine (Sigma-
Aldrich, 15 μg/ml, 30 min at 37°C) and laminin (Sigma-Aldrich, 10 μg/ml, 3 h at 37°C), and 
cultured in DMEM/F12 medium supplemented with 20 ng/ml EGF (Prepotech), 20 ng/mlL FGF-2 
(Peprotech), 1% N2 supplement (Life Technologies), 20 μl/ml B27 supplement (Life 
Technologies), 20 μg/ml additional insulin (Sigma-Aldrich), 1.6 g/l additional glucose (Sigma-
Aldrich) and 1% penicillin/streptomycin at 37ºC and 5% CO2 humidified environment. 
Cells were incubated under the standard conditions referred above until 70-80% 
confluence was reached. Cells were then labeled by incubating with the corresponding culture 
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medium with different concentrations of MNPs for 48h (in the case of HCT116)
17
 or for 4h 
followed by 24h recovery in fresh culture medium (in the case of ReNcell VM).
18,19
 Nanoparticles 
were sterilized by filtration with a sterile membrane filter of 0.20 µm pore diameter (MNP-DMSA) 
or by autoclaving 20 min at 120ºC (MNP-DMSA-EPS). 
4.2.6. Multi-lineage differentiation of ReNcell VM 
ReNcell VM differentiation into neuronal and glial lineages was induced by changing the 
culture medium and withdrawing EGF and FGF-2. Cells were cultured using a 1:1 mixture of 
DMEM/F12 supplemented with N2 (1x) and Neurobasal medium (Life Technologies) 
supplemented with B27 (1×). Medium was changed every 2-3 days. The differentiation process 
was carried out for 14 days. 
Differentiation was evaluated by immunostaining for the neuronal marker β-III Tubulin 
(Tuj1, Covance) and for astrocyte marker glial fibrillary acidic protein (GFAP, Millipore). Cells 
were fixed with paraformaldehyde (PFA, 4%, Sigma) for 30 min at room temperature, and then 
washed twice with phosphate buffered saline (PBS, Life Technologies). Cells were incubated for 
45 min at room temperature with blocking solution (PBS with 0,1% Triton X-100 and 10% 
normal goat serum (NGS)). Afterwards, cells were incubated at 4°C overnight with the primary 
antibodies diluted (Tuj1 1:2000, GFAP 1:100) in staining solution (PBS with 0,1% Triton X-100 
and 5% NGS). Cells were then washed once with PBS and incubated with the appropriate 
secondary antibody (Life Technologies, dilution 1:500) for 1 h at room temperature in a dark 
container. Finally, cells were washed once with PBS, incubated with DAPI (1.5 μg/ml in PBS, 
Sigma) for 2 min at room temperature and washed twice with PBS. The stained cells were 
visualized under a fluorescence microscope (Leica DMI 3000B). 
4.2.7. Cytotoxicity evaluation 
The impact of nanoparticles and Fucopol on the viability of HCT116 and ReNcell VM 
cultures was evaluated using a standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) colorimetric assay as described previously.
20
 Briefly, cells were seeded in 96 
well plates at 7.5 ×10
3
 cells/well and labeled with MNP-DMSA and MNP-DMSA-EPS at different 
iron concentrations. Cells were also incubated with EPS at concentrations corresponding to the 
EPS content in MNP-DMSA-EPS at the chosen iron concentrations (calculated from TGA data). 
After labeling, the culture medium was removed and replaced by fresh medium 
containing MTT (0.45 mg/ml). After 3 h of incubation in standard culture conditions, the medium 
was replaced by dimethyl sulfoxide (DMSO, Sigma-Aldrich) to dissolve the formazan crystals 
obtained as a result of MTT metabolization. The absorbance of the wells at 540 nm 
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(abs@450nm) and 630 nm (abs@630nm) was measured in a microplate reader (Microplate 
Titre Infinite F200, TECAN Spectra). Cell viability was calculated using the equation: 
 𝑐𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (%) =  
(𝑎𝑏𝑠@540𝑛𝑚 − 𝑎𝑏𝑠@630𝑛𝑚)𝑠𝑎𝑚𝑝𝑙𝑒
(𝑎𝑏𝑠@540𝑛𝑚 − 𝑎𝑏𝑠@630𝑛𝑚)𝑐𝑜𝑛𝑡𝑟𝑜𝑙
× 100 (4.1) 
where sample refers to cells incubated with nanoparticles or EPS, and control refers to cells 
without nanoparticles or EPS. 
Determination of the half maximal inhibitory concentration (IC50) for each nanoparticle 
type and EPS was performed by fitting the viability data to a dose-response sigmoidal curve.
20
 
4.2.8. Identification of cellular iron by Prussian blue staining 
For bright field microscopy observation, cells were seeded in coverslips on the bottom 
of the wells of 24-well plates at 1×10
5
 cells/well, incubated in standard conditions and labeled 
with MNP-DMSA (55 µg Fe/ml for HCT116 and 50 µg Fe/ml for ReNcell VM) or MNP-DMSA-
EPS (82 µg Fe/ml for HCT116, and 16 µg Fe/ml for ReNcell VM). After labeling, cells were 
stained with Prussian blue for iron identification and counterstained with neutral red as 
described previously
20
 and visualized by bright field microscopy. Slides were observed using an 
Olympus CX41 microscope equipped with an Olympus SC30 camera. 
4.2.9. Intracellular localization of magnetic nanoparticles 
To determine the intracellular location of MNP-DMSA-EPS, fluorescent labeling of 
lysosomes with GFP was performed and preparations were observed under fluorescence and 
bright field microscopy to look for co-localization of nanoparticles and lysosomes. HCT116 and 
ReNcell VM cells were seeded in coverslips at the bottom of 35 mm petri dishes or wells of 24-




, cultured in standard conditions and labeled with MNP-DMSA-EPS 
at 82 µg Fe/ml and 16 µg Fe/ml, respectively. 20 h before the end of the incubation time, Cell-
Light Lysosomes-GFP, BacMam 2.0 reagent (Life Technologies, USA) was added directly to the 
cells (25 particles per cell) and left incubating overnight. Cells were, then, washed with PBS and 
fixed with ice-cold paraformaldehyde (4% v/v in PBS). The preparation was air dried and 
mounted in the microscope slide using 5 µl of DAPI solution. Slides were observed using an 
Olympus BX51 microscope equipped with an Olympus DP50 camera and the Cell F View Image 
System Software. 
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4.2.10. Iron quantification 
Cells were plated at 1×10
5
 cells/well in 24-well plate wells, cultured in standard 
conditions and labeled with MNP-DMSA (54 µg Fe/ml for HCT116, and 46 µg Fe/ml for ReNcell 
VM) or MNP-DMSA-EPS (57 µg Fe/ml for HCT116, and 16 µg Fe/ml for ReNcell VM), as 
quantified by ICP in the culture media. After labeling, the supernatant was collected from each 
well and cells were detached from the wells, re-suspended in culture medium, counted using a 
hemocytometer and centrifuged for 10 min at 5000 rpm. Cell pellet (fraction 1), cell supernatant 
(fraction 2) and well supernatant (fraction 3) were separately digested with 100 µl of aqua regia 
for 30 min at 90ºC, diluted to 1 ml with milliQ water and analyzed separately for iron by ICP-
AES. The iron in the cellular fraction (sum of fraction 1 and fraction 2) was normalized to the 
number of cells and to the total mass of iron (sum of the three fractions).  
4.2.11. In vitro MRI of cell phantoms 
Cells were plated in 24-well plates at 1×10
5
 cell/well, cultured in standard conditions 
and labeled with MNP-DMSA-EPS at three increasing iron concentrations (61.5, 82 and 102.5 
µg Fe/ml for HCT116 cells and 12, 16 and 20 µg Fe/ml for ReNcell VM cells). After labeling, 
cells were prepared for MR imaging as described previously.
20
 Briefly, cells were washed, 
collected by centrifugation, fixed with cold paraformaldehyde, re-dispersed in PBS and counted 
using a hemocytometer. 3×10
5
 HCT116 cells and 5.7×10
5
 ReNcell VM cells were dispersed in 
0.1 ml of PBS, mixed with 0.2 ml aliquots of fresh 0.75% (m/v) agarose and transferred to 5 mm 
diameter NMR tubes for imaging after solidifying. T2-weighted MR images were obtained in a 
magnetic field of 7 T, at 25 ºC, using a Bruker Avance III Spectrometer (160 G/cm imaging 
gradient) and a Flash imaging sequence (TR = 110 ms, TE = 1.7 ms, with a 20º excitation angle 
and NEX of 32). MRI signal was quantified using ImageJ software (National Institutes of Health) 
to calculate the histogram, the average pixel value and the integrated density (sum of all pixel 
values divided by the average pixel value) over a 6 mm
2 
circular region of interest placed in the 
center of each cell phantom image. 
4.3 Results and Discussion 
4.3.1. Particle size, composition and surface chemistry  
Iron oxide magnetic nanoparticles were synthesized by thermal decomposition of 
iron(III) acetylacetonate in benzyl ether in the presence of tetradecanediol, oleic acid and 
oleylamine. The resulting particles are monodisperse but hydrophobic. To render them 
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hydrophilic, the oleic moieties originally at the surface of the particles were replaced by DMSA 
through a ligand-exchange reaction,
15
 leaving carboxylic acid groups at the surface of the 
particles. The carboxylate functionalities were then used as chemical anchors to couple Fucopol 
exopolysaccharide (EPS) through the amine groups of the associated protein. EDC/NHS 
chemistry was chosen to promote the covalent conjugation of the carboxylic and amine groups. 





forms a network that entraps multiple cores of MNP-DMSA (which alone present dh = 15±2 nm; 
dcore= 7±1 nm), forming aggregates with hydrodynamic diameter of 168 ± 40 nm (Figure 4.1 A 
and B) and polydispersity index of 0.25. Each aggregate (particle) is thus estimated to contain 
14000 iron oxide magnetic cores.  
 
Figure 4.1 Characterization of size and composition of the nanoparticles before and after EPS coating. (A) 
Morphology of MNP-DMSA and MNP-DMSA-EPS by TEM (scale bars: 100 nm); (B) hydrodynamic 
diameters; (C) FTIR spectra of particles and EPS; (D) thermogravimetric analysis of particles and EPS; (E) 
evolution of zeta potential with pH.  
Despite being pointed out as a drawback of polysaccharides, the natural batch-to-batch 
variability of Fucopol was not a problem in this work. Namely, no influence on MNP-DMSA-EPS 
size, morphology and colloidal stability was observed when different batches of polymer were 
employed.  
Dispersion of the nanoparticles in physiological media like PBS or cell culture medium 
supplemented with fetal bovine serum (FBS) resulted in aggregation and increase of 
polydispersity (Figure 4.2 A and B, respectively). Interestingly, while MNP-DMSA maintain the 
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Z-Average in PBS and culture medium, MNP-DMSA-EPS show stronger aggregation in PBS 
than in culture medium and, after 2 h of incubation in the later conditions, tend to their native Z-
Average (139 ± 35 nm, measured in water at pH 7). This behavior thus shows that interaction 
with the dispersant is a dynamic process.  
 
Figure 4.2. Variation of hydrodynamic diameter, polydispersity index and zeta potential of MNP-DMSA and 
MNP-DMSA-EPS dispersed in different conditions. (A and C) MNPs dispersed in phosphate buffered 
saline (PBS); (B and D) MNPs dispersed in DMEM culture medium with fetal bovine serum (FBS). 
Measurements were taken immediately after adding the particles to the dispersants and after 2 h of 
incubation in those dispersants.  





, the typical bands from Fe-O bonds vibrations in the spinel structure of 
magnetite.
21
 Compared to MNP-DMSA, extra bands of weak intensity attributed to the oxidation 
of magnetite to maghemite appear together with these two main bands, in particular in the 600 
cm
-1
 region, for MNP-DMSA-EPS.
21
 The coating reaction thus has an effect on the iron oxide 
crystalline structure at the surface of the particles. FTIR was also used to confirm the presence 
of the EPS shell on the nanoparticles. Indeed, the Fucopol fingerprint band (the envelope 




 is also present in MNP-DMSA-EPS spectrum and 
not in that of MNP-DMSA. This band corresponds to skeletal C-O and C-C vibrations bands of 
glycosidic bonds and pyranoid rings.
22
 Also, the less intense band at 1265 cm
-1
, present in both 
EPS and MNP-DMSA-EPS spectra, can be associated with the vibration of C-O-C of acyl 
groups.
22
 The band present at ~1650 cm
-1
 in MNP-DMSA-EPS may be attributed to 




































































































































Chapter 4: A value-added exopolysaccharide as a coating agent for MRI nanoprobes  
100 
through the covalent conjugation of EPS amine and DMSA carboxyl groups. It may also be 
associated with the vibrations of C=O from carboxylates present in EPS. The appearance of a 
band at around 1540 cm
-1
 in the spectrum of MNP-DMSA-EPS that resembles the amide II 
band (associated with N-H bending and C-N stretching vibrations in amide bonds),
23
 confirms 
the effectiveness of the covalent conjugation of EPS onto the nanoparticles.  
The TGA curves (Figure 4.1 D) also support the presence of EPS on MNP-DMSA-EPS 
due to the similar weight loss profiles of this sample and free EPS between 200ºC and 800ºC (a 
first accentuated step at 275ºC followed by a less pronounced and longer step). The curves of 
MNP-DMSA and MNP-DMSA-EPS present an initial weight loss of 5% due to water removal, 
followed by loss of DMSA or DMSA and EPS. MNP-DMSA curve reveals that DMSA is lost at 
around 200ºC and corresponds to approximately 11% of MNP-DMSA total weight. After coating 
with EPS, 40% of the nanoparticles weight is lost (Figure 4.1 D), which means that EPS 
constitutes 29% of the nanoparticles total weight. Taking in consideration the EPS molecular 
weight, the density of Fe2O3 (5.24 g/cm
3
) and the number of cores per aggregate calculated 
above, one can estimate 725 EPS molecules per aggregate, that corresponds to 0.05 EPS 
molecules per core.  
Due to the presence of succinate, pyruvate and glucuronic acid in the composition of 
EPS,
7
 EPS-coated nanoparticles maintain negative zeta potential for pH values higher than 3 
(Figure 4.1 E). However, the presence of salt in solution affects the zeta potential. We observe a 
value of -32 ± 4 mV in milliQ water, at pH 7, which increases to -23.2 ± 0.2 mV when the 
dispersion contains 0.01 M of KNO3. This shows that colloidal stability does not depend only on 
steric interactions between the polymer chains but also on electrostatic interactions. It is known 
that interaction of nanoparticles with complex biological fluids leads to the formation of a protein 
corona that changes the particles’ surface properties and may influence their stability and 
interaction with cells.
24–26
 In this work, besides causing an initial aggregation of MNP-DMSA and 
MNP-DMSA-EPS, the interaction of particles with cell culture medium supplemented with FBS 
increased their surface charge to values near neutral (Figure 4.2. D), probably due to adsorption 
of proteins and other biomolecules that compose the culture medium onto the surface of the 
MNPs.  
4.3.2 Magnetic properties and relaxivities measurements 
The magnetization measurements at room temperature (Figure 4.3 A) revealed that 
MNP-DMSA and MNP-DMSA-EPS present superparamagnetic behavior. Wasp-waist loops are 
observed for both samples (Figure 4.3 A and Figure 4.4 A), but in larger extent for MNP-DMSA-
EPS. This indicates that the iron cores are composed of two distinct magnetic phases
27,28
 and 
that the EPS coating reaction magnified the differences in magnetic anisotropy of those two 
                                 Chapter 4: A value-added exopolysaccharide as a coating agent for MRI nanoprobes 
101 
phases. This is consistent with a core-shell structure for the magnetic cores in MNP-DMSA-
EPS, composed of a well crystalline magnetite core and a more oxidized surface layer, as 
suggested by the FTIR spectra (Figure 4.1 C), and further distorted by the polymer coupling as 
suggested by the saturation at larger fields (Figure 4.3 A). When the exchange between a soft 
magnetic material and a hard material is positive, the loop is conventional. However, for 




Figure 4.3. Evaluation of magnetic and relaxometric properties of MNP-DMSA and MNP-DMSA-EPS. (A) 
Magnetization loops of the nanoparticles before and after coating with EPS, measured at 250 K; (B) 
Determination of longitudinal (r1) and transversal (r2) relaxivity values before and after coating with EPS 
(circles: 1/R1; triangles: 1/R2); (C) In vitro T2-weighted MRI phantoms of water dispersions of MNP-DMSA-
EPS at different iron concentrations. 
To evaluate the potential of the EPS-coated nanoparticles as MRI contrast agent we 
have evaluated their ability to change the proton longitudinal (T1) and transverse (T2) relaxation 
times at room temperature. Figure 4.3 B shows the linear dependence found between the 
longitudinal (R1=1/T1) and transverse (R2=1/T2) proton relaxation rates and iron concentration 
for MNP-DMSA and MNP-DMSA-EPS in water suspensions. From the slope of these linear 









) as it is typical of 
superparamagnetic nanoparticles, which can act as negative MRI contrast agents 









), MNP-DMSA-EPS maintain the longitudinal value but increase 
the transversal relaxivity (Figure 4.3 B). The larger transverse relaxivity could be 
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associated with the clustered nature of MNP-DMSA-EPS because the aggregation of 
several small nanoparticles increases the effective magnetic size of the system.
29,30
 
However, the peak for the blocking temperature in the zero field cooling curve (ZFC) of 
MNP-DMSA-EPS (Figure 4.4 B) is not significantly shifted to the right in comparison to 
the uncoated nanoparticles, suggesting that the aggregation alone does not justify the 
increase in r2. On the other hand, significant dipolar interactions do take place within 
MNP-DMSA-EPS as ZFC curve keeps increasing after the blocking temperature, which 
also has the effect of increasing the effective magnetization of the nanoparticles and, 
consequently, can lead to the increase of the transverse relaxivity value.  
 
Figure 4.4. Details regarding magnetic properties of MNP-DMSA and MNP-DMSA-EPS. (A) Detail 
of MNP-DMSA and MNP-DMSA-EPS magnetization loops. (B) Zero-field cooling (ZFC) and field cooling 
(FC) curves. 
Comparison of MNP-DMSA-EPS with similar hydrodynamic size commercial MRI 
agent Endorem/Feridex (dh between 120 nm and 180 nm) reveals that our nanoparticles 









Endorem/Feridex) at the same magnetic field
31
, what makes the ratio r2/r1 1.8 times 
larger for our particles (148 vs. 83). This ratio is used to quantify and compare the 
efficacy of a negative contrast agent for MRI. For negative contrast agents, larger r2/r1 
ratios indicate more sensitive systems, as lower nanoparticle concentration is sufficient 
to darken MRI signal. Therefore, we anticipate that our EPS-coated MNP could increase 
the efficacy of MRI contrast compared to Endorem/Feridex, which has also a bacterial 
exopolysaccharide coating and similar clustering degree, given the respective 
hydrodynamic diameter. In the T2-weighted MRI phantom images obtained for aqueous 
suspensions of MNP-DMSA-EPS (Figure 4.3 C), it is visible that signal intensity 
decreases (darkening) with the increase of nanoparticle concentration, similar to what 
happens with dispersions of commercial superparamagnetic contrast agents.
32
 Even for 
                                 Chapter 4: A value-added exopolysaccharide as a coating agent for MRI nanoprobes 
103 
the lower iron concentration (0.1 mM = 5.6 µg/ml) there is a noticeable signal difference 
between water and the nanoparticles dispersion. 
4.3.3 Cell-nanoparticle interactions 
Given the promising performance of MNP-DMSA-EPS, revealed by their relaxivities 
values, we further tested their efficacy as MRI negative contrast agent to label in vitro cultured 
cells. We have used HCT116 and ReNcell VM human cell lines as model systems to study 
interactions between MNPs and cells, namely, the impact on cell viability, iron uptake, 
intracellular localization of internalized nanoparticles and effect on MRI cell phantoms. 
We aimed to assess the impact of Fucopol (EPS) coating on nanoparticle cytotoxicity. 
Therefore, for comparison purposes, we have evaluated MNP-DMSA-EPS, MNP-DMSA and 
EPS cytotoxicity profiles in parallel, using the MTT assay (colorimetric test based on cellular 
metabolic activity) for this purpose. 
In the concentrations range tested, the two cell lines present distinct viability profiles 
after incubation with MNPs or EPS alone (Figure 4.5, Figure 4.6). After 48h of incubation with 
cells, MNP-DMSA, MNP-DMSA-EPS and EPS have an effect on the viability of HCT116 cells 
(Figure 4.5 A), with relative half maximal inhibitory concentrations (IC50) of approximately 55 µg 
Fe/ml for MNP-DMSA, 82 µg Fe/ml for MNP-DMSA-EPS and 96 µg Fe/ml for free EPS 
dissolved in the culture medium. Interestingly, HCT116 cell viability in presence of MNP-DMSA-
EPS is lower than in the presence of MNP-DMSA or EPS alone. Stronger stress reaction of 
colon epithelial cancer cells to stabilized MNP compared to bare MNP or free stabilizer 
molecules were reported previously and justified by increased contact area between cells and 
stabilizer molecules upon contact with coated MNPs.
33
 The different reactions to the same 
particle types are probably related with distinct sensitivity of the cell types to the tested materials 
and with nanoparticles exposure times. As Laurent et al. have previously demonstrated
34
, 
cytotoxicity profile resulting from the same nanoparticles, iron concentrations and incubation 
times is strongly dependent on cell type. On the other hand, exposition time is also an important 
factor that influences the response of a certain cell line to the presence nanoparticles. In some 
cases, longer incubation times promote the recovery of viability,
17
 but in others it enhances the 
particles cytotoxic effect.
17,35
 In our study, 4h exposition of ReNcell VM cells to nanoparticles or 
EPS followed by 24h of recovery did not cause a pronounced decrease in the cell viability profile 
(Figure 4.5 B, Figure 4.6), which is similar to the results found by other authors for primary 
human fetal neural precursor cells
19
 and adipose-tissue derived stem cells.
35
 In the iron 
concentration range and exposition time used in our work, ReNcell VM cells viability is 
maintained above 80% and no IC50 value is reached for the three materials. 
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Figure 4.5. Cell cytotoxicity assay results for HCT116 and ReNcell VM cells incubated with MNPs and 
EPS. (A) HCT116 cell line, after 48h exposition to nanoparticles and EPS; (B) ReNcell VM cell line, after 
4h exposition to nanoparticles and EPS plus 24h of recovery in fresh medium. Data is expressed as mean 
± standard deviation of at least two independent experiments. Different symbols indicate statistical 
difference of cells incubated with MNP-DMSA (*), MNP-DMSA-EPS () or EPS () compared to untreated 
control cells. Regular two-way ANOVA, followed by post-hoc pairwise comparison with Tukey’s test was 
performed for statistical analysis using GraphPad Prism 6.0 software (USA); 1 symbol (p<0.05), 2 symbols 
(p<0.005), 3 symbols (p<0.001). 
 
Figure 4.6. Representation of cell cytotoxicity assay results in logarithmic form (log10 [Fe] (or log10 [EPS])). 
Effect of (A) MNP-DMSA, (B) MNP-DMSA-EPS and (C) EPS on cell viability for HCT116 (grey symbols) 
after 48h of incubation and ReNcell VM (black symbols) after 4h of incubation plus 24h of recovery in fresh 
medium. Points are connected by a B-spline to guide the eye.  
Microscopic observation of Prussian blue stained preparations (Figure 4.7 A) allowed a 
preliminary evaluation of the particles labeling efficacy. No significant alteration of cell 
morphology was detected in MNP treated cells compared to untreated cells and no iron was 
detected inside the nucleus. MNP-DMSA-EPS are visible in both cell types as blue spots and 
aggregates distributed in the cytoplasm or attached to the cell surface. In ReNcell VM cells the 
blue spots are larger and more intense. This may be related with a stronger uptake of MNP-
DMSA-EPS in ReNcell VM than in HCT116 cells or simply reflects the different incubation 
conditions used for the two cell types. Much less cellular uptake was observed when MNP-
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DMSA were used. Both particle types possess negative zeta potential (that comes close to 
neutral after contact with culture medium), however MNP-DMSA-EPS present higher 
internalization in the two cell lines used in this work. Interactions between the cell membranes 
and nanoparticles’ surfaces probably explain the first contact between MNPs and cell 
membrane, but given the size of the aggregates formed by MNP-DMSA-EPS, cell membrane-
nanoparticle interactions may be facilitated. Moreover, the presence of fucose residues (which 
are known to be involved in cell-cell adhesion, cell-matrix adhesion, and cell-cell signaling 
processes
36
) may also contribute to enhanced uptake of MNP-DMSA-EPS compared to MNP-
DMSA through interaction with cell surface receptors. 
 
Figure 4.7. Observation and quantification of iron in cell cultures incubated with MNP-DMSA and MNP-
DMSA-EPS. HCT116 cells were exposed to the nanoparticles for 48h. ReNcell VM cells were exposed to 
the nanoparticles for 4h, followed by a recovery period of 24h. (A) Bright field microscopy images of 
Prussian blue stained cells (scale bar: 10µm); (B) Proportion of total iron per cell, quantified by ICP.  






MNP in the culture 
medium 
(µg Fe/ml) 


















HCT116 48 h 54 46 0.57 3.00 1.22 8.35 
ReNcell VM 
4h + 24 h 
recovery 
57 16 0.62 6.30 1.11 4.76 
Quantification of iron in cell fractions by ICP-AES after labeling (Figure 4.7 B and Table 
4.1) confirmed the Prussian blue observations. Since we have incubated HCT116 and ReNcell 
VM cells with different iron concentrations for each particle type, it was important to normalize 
the mass of cellular iron to the total mass of iron from MNPs in cell culture and to the number of 
cells. The normalized values show the same percentage of iron uptake by both cell lines when 
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incubated with MNP-DMSA However, after EPS conjugation to MNP-DMSA, a 5-fold and a 10-
fold increase of cellular iron percent was observed for HCT116 and ReNcell VM cells, 
respectively (Figure 4.7 B and Table 4.1). In this case, cellular iron is mainly due to internalized 
nanoparticles with a small contribution of nanoparticles adsorbed to the cell surface. On the 
other hand, for MNP-DMSA, internalized and adsorbed nanoparticles contribute in equal 
proportions for the total iron found per cell (Figure 4.8 and Table 4.2). In ReNcell VM, although 
particle concentration and exposition time were lower, the double percentage of iron was found 
in the cellular fraction when compared with HCT116 cells (Table 4.1). According to the literature, 
fucose-galactose compounds mediate a pathway for the modulation of neuronal growth and 
morphology
37
 and can be used in culture of neurons in vitro to induce neuronal growth and 
neurite elongation.
38
 Fucose and galactose are the main components of Fucopol and thus this 
EPS may contribute to the enhanced MNP-DMSA-EPS uptake by neural stem/progenitor cells 
in relation to HCT116 cells. 
 
Figure 4.8. Contribution of internalized and adsorbed nanoparticles for the cellular iron found in cells after 
labeling with MNP-DMSA or MNP-DMSA-EPS. (A) HCT116 cells (B) ReNcell VM cells.  
Table 4.2. Distribution of cellular iron between internalized and adsorbed fractions 
 
Cell line 
HCT166 ReNcell VM 
% internalization % adsorption % internalization % adsorption 
MNP-DMSA 63 37 53 47 
MNP-DMSA-EPS 80 20 85 15 
Comparison of our results with other studies is complex because several factors can 
influence labeling efficiency. These include, for example, cell type, concentration of iron, 
incubation time, presence/absence of transfection agents, nanoparticle coating material or even 
the experimental protocol used for labeling efficiency evaluation. Previous reports dealing with 
human colon cancer and neural stem cells treated with iron oxide nanoparticles coated with 
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Compared to our results, LS174T colon cancer cell line presented lower iron uptake upon 
incubation with dextran-coated MNP (0.006 pg Fe/cell, after incubation for 1h at 100 µg/ml) but 
enough to obtain MRI contrast in vitro.
39
 More recently, oleic acid coated MNP encapsulated in 
the polysaccharide hyaluronan (HA) were shown to have an inhibitory effect towards several 
human cancer cell lines (including HCT116) and visible by MRI after injection in a murine 
intramuscular glioblastoma tumor model. While nanoparticles studied in our work were non-toxic 
at low iron concentrations, and do not inhibit growth, HA-MNPs originated negative viabilities at 
10 – 500 µg Fe/ml for 24, 48 and 72 h.
40
 Regarding stem cells, the standard MRI labeling 
protocols are based in the utilization of a transfection agent (TA) together with commercially 
available iron oxide magnetic nanoparticles to promote internalization.
6,18,41
 However, TAs are 
usually complex to use and cytotoxic.
6,42
 Therefore, incubation of cells with the nanoparticles 
alone would be preferred. Some work has been done on modification of polysaccharide 
coatings, namely with positively charged chemical groups, to produce magnetic nanomaterials 
that provide enough labeling efficacy per se
11,35
 but in this work we have evaluated the 
performance of MNP coated with the EPS Fucopol without any modification. We have seen that 
4h of incubation with MNP-DMSA-EPS at 16 µg Fe/ml allowed a labeling efficiency of 5 pg 
Fe/cell in ReNcell VM (Table 1), similar to what was reported previously for Feridex to label 
neural progenitor cells (75 µg Fe/ml, 48 h, uptake of 5.1 pg Fe/cell)
43
 and mesenchymal stem 
cells derived from the iliac crest bone marrow (25 µg Fe/ml, 24h, uptake of 4.9 pg Fe/cell).
44
 
Adipose tissue-derived stem cells labeled with the experimental TMAD-03 (trimethylamine 
dextran-coated) MNPs (10 µg Fe/ml, 1h) internalized slightly higher amounts of iron (~8 pg 
Fe/cell).
35
 Our results thus show that, in particular for neural stem/progenitor cells, MNP-DMSA-
EPS allow iron internalization efficiencies identical to those reported with commercial contrast 
agents, using lower iron concentrations, short incubation times and without using TA. 
MNP-DMSA-EPS present hydrodynamic diameter in the range of 170 nm, therefore 
internalization by passive diffusion across the cell membrane would not be possible. The 
anticipated cell uptake mechanism is endocytosis, which is described for experimental and 
commercial MNPs in this size range.
45,46
 
In order to confirm this assumption, a co-localization study of MNP-DMSA-EPS and 
lysosomes was performed, since these structures are the end-destination of materials 
internalized by endocytosis. Figure 4.9 shows bright field and fluorescence microscopy images 
of cells with GFP-labeled lysosomes after incubation with MNP-DMSA-EPS. It is clear that, in 
fact, nanoparticles (represented by black dots in bright field images) co-localize with lysosomes 
(visible as bright dots under fluorescence images) in the merged images (Figure 4.9 A-a’’ and 
Figure 4.9 B-b’’). Large MNP-DMSA-EPS aggregates that were not internalized are also visible 
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in the bright field images as white-shining structures at the cell surface (Figure 5A-a) and in the 
extracellular space (Figure 4.9 B-b).  
 
Figure 4.9. Tracking the localization of MNP-DMSA-EPS within (A) HCT116 cells and (B) ReNcell VM 
cells by microscopy. (a and b) bright field; (a’ and b’) GFP labeling of lysosomes and (a’’ and b’’) merged 
images. (Scale bar: 10 µm). 
4.3.4 Differentiation of MNP labeled neural stem/progenitor cells 
Since ReNcell VM is a human neural stem/progenitor cell line, it is important to ensure 
that multipotency is maintained in the presence of the nanoparticles. After labeling with MNP-
DMSA and MNP-DMSA-EPS, the cells were induced to differentiate for 14 days and the ability 
to generate neurons and glial cells was inspected by immunohistochemistry against neuronal 
(β-III Tubulin) and glial cell (GAFP) markers. As shown in Figure 4.10, no significant differences 
in expression of these markers in labeled cells (Figure 4.10 d-f and Figure 4.10 g-i) are 
observed when compared against unlabeled control cells (Figure 4.10 a-c), indicating that the 
presence of MNPs does not have an impact on multipotency. Our results are in accordance with 
previous studies, where under similar culture conditions, but using MNPs with a different coating 




After the 14 days culture period, aggregates of MNP-DMSA-EPS are still visible in the 
culture (extracellular space and near the cell outer membranes), similar to what was observed in 
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Prussian blue images (Figure 4.7 A) suggesting long term retention of MNP, which is needed for 
in vivo cell tracking in cell-replacement therapies.  
 
Figure 4.10. Immunohistochemistry of post-labeled ReNcell VM cells at day 14 of culture. Scale bar: 20 
µm. 
4.3.5 In vitro MRI of MNP-DMSA-EPS labeled cells 
As concluded from the obtained relaxivities, MNP-DMSA-EPS are potentially efficient to 
produce contrast enhancement in MRI. In addition, ICP-AES analysis showed that these 
nanoparticles are internalized by both cell lines. Therefore, to evaluate MNP-DMSA-EPS 
efficacy to provide contrast enhancement after being internalized by the cells, agarose 
dispersions of labeled cells were studied by MRI. Hypointense regions are visible in T2-weighted 
MR images of MNP-DMSA-EPS labeled cells in contrast to unlabeled (control) cells (Figure 
4.11), which confirms internalization (or surface adherence) of particles. However, in contrast to 
what is observed for HCT116 cells, labeling ReNcell VM cells with increasing particle 
concentrations originated increasingly darker images, as is evident in C1, C2, and C3 phantoms 
and respective histograms in Figure 4.11 A and Figure 4.11 B. Figure 4.11 C shows the 
quantification of the phantoms grey densities and confirms that for neural progenitor/stem cells, 
Chapter 4: A value-added exopolysaccharide as a coating agent for MRI nanoprobes  
110 
hypointensity increases with the concentration of nanoparticles used for labeling. Although for 
C1 grey density is identical to that of unlabeled cells, for C2 and C3 signal losses of 20% and 
43% were obtained, respectively. A linear relation was found for the variation of the integrated 
density of ReNcell VM MRI phantom images as a function of the iron concentration used for 
labeling (r
2 
= 0.997 ) (Figure 4.11 D).  
MRI labeling efficacy depends on the cell line and on the labeling conditions. Our 
results indicate that the conditions used in this work are adequate to label and detect ReNcell 
VM cells by in vitro MRI, but to label HCT116 cells further optimization may be required. In a 
previous work, we have shown MNP dose dependent contrast enhancement using the same 
colorectal cancer cell line and incubation period, with gum Arabic-coated MNP-DMSA at lower 
iron concentrations than in the present study.
20
 Besides the distinct iron loads, differences in 
composition of the polysaccharide coatings could cause distinct interactions between cell 
membranes and particles, which justify the differences in detectability by MRI.  
The use of SPIONs to track and monitor stem cells after transplantation is important to 
help understanding the dynamics of cells proliferation, differentiation and migration. Therefore 
several approaches have been reported to develop effective MRI nanoprobes to label stem 
cells.
6
 When compared to our results for neural stem cells, Yukawa et al.
35
 obtained only subtle 
signal decrease in T2-weighted MRI phantom images of mesenchymal stem cells incubated with 
TMAD-03 at increasing iron concentrations (20, 30 and 50 µg Fe/ml). On the other hand, 
Andreas et al.
44
 reported MRI signal losses of approximately 20% and 50% for mesenchymal 
stem cells incubated for 24h with Resovist at 50 and 100 µg Fe/ml, respectively. Interestingly, 
MNP-DMSA-EPS gave rise to similar signal losses at lower iron doses (Figure 4.7C). 
Eamegdool et al.
19
 found out that the minimum iron uptake necessary for full identification of 
neural precursor stem cells neurospheres by in vitro MRI was between 5 and 10 µg Fe/ml. We 
thus hypothesize the feasibility of neurosphere labeling with MNP-DMSA-EPS given the good 
labeling efficacy and MRI signal obtained in the referred range of iron concentrations, in our 
work.  
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Figure 4.11. Efficacy of MNP-DMSA-EPS for in vitro MRI cell labeling. In vitro MRI images and 
corresponding histograms of (A) HCT116 and (B) ReNcell VM cells labeled with increasing concentrations 
of MNP-DMSA-EPS, from C1 to C3, compared with unlabeled control cells. (C) Grey density quantification 
of images in (A) and (B). For HCT116 cells, C1= 61.5 µg Fe/ml, C2 = 82 µg Fe/ml, C3 = 102.5 µg Fe/ml. For 
ReNcell VM cells, C1= 12 µg Fe/ml, C2 = 16 µg Fe/ml, C3 = 20 µg Fe/ml. (D) Linear adjustment of signal 
intensity (integrated density) of ReNcell VM MRI phantom images as a function of iron concentration in 
MNP-DMSA-EPS added to the culture medium. The first data point (signal intensity of unlabeled cells in 
agarose) was not accounted for the fitting. 
4.4 Conclusion 
We have demonstrated the feasibility of a new biopolymer, the EPS Fucopol, as a 
coating material for iron oxide magnetic nanoparticles, and the suitability of the hybrid 
biopolymeric-magnetic particles for in vitro cell labeling by MRI. Fucopol is a biodegradable 
exopolysaccharide produced by Enterobacter A47 DSM 23139 when this bacterium is grown in 
a bioreactor using glycerol as a carbon source. The nanosystem preparation method was 
reproducible even when using different batches of EPS. Covalent coupling of the biopolymer 
onto DMSA-functionalized MNP was effective and produced aggregates with hydrodynamic size 
in the range of 170 nm and stable negative zeta potential. The relaxivities ratio r2/r1 is higher 
than the one reported for the commercial MRI contrast agent Feridex, with similar size and 
coated with the bacterial polysaccharide dextran. The in vitro cell culture assays showed that 
EPS-coated nanoparticles were internalized via endocytosis by the human cell lines HCT116 
and ReNcell VM. Under the tested conditions, MNP-DMSA-EPS did not show cytotoxic effect in 
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the neural stem/progenitor cell line nor affected their multipotency after 14 days of culture. In 
contrast to what was observed for HCT116, MNP-DMSA-EPS provided iron dose dependent 
MRI contrast enhancement in agarose dispersions of cells. The amount of cell-associated iron 
after ReNcell VM incubation with EPS-coated nanoparticles at the tested conditions is similar to 
the values reported for other stem cell lines labeled with Feridex for longer incubation periods 
and higher iron concentrations, suggesting potential applicability of our nanoparticles for stem 
cell labeling. Given the availability of carboxylic and hydroxyl groups in EPS, reporter and/or 
targeting molecules could be further conjugated to produce multimodal imaging agents with 
increased affinity for desired cell types. We conclude that EPS Fucopol-coated MNP are viable 
alternative tools to develop contrast agents for MRI techniques, being able to efficiently label 
cells through incubation without the need of additional transfection agents.  
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Chapter 5 
An affinity triggered MRI nanoprobe for  
pH-dependent cell labeling  
Iron oxide magnetic nanoparticles (MNP) are negative contrast agents for Magnetic 
Resonance Imaging (MRI), with a particular focus in oncology as nanoprobes for tumor-specific 
imaging. Acidity is ubiquitous in malignant tumors microenvironment and can be explored for 
cancer cell labeling. This work presents a proof-of-concept of a multilayer iron oxide nanoprobe 
for MRI targeting tumoral pH. The biologically derived and pH-sensitive affinity pair 
iminobiotin/neutravidin was used as a linker between a poly-l-lysine (PLL) inner layer and a 
biotinylated poly(ethyleneglycol) (bPEG) outer layer on the MNPs. The nanoparticles’ uptake by 
HCT116 cells in vitro is activated by tumor acidic pH as a 2-fold increase in iron uptake per cell 
was observed at acidic pH compared to physiological pH. This difference was particularly clear 
by visualizing T2-weighted MR images of cells incubated with the nanoparticles at both pH 
conditions. Increased cellular uptake of the nanoprobe in acidic pH resulted in enhanced 
contrast in MR images, which allowed cells cultured in physiological medium to be distinguished 
from others cultured in acidified medium. This targeting strategy is potentially applicable to the 
generality of tumors since the typical hypoxic conditions and high glycolysis rate in cancer cells 
create an acidic environment common to all cancer types.  
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5.1. Introduction 
Nanotechnology research has triggered the development of colloidal iron oxide 
magnetic nanoparticles (MNP) for molecular magnetic resonance imaging (MRI), delivery of 
therapeutics, hyperthermia or theranostics of several diseases.
1–4
 Cancer, in particular, has 
been widely studied due to the need to accurately detect it at an early stage and to deliver 
treatment specifically to the affected tissues. Tumor targeted MNP-based systems are valuable 
approaches for that purpose as they combine the inherent MRI contrast enhancement 
properties of superparamagnetic iron oxide nanoparticles (for diagnosis) with the versatility for 
surface functionalization with biologically or chemically active moieties (for targeting and 
therapy).  
A possible tumor-targeting strategy consists in creating nanoparticles activated by 
tumor physiochemical characteristics.
5
 In this context, pH difference between the extracellular 
medium of tumors and healthy tissues can be used to engineer tumor-targeted nanoparticles.
6,7
 
Acidic extracellular tumor pH mainly results from the high rate glycolytic metabolism and poor 
perfusion typically found in tumors, as 90% of the pyruvate generated by glycolysis is converted 
to lactic acid, and co-transported outside the cell with H
+
 ions. This process, associated with 
decreased blood flow rate and poor lymphatic drainage in the tumor, leads to the accumulation 
of H
+
 ions in the extracellular medium thereby causing acidity (pH ranging approximately 
between 6.5 and 7.0) compared with healthy tissues and blood (pH around 7.4).
5,8,9
  
One of the strategies for pH-activation of nanoparticles relies on the hypothesis that the 
nanoparticles maintain stealth during blood circulation and passively accumulate at tumor sites 
where, activated by the acidic environment, transform into a more cell-interactive form for 
enhanced tumor cell internalization, cytotoxicity or release of encapsulated cargo. For example, 
MNP with a glycol-chitosan (GC) coating generated a T2*-weighted MR contrast agent with 
enhanced cellular interactions and MRI contrast at tumor pH both in vitro and in vivo due to the 
pH-titrable charge of GC, which becomes positive under acidic conditions.
10
 Mok et al.
11
 
reported a dual therapeutic and MR imaging MNP nanosystem for chlorotoxin-mediated tumor-
targeted delivery of siRNA. This system makes use of the acid-hydrolyzable linkage between 
citraconic anhydride and primary amines to block the cytotoxic effect of polyethylenimine (PEI) 
and reduce cellular interactions at physiological pH. At acidic conditions, due to citraconic 
anhydride removal, the positive charges of PEI are unblocked and promote cytotoxicity, 
chlorotoxin is exposed (for receptor-mediated tumor cellular uptake) and siRNA delivered to the 
intracellular medium. Saha et al.
12
 developed a pH-sensitive MR contrast agent using 
melamine-dendron functionalized MNP. In this system, large R2 values are provided at low pH 
in physiological salt conditions and decrease for higher pH, with a sharp inflection at pH value 
just below the pKa of melamine monomer (~5) due to the pH-dependent transient and reversible 
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clustering of magnetic cores modulated by the interplay between surface charge at different pHs 
and ionic strength. A more complex nanosystem was recently reported by Ling et al.,
13
 who 
developed a multifunctional pH-sensitive nanosystem composed of self-assembled ultrasmall 
MNP, a fluorescent tag, a photodynamic therapeutic moiety and pH-sensitive ligands. The 
authors engineered polymeric pH-sensitive ligands based on a protonable imidazole group and 
used them to fabricate magnetic nanogrenades that upon exposure to acidic extratumoral pH 
switch charge from negative to positive and swell, promoting cellular uptake. Once inside the 
cell, the system disassembles and activates T1-weighted MRI contrast and photoactivity for 
therapeutic effect.  
As an alternative to chemically engineered pH-dependent materials, specific bio-
recognition interactions can be explored to derive pH-sensitivity. The complex formed by biotin 





between a protein and ligand, and once formed is not affected by extreme conditions such as 
pH variations. However, the guanido-version of biotin (iminobiotin) binds to avidin and its 
derivatives in a pH-dependent fashion. At pH 9.5-11.0, the avidin-iminobiotin complex binds 
tightly (Kd = 3.4×10
-10 
M) but the bond strength decreases with pH until complete dissociation at 




 Due to the reversible binding property, this affinity pair has been utilized in 
bioseparation applications,
16–18
 in the production of thin films decomposable by pH
19
 and in the 




In this work, we explore for the first time the neutravidin-iminobiotin pH-dependent 
affinity interaction to develop an affinity-triggered MNP-based MRI nanoprobe for preferential 
labeling of tumor cells. The system consists of a multilayer-coated magnetic nanoprobe with a 
pH-removable PEG layer. Increased cellular uptake is triggered by the acidic tumor 
microenvironment, thereby rendering the cancer cells visible by MRI (Figure 5.1). The multilayer 
system was deposited onto meso-2,3-dimercaptosuccinic acid-functionalized MNP and 
characterized regarding its size and surface charge after adding each material. The pH 
responsivity of the final particles was evaluated first in buffer solutions at different pHs and then 
in in vitro cultures of colorectal carcionoma cells (HCT116 cell line) at acidic and physiological 
pH. Cell phantoms were imaged by MRI to evaluate their efficacy to provide differential contrast 
depending on the pH of the cultures. 
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Figure 5.1. Schematic representation of the multilayer pH-sensitive MNPs and concept for achieving 
preferential interactions with tumoral cells. (A) Overall effect of pH on the MNPs; (B) detail of the multilayer 
pH-sensitive system built on top of DMSA stabilized MNP. The inner cationic layer of poly-l-lysine (PLL) is 
employed to promote cell adhesion and consequent cellular uptake. The outer layer of poly(ethyleneglycol) 
(PEG) works as antifouling, stealth material to prevent non-specific cell uptake. PLL is partially modified 
with iminobiotin (ib), and PEG bears a biotin (b) moiety. Neutravidin (Nav) interconnects these two 
materials. In physiological pH, PEG chains cover the cationic PLL layer to minimize cell interactions, 
whereas in acidic pH, due to the loss of affinity between Nav and ib, Nav-bPEG complex is released and 
unshields the positive charges from PLLib. 
5.2. Experimental Section 
5.2.1. Materials 
All materials were purchased from Sigma Aldrich unless otherwise specified. 
5.2.2. Production of multi-layer functionalized magnetic nanoparticles  
5.2.2.1. Synthesis and phase transfer of iron oxide magnetic nanoparticles (MNP-
DMSA) 
Hydrophobic iron oxide magnetic nanoparticles were synthesized using a variation of 
Sun’s thermal decomposition method,
21,22
 as described previously.
23
 Briefly, iron 
tri(acetylacetonate) is decomposed at high temperatures (300 ºC) in benzyl ether, 1,2-
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tetradecanediol is used as reducing agent, and oleic acid and oleylamine are used as 
surfactants for the formation of hydrophobic and monodisperse magnetite nanoparticles (MNP). 
To render these MNP hydrophilic, a ligand-exchange reaction with DMSA was employed.
23
 
Briefly, a dispersion of hydrophobic MNP in toluene was mixed with a solution of DMSA in 
dimethylsulfoxide (DMSO). After 48 h incubation at room temperature, the solvent containing 
the oleic acid and oleylamine was discarded and the black hydrophilic nanoparticles were re-
dispersed in ethanol. After several washes by centrifugation the nanoparticles were re-
dispersed in milliQ water, basified to pH 10 and dialyzed against milliQ water (four complete 
water changes) to provide the final DMSA coated MNP (MNP-DMSA). MNP-DMSA pH was re-
adjusted to 7 and particles were filtered through a syringe filter with 0.2 µm diameter pore prior 
to further use. 
5.2.2.2. Coating MNP-DMSA with iminobiotin-modified poly-L-lysine (PLLib) (MNP-
DMSA-PLLib) 
Poly-L-lysine (MW 15000 – 30000 Da) was functionalized with NHS-activated 
iminobiotin (Thermo Scientific) on approximately 30% of its primary amines by incubation in 
aqueous conditions (borate buffer 50 mM, pH 8) for 2 h at 4ºC. Prior to use, the modified PLL 
was dialyzed against water in a MWCO 10 kDa dialysis membrane, with four complete water 
changes, to remove unreacted iminobiotin and reaction leftovers. The biotinylation yield is the 
ratio between the number of primary amines in PLLib after the reaction with NHS-iminobiotin 
and the number of primary amines in native PLL. The Kaiser test was used to estimate the 
amount of primary amines, as described previously.
24
 
For the deposition of PLLib layer, MNP-DMSA (at 0.7 mg/ml) were added dropwise to 
an equal volume of PLLib solution (at 1.25 mg/ml) under magnetic agitation (600 rpm) and left 
incubating under gentle magnetic agitation (200 rpm) for 2 h at room temperature. Dialysis in a 
MWCO 50 kDa membrane against milliQ water (four complete water changes) was used to 
wash the particles prior to further use. Filtration near the flame through a syringe filter with 0.2 
µm diameter pore was performed to ensure sterility of the particles for the following steps and 
in-vitro testing. 
5.2.2.3. Coating MNP-DMSA-PLLib with Nav-bPEG conjugates (MNP-DMSA-PLLib-
Nav-bPEG) 
Biotin-modified PEG (20 kDa, Lyasan Bio) (bPEG) was incubated with neutravidin 
(Thermo Scientific) (Nav) to produce Nav-bPEG conjugates. Nav was reconstituted in water 
milliQ to (A) 5 mg/ml or (B) 0.5 mg/ml and dissolved with Phosphate Buffered Saline (10 mM, 
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150 mM NaCl) (PBS) at pH 7.4 to (A) 2.3 mg/ml or (B) 0.23 mg/ml. Then, bPEG (8.4 mg/ml in 
PBS, pH 7.4) was added to Nav (A) solution in the proportion of 2 mol (bPEG) / mol (Nav), and 
to Nav solution (B) in the proportion of 20 mol (bPEG) / mol (Nav). After 2 h of incubation at 
room temperature under magnetic stirring (450 rpm), 1 ml of MNP-DMSA-PLLib at 0.3 mg/ml 
was added dropwise to 3.16 ml of Nav-bPEG solution (A) and (B) under stronger magnetic 
stirring (600 rpm) and left incubating under gentle magnetic agitation (200 rpm) for 2 h at room 
temperature.  
All the materials, including buffers and water, were autoclaved prior to use and the 
reactions were performed near the flame to maximize the sterility condition of the produced 
particles. 
5.2.2.4 Characterization of magnetic nanoparticles 
Nanoparticle hydrodynamic diameter (dh) and zeta potential were characterized using a 
Zetasizer Nano ZS (Malvern). The mean value of the intensity-weighted size distribution 
measured at pH 7 in low salt conditions (water for MNP-DMSA and MNP-DMSA-PLLib or 1 mM 
phosphate buffer for MNP-DMSA-PLLib-Nav-bPEG) was considered as the dh of the pristine 
nanoparticles. The Z-average was considered instead when characterizing the size of the 
particles after dialysis to PBS with 150 mM NaCl at different pH values. Zeta potential of the 
pristine nanoparticles was measured in low salt conditions. Variation of zeta potential of MNP-
DMSA and MNP-DMSA-PLLib with pH was measured in a 10 mM KNO3 solution (HNO3 or KOH 
solutions were used for pH adjustment). The primary amine groups on MNP-DMSA-PLLib were 
quantified through the Kaiser test
24
 and from this characterization, the amount of PLL and ib on 
the particles was estimated. MNP-DMSA concentration was determined by drying and weighting 
a known volume of particles. The concentration of particles subsequently modified with PLLib 
and Nav-bPEG was estimated by correction of MNP-DMSA concentration value with the 
respective dilution factor (resulting from the coating reactions and dialyses). The iron content in 
MNP samples was determined by Inductively Coupled Plasma - Atomic Emission Spectroscopy 
(ICP-AES) (Horiba Jobin-Yvon, Ultima). 
5.2.2.5. Examination of pH dependent Nav-bPEG release  
The pH dependence of Nav-bPEG release was investigated by dialyzing MNP-DMSA-
PLLib-Nav-bPEG inside 300 kDa Float-a-Lyzers (Spectrum Laboratories) to PBS at pH 5, pH 
6.5, pH 7.4 or pH 8.5. After 20 h of dialysis, the total protein content of the dialysates was 
quantified using the bicinchoninic acid test
25
 (QuantiPro BCA assay kit) and normalized to the 
mass of MNP and to the mass of Nav-bPEG used for the coating reaction (mass(Nav-bPEG)in), 
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quantified in the same assay. To correct the total protein concentration values regarding PLLib 
that is also released during dialysis, control dialyses of MNP-DMSA-PLLib were performed and 
PLLib released to the dialysates was quantified using the same test. PLLib released per mg of 
MNP at each pH was then subtracted from the total protein released per mg of MNP to obtain 
the mass of Nav-bPEG released per mg of MNP at each pH condition. Normalization to 
mass(Nav-bPEG)in gives the percentage of Nav-bPEG released per mg of MNP (% Nav-
bPEGin/mg MNP) 
Briefly, for the bicinchoninic acid test, samples of the dialysates were individually added 
to wells of a 96 well plate (150 µl/well) to which the QuantiPro reagent (150 µl of a freshly 
prepared mixture composed by 25 parts of reagent QA, 25 parts of reagent QB and 1 part of 
reagent QC) was added. After 1 h of incubation at 60°C in the dark, absorbance at 560 nm was 
read in a microplate reader (Infinite M200, Tecan). For each assay, a calibration line using a 
protein standard (0 – 30 µg/ml bovine serum albumin, BSA) was performed and used to 
determine the protein concentration of the tested samples.  
5.2.3. Characterization of in vitro cell-MNP interactions 
5.2.3.1. Cell culture and labeling 
Human colorectal carcinoma cells (HCT116 cell line) were cultured in Dulbecco’s 
modified Eagle’s medium (DMEM, Life Technologies, USA) supplemented with 10% (v/v) fetal 
bovine serum (Life Technologies, USA) and 1% (v/v) of penicillin-streptomycin (Life 
Technologies, USA) at 37 ºC with 99% relative humidity and 5% CO2.  
For magnetic cell labeling, cells were seeded in 24-well plates (at 1 × 10
5
 cells/well) with 
either regular or acidic culture medium (0.4 ml) and incubated for approximately 24 h to allow 
cell adhesion. Then, the culture medium was replaced by fresh medium (either regular or acidic) 
containing the magnetic nanoparticles (MNP-DMSA-PLLib, MNP-DMSA-PLLib-Nav-bPEG (A) 
and MNP-DMSA-PLLib-Nav-bPEG (B)) at 10 µg Fe/ml. After 5 h of incubation, the cell-MNP 
interaction assays detailed hereafter were carried out. DMEM medium was acidified to pH 6.5 
by adding some drops of HCl (0.1 M – 5 M) prior to cell seeding and filtered under sterile 
conditions with a 0.2 µm syringe filter. MNP-DMSA-PLLib-Nav-bPEG (A) and (B) were 
subjected to pretreatments at pH 7.4 and pH 6.5 for 20 h before being dispersed in culture 
medium and added to the cells. 
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5.2.3.2. Identification of cellular iron by Prussian blue staining 
Cells were seeded in coverslips on the bottom of the wells and incubated with 
nanoparticles, after which cells were stained with Prussian blue for iron identification and 
counterstained with neutral red as described previously.
26
 Preparations were mounted on 
microscope slides using 1 drop of glycerol 1:3 (v/v in PBS) or 1 drop of ProLong Gold Antifade 
Mountant with DAPI (Life Technologies) for fluorescent staining of cell nuclei. The slides were 
observed under bright-field and fluorescent illumination using an Olympus BX51 microscope 
equipped with an Olympus DP50 camera and the AnalySIS Soft Imaging software. 
5.2.3.3. Intracellular localization of magnetic nanoparticles 
Cells were dispersed in culture medium supplemented with Cell-Light Lysosomes-GFP, 
BacMam 2.0 reagent (Life Technologies, USA) (22 particles per cell), seeded in coverslips on 
the bottom of the wells and incubated for 24h according to the supplier’s instructions. Then, 
cells were labeled with the MNP and, after the 5 h incubation period, washed with PBS and 
fixed with ice-cold paraformaldehyde (4% v/v in PBS) for 15 min in the dark. After removing the 
paraformaldehyde and washing with PBS, the preparation was air dried and mounted in the 
microscope slide using a drop of ProLong Gold Antifade Mountant with DAPI (Life 
Technologies). Slides were observed using an Olympus BX51 microscope equipped with an 
Olympus DP50 camera and the Cell F View Image System Software. 
5.2.3.4. Iron uptake quantification 
After labeling, well supernatants were collected (separately); cells were detached from 
the wells using trypsin, re-suspended in culture medium, counted using a hemocytometer and 
centrifuged for 10 min at 5000 rpm. Cell pellet (fraction 1), cell supernatant (fraction 2) and well 
supernatant (fraction 3) were separately digested with 100 µl of aqua regia (concentrated 
HCl/HNO3, 3:1 (v/v)) for 30 min at 90ºC, diluted to 1 ml with milliQ water and analyzed 
separately for iron by ICP-AES. The iron in the cellular fraction (sum of fraction 1 and fraction 2) 
was normalized to the number of cells and to the total mass of iron (sum of the three fractions). 
A control sample containing only cells was also quantified to provide a calibration for the native 
iron content of cells. 
5.2.3.5. Determination of cell viability 
After cell incubation with nanoparticles, the culture medium was removed and cells 
were detached from the wells using trypsin. Trypsin action was neutralized by adding an equal 
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volume of culture medium to the wells and mixing. Trypan blue was added in equal volume to 
10 µl of these cell suspensions. The viable cells per well were counted using a hemocytometer. 
The percentage of cell viability in respect to the control (untreated cells) was determined 
assuming that the number of cells in the control well corresponded to 100% viability.
27
 
5.2.3.6. In vitro MRI of cell phantoms 
For in vitro MRI, cells were seeded at 1.25×10
5
 cells/well with 0.5 ml of culture medium 
and two wells per condition were prepared in order to provide sufficient cells for imaging. After 
labeling with MNP-DMSA-PLLib-Nav-bPEG (A) and MNP-DMSA-PLLib-Nav-bPEG (B), cells 
were prepared for MR imaging as described previously.
26
 Briefly, cells were washed with PBS, 
detached with trypsin and centrifuged. The pellet was collected and re-suspended in ice-cold 
paraformaldehyde to fix the cells. To remove the paraformaldehyde, cells were centrifuged and 
the pellet was re-dispersed in PBS and counted using a hemocytometer. Cell dispersions of 
9×10
4
 cells in 0.2 ml of PBS were prepared for each condition and mixed with 0.1 ml aliquots of 
fresh 2 % (w/v) agarose. The samples were then transferred to 5 mm diameter NMR tubes for 
imaging after solidifying. The final concentration of agarose was 0.5% (w/v) and the final 
concentration of cells was 3×10
5
 cells/ml. 
T2-weighted magnetic resonance (MR) images were obtained in a magnetic field of 7 T, 
at 25ºC, using a Bruker Avance III Spectrometer (160 G/cm imaging gradient) and a Fast Low 
Angle Shot gradient (FLASH) imaging sequence with repetition time (TR) = 110 ms, echo time 
(TE) = 1.7 ms, excitation angle of 20º and number of excitations (NEX) = 32.  
For the samples of cells incubated with MNP-DMSA-PLLib-Nav-bPEG (B) in regular 
and in acidic culture medium, T2 relaxation times were also determined. Briefly, the average 





placed in the center of each cell phantom, for different echo times. The signal intensities were 
then plotted against echo times and the signal intensity (SI) function was fitted to the data 
according to the exponential decay equation SI = A + C e
(-t/T2)
, where SI is the signal intensity, t 
is the echo time, A is an off-set constant and C is a pre-factor constant. Resulting from these 
fittings, the transverse relaxation time T2 was obtained. 
5.2.4. Statistical Analysis 
All data in figures and text is given as mean ± standard deviation. Statistical analysis 
was performed by GraphPad Prism 6.0 software. One-way or two-way ANOVA complemented 
with Tukey’s test or Bonferroni’s test for multiple comparisons were used when applicable. 
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The threshold for significance was P = 0.1 and P-values < 0.1 (*), <0.05 (**), <0.005 
(***) and <0.0001 (****) were considered significant. 
5.3. Results and discussion 
5.3.1. Multi-layer MNP assembly 
Hydrophobic iron oxide magnetic nanoparticles coated with oleylamine and oleic acid 
(MNP-OA) were synthesized by the thermal decomposition method and transferred to aqueous 
phase by replacement of the oleic acid and oleylamine moieties at their surface by DMSA 
molecules.
23
 This process provided the negatively charged template nanoparticles (MNP-
DMSA) for further functionalization with the pH-responsive layer system through sequential 
deposition of coating materials. The assembly of the multi-layered magnetic nanoprobes was 
followed by assessing, at each layering step, particles size and surface charge (Figure 5.2 and 
Table 5.1).  
 
Figure 5.2. Multi-layer MNP assembly. (A) Variation of zeta potential with pH for MNP-DMSA and MNP-
DMSA-PLLib; (B) variation of size distribution after sequential deposition of layers onto MNP, measured in 
low salt conditions; and (C) zeta potential of the particles after addition of each layer, measured in low salt 
conditions. 
The first layer to be added onto of MNP-DMSA was PLL. In order to provide PLL with 
pH-sensitive anchoring points for the linker neutravidin (Nav) and still maintain its cationic 
character, partial functionalization of PLL’s free amino groups with iminobiotin was carried out. 
About 28% of the PLL’s free amino groups were covalently bound to iminobiotin (36 mol (ib) / 
mol (PLL)).  
Iminobiotin-modified PLL (PLLib) was then deposited onto MNP-DMSA by electrostatic 
adsorption to produce positively charged nanoprobes with anchoring points for Nav (1.6 µmol 
(ib) / mg (MNP)). As can be seen in Figure 5.2 A, there was a complete reversal of the particles 
surface charge due to the presence of amino groups from PLLib. The isoelectric point of the 
particles shifted from pH 1.5 to pH 11 and therefore, the negative zeta potential observed for 
MNP-DMSA became positive for MNP-DMSA-PLLib over a wide range of pH values. The 
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observed increase of hydrodynamic diameter from 16 nm to 139 nm also supports the presence 
of an extra coating on top of MNP-DMSA. The colloidal suspensions of MNP-DMSA-PLLib were 
very stable at pH 7.4 and low salt concentrations (1 mM PBS), with a clean size distribution and 
relatively low PdI (Figure 5.2 B and Table 5.1), but physiological salt conditions (10 mM PBS, 
150 mM NaCl) caused flocculation (after ~20 h). This phenomenon was not observed upon 
addition of the PEG shell, which helped to stabilize the multilayer nanoparticles through inter-
particle steric interactions provided by the neutral hydrophilic chains of the polymer. 
Table 5.1. Average hydrodynamic diameter and zeta potential of multi-layer nanoparticles at each 
assembly step. 
Nanoparticles dh (nm) pdI Z-Ave (nm) Zeta potential (mV) 
MNP-OA 10 ± 0.3 0.14 ± 0.06 12 ± 3.2 n. a. 
MNP-DMSA 16 ± 0.1 0.19 ± 0.01 15 ± 0.1 -29.1 ± 5.2 
MNP-DMSA-PLLib 139 ± 10.1 0.22 ± 0.01 97 ± 0.8 48.1 ± 1.4 
MNP-DMSA-PLLib-Nav-bPEG (A) 146 ± 7.5 0.31 ± 0.05 109 ± 1.6 -0.4 ± 0.3 
MNP-DMSA-PLLib-Nav-bPEG (B) 302 ± 15.6 0.25 ± 0.013 261 ± 7.9 2.6 ± 0.1 
 
The PEG shell is actually a neutravidin-PEG conjugate (Nav-bPEG) in which PEG is 
functionalized with biotin (bPEG) in one of the chain terminus for strong binding (Kd = 10
-15 
M) to 
neutravidin. Neutravidin then forms a pH-sensitive bond with iminobiotin from MNP-DMSA-
PLLib (Figure 5.1) because Nav-ib affinity is pH-dependent. Two types of multilayer 
nanoparticles were produced (A and B) by using as a final layer Nav-bPEG conjugates with 
different proportions of Nav to bPEG (Table 5.2). 
The deposition of the Nav-bPEG layer resulted in the neutralization of the particles 
surface charge at pH 7.4, for both (A) and (B) particles (Figure 5.2 C and Table 5.1), which 
shows that the inner cationic PLLib layer was effectively shielded by the neutral PEG chains 
bound to the particles. PEG also contributed for particles stabilization under physiological salt 
conditions, since flocculation was not observed, unlike MNP-DMSA-PLLib. Neutralization of 
surface charge with PEG is important from a biological point of view because PEG is known to 
provide stealth properties to nanoparticles, due to its hydrophilicity, flexibility, and neutral charge 
in biological fluids. PEG-coated nanomaterials usually have longer circulation times in the blood 
stream and escape more effectively to the monophagocytic system.
28–30
 Hydrodynamic diameter 
increased in both particle types, supporting the presence of an additional coating on top of 
MNP-DMSA-PLLib, but the increase was much larger for (B) particles. Due to the larger 
proportion of bPEG to Nav in Nav-bPEG(B)-coated particles (Table 5.2), there is a tendency for 
the formation of larger aggregates that deposit by gravity when the particles are left standing in 
rest but simple agitation provides re-dispersion. Nav-bPEG(A)-coated particles, on the other 
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hand, were stable, without visible deposition. In this case, the proportion of PEG to Nav and 
MNP is sufficient to provide particle stabilization trough steric interactions and avoid deposition 
by gravity.  
5.3.2. pH-dependent MNP response 
To evaluate pH sensitivity, the multilayer nanoparticles were exposed to different pH 
conditions by means of dialysis to PBS at pH 5, 6.5, 7.4 and 8.5. Quantification of Nav-bPEG in 
the buffers after 20 h revealed that the release of Nav-bPEG shell from the nanoparticles differs 
with pH, as expected, (Figure 5.3) and analysis of samples by DLS showed the consequences 
on the surface charge, size and polydispersity of the samples (Figure 5.4). 
 
Figure 5.3. pH-dependent dissociation of Nav-bPEG layer from multilayer nanoparticles as a result of 20 h 
exposition to different pH buffers. (A) MNP-DMSA-PLLib-Nav-bPEG(A) and (B) MNP-DMSA-PLLib-Nav-
bPEG(B). (n for each condition is represented between brackets below the graphs). One-Way ANOVA 
complemented with Tukey’s test for multiple comparisons was used to determine P-values.  
Table 5.2. Characterization of Nav-bPEG layer. Nav-bPEG conjugation proportion, Nav-bPEG layering 









Nav-bPEG layer on the nanoparticles 
mg Nav-bPEG / mg MNP 
mol bPEG / mol Nav 
mg (Nav-bPEG)in / mg 
MNP 
pH 5 pH 6.5 pH 7.4 pH 8.5 
(A) 2 26.4 ± 2 19.2 ± 0.3 22.5 ± 0.9 23.8 ± 2.01 25.1 ± 0.2 
(B) 20 3.2 ± 0.6 1.0 ± 0.1 1.8 ± 0.2 2.2 ± 0.4 2.7 ± 0.1 
The strength of Nav-ib binding its maximal between pH 9.5 and pH 11 (Kd =10
-10
) and 





accordance with this pH-dependent affinity, Figure 5.3 shows that there was a significant 
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pH conditions. In basic environment (pH 8.5), due to the strong affinity interaction between the 
ib on the particles and the Nav from Nav-bPEG, most Nav-bPEG is kept bound to the particles. 
On the other hand, in acidic environment (pH 5), close to the lower limit of affinity, maximal 
dissociation of Nav-bPEG from the ib anchors on the particles is triggered. The release of Nav-
bPEG was incomplete in all of the tested conditions and was lower for MNP-DMSA-PLLib-Nav-
bPEG(A). Probably, due to the higher proportion of Nav-bPEG to MNP used to functionalize 
MNP-DMSA-PLLib-Nav-bPEG(A) (Table 5.2), these particles form more compact aggregates 
than MNP-DMSA-PLLib-Nav-bPEG(B). The entrapment of Nav-bPEG within the aggregates 
could hamper the respective release to the dialysates despite the pH-triggered dissociation from 
ib anchors on the particles. 
In Figure 5.4 A, we see that the level of Nav-bPEG shell dissociation in type (A) 
particles did not expose sufficient PLLib positively charged groups to change the particles zeta 
potential to positive in the tested conditions. Indeed, neutral zeta potential is observed at all pH 
conditions, suggesting that there is still PEG covering the PLLib layer. On the other hand, type 
(B) particles suffered charge reversal to positive from pH 7.4 to pH 6.5 and at pH 5 had a zeta 
potential of +10 mV, but yet, did not equal the zeta potential of MNP-DMSA-PLLib (subjected to 
the same pH treatments), which is in accordance with a partial dissociation of the Nav-bPEG 
from the particles.  
 
Figure 5.4. Effect of pH treatment on multilayer nanoparticles surface charge and size. (A) Zeta potential 
compared to MNP-DMSA-PLLib subjected to the same treatment. (B) Hydrodynamic diameter and 
polydispersity index (MNP-DMSA-PLLib were impossible to measure due to the high polydispersity of the 
samples). 
In the case of MNP-DMSA-PLLib-Nav-bPEG(A), despite the significant differences 
between the percent of Nav-bPEG release at all tested pHs, particles’ hydrodynamic size was 
kept approximately constant, around 130 nm (the exception is for pH 5, with dh=190 nm) with 
only a slight increase of the polydispersity under acidic pH conditions (Figure 5.4 B). We might 
conclude that the amount of Nav-bPEG shell released was not sufficient to cause important 
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structural disorganization of nanoparticles. In fact, size distribution profiles at the different pH 
are kept very similar; only at pH 5 is noticeable the presence of an extra size peak around 30 
nm, suggesting some degree of particle dissociation (Figure 5.5 A).  
In the case of MNP-DMSA-PLLib-Nav-bPEG(B), although the amount of Nav-bPEG per 
mass of MNP is approximately 10 times lower than in MNP-DMSA-PLLib-Nav-bPEG(A), the 
proportion of bPEG to Nav is 10 times higher (Table 5.2). Therefore, and because Nav binds a 
maximum of four ligands per molecule, part of the bPEG is certainly adsorbed non-specifically 
onto the particles and contributes to the formation of larger nanoparticle aggregates than for 
MNP-DMSA-PLLib-Nav-bPEG(A), even at physiological and basic pH (Figure 5.4 B). At acidic 
pH, triggered by the lower affinity of the pair ib-Nav, Nav-bPEG dissociates from the particles 
and might take with it some adsorbed Nav-bPEG and bPEG. Under these conditions, positive 
charges from PLLib which were hidden at higher pHs, become exposed and the particles 
become polydisperse due to the interaction with buffer salt and start flocculating, similar to 
MNP-DMSA-PLLib under the same conditions. Size distributions are presented in Figure 5.5 B. 
 
Figure 5.5. Variation of multilayer nanoparticles size distributions after being exposed to PBS at different 
pHs. (A) MNP-DMSA-PLLib-Nav-bPEG(A) and (B) MNP-DMSA-PLLib-Nav-bPEG(B). 
5.3.3. pH-dependent MNP cellular uptake and MR imaging 
After observing the pH-dependent erosion of Nav-bPEG shell in saline buffers and the 
resultant alterations in particles charge and sizes, particles interactions with cells were 
evaluated. To mimic the tumoral environment and compare the results with physiological 
conditions, assays with the human colorectal carcinoma HCT116 cell line were performed in 
acidified culture medium and in standard, non-modified culture medium.  
Bright field microscopy of cell preparations stained with Prussian blue after 5 h of 
incubation with MNP-DMSA-PLLib, MNP-DMSA-PLLib-Nav-bPEG(A) and MNP-DMSA-PLLib-
Nav-bPEG(B) in physiological (Figure 5.6 A-D) and acidic conditions (Figure 5.6 a-d) were 
employed to qualitatively evaluate iron uptake. The Prussian blue images show efficient uptake 
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of the MNP-DMSA-PLLib, MNP-DMSA-PLLib-Nav-bPEG(A) and MNP-DMSA-PLLib-Nav-
bPEG(B), as can be seen by the blue shades inside the cells and attached to the cell 
membranes, and no clear distinction could be made regarding differences in uptake level 
between physiological (Figure 5.6 A-D) and acidic cultures (Figure 5.6 a-d). The cellular 
distribution of iron from MNP-DMSA-PLLib-Nav-bPEG(A) (Figure 5.6 C and 5.6 c) in the cells is 
similar to the one of MNP-DMSA-PLLib, mainly intracellular (Figure 5.6 B and 5.6 b). However 
in cells treated with MNP-DMSA-PLLib-Nav-bPEG(B), besides the internalized iron, larger 
amounts of iron are observed surrounding the cells, attached to the cell membrane. This 
difference is explained by the higher hydrodynamic diameter of Nav-bPEG(B) multilayer MNP 
(Figure 5.4), but also reflects the differences between the two Nav-bPEG coatings in terms of 
MNP’s surface chemistry.  
 
Figure 5.6. Bright field microscopy images of preparations stained with Prussian blue for iron identification, 
obtained after exposing HCT116 cells to multilayer nanoparticles at 10 µg Fe/ml for 5 h. (A-D) cells 
incubated in physiological culture medium. (a-d) cells incubated in acidic culture medium. (A and a) 
untreated cells; (B and b) MNP-DMSA-PLLib; (C and c) MNP-DMSA-PLLib-Nav-bPEG(A); (D and d) MNP-
DMSA-PLLib-Nav-bPEG(B)). Scale bar: 10 µm. 
When a nanomaterial is put in contact with biological environment, a protein layer 
(protein corona) rapidly forms around the nanoparticle that overall will affect the interaction of 
the material with the tissues or cells.
31,32
 Generally, neutral and anionic nanoparticles show 
lower interactions with medium proteins than cationic ones, that interact strongly with proteins 
and undergo nonspecific binding and, in some cases, can cause cell lysis.
33–35
 Since we have 
used culture medium supplemented with fetal bovine serum (FBS), it is likely that our MNPs 
may interact first with the culture medium components and afterwards with the cells. Under this 
hypothesis we can assume that, in the case of MNP-DMSA-PLLib-Nav-bPEG(B), nonspecific 
adsorption of culture medium proteins enhanced the particles interactions with cells 
comparatively to the other particle types. Since MNP-DMSA-PLLib-Nav-bPEG(B) have a more 
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positive zeta potential at tumor pH and broader distribution of sizes than MNP-DMSA-PLLib-
Nav-bPEG(A) (Figure 5.4), interactions with medium proteins are favored and probably only the 
small particles could enter the cells whereas the large ones stayed attached to the membranes 
by electrostatic interactions with negatively charged cell membrane or through interactions 
mediated by the medium proteins associated with the particles.  
 
Figure 5.7. Tracking nanoparticles localization after incubation of HCT116 clels for 5 h in acidic culture 
medium at 37°C and 4°C with MNP-DMSA-PLLib, MNP-DMSA-PLLib-Nav-bPEG(A) and MNP-DMSA-
PLLib-Nav-bPEG(B) at 10 µg Fe/ml. Scale bar: 20 µm. 
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Further inspection of nanoparticle internalization was carried out by observing co-
localization of nanoparticles and GFP-labeled lysosomes after 5 h of incubation. Figure 5.7 
shows the results for cells incubated with MNPs in acidic conditions, but the same observations 
were made when physiological culture media was used. At 37 ºC, in the bright field microscopy 
images, MNPs are identified as black spots and aggregates of black spots in regions of the 
cytoplasm surrounding the nucleus, which co-localize with green-labeled lysosomes, visible by 
fluorescent microscopy. When incubation was carried out in the same conditions but at low 
temperature (4 ºC), MNPs were detected mainly in the extracellular medium and attached to the 
cell membrane (in particular for MNP-DMSA-PLLib-Nav-bPEG(B)), but not in the lysosome 
regions. These results indicate that the three types of nanoparticles are internalized via an 
endocytosis pathway, since at low temperature, energy-dependent processes in the cell (like 
endocytosis) are blocked and the end-destination of material internalized by endocytosis is the 
lysosomes. This result is in accordance with other works where PLL-coated iron oxide 
nanoparticles and multilayer nanoparticles with PEG shell were employed.
20,36
 Also, given the 
multilayer and PLLib coated nanoparticles sizes (>100 nm), other mechanisms would not be 
expected.  
In order to evaluate the effect of the Nav-bPEG coating layer on particles cytotoxicity, 
cell viability was evaluated after 5 h of incubation with the PLLib-coated nanoprobes and with 
both multilayer nanoprobes at 10 µg Fe/ml. Figure 5.8 A shows that both type (A) and type (B) 
Nav-bPEG shells tend to reduce the cytotoxic effect of the nanoparticles because cells treated 
with MNP-DMSA-PLLib presented much lower viability than cells treated with MNP-DMSA-
PLLib-Nav-bPEG. Indeed PEG coatings are commonly used to coat magnetic nanoparticles for 
biocompatibility purposes due to its hydrophilicity, low immunogenicity and low toxicity.
30,37,38
 
Compared to MNP-DMSA-PLLib, which are cytotoxic in both physiological (P <0.1) and acidic 
environments, MNP-DMSA-PLLib-Nav-bPEG(A) and MNP-DMSA-PLLib-Nav-bPEG(B) maintain 
cell viability levels similar to the one of untreated cells. Interestingly, at pH 7.4, there is a 
significant difference (P<0.05) between viability of cells incubated with PLLib-coated 
nanoparticles and cells incubated with multilayer nanoparticles with Nav-bPEG(B) shell. This 
difference is not observed for the multilayer nanoparticles with Nav-bPEG(A) shell, though. 
Therefore, under physiological conditions, Nav-bPEG(B) layer promotes an effective shield for 
the positive charges in PLLib layer that (if too exposed) would cause a cytotoxic effect on cells. 
These results are in accordance with the microscopic observations of cells treated with MNP-
DMSA-PLLib and MNP-DMSA-PLLib-Nav-bPEG (Figure 5.6). The protective effect of Nav-
bPEG(B) shell tends to be slightly less efficient at acidic pH, probably due to its partial 
dissociation from the nanoparticles (Figure 5.3 B), in accordance with the increase of zeta 
potential in PBS at pH 6.5 (Figure 5.4 A). 




Figure 5.8. pH-dependent cell-nanoparticle interactions after 5 h of incubation with the nanoprobes at 10 
µg Fe/ml in acidic (pH 6.5) and physiological (pH 7.4) culture medium. (A) Cell viability by Trypan blue cell 
counting (n=2); (B) Cellular iron uptake, quantified by ICP-AES (n=3). (C) In vitro MRI of unlabeled cells 
and cells labeled with MNP-DMSA-PLLib-Nav-bPEG(A) and MNP-DMSA-PLLib-Nav-bPEG(B). (D) 
Determination of the transversal relaxation time, T2, for MNP-DMSA-PLLib-Nav-bPEG(B) labeled cell 
samples. For cell viability, regular two-way ANOVA complemented with Bonferroni´s test was used to 
compare the effect of MNPs at the same pH and to compare the effect of a given MNP at pH 6.5 vs. pH 
7.4. For iron uptake, regular two-way ANOVA complemented with Bonferroni’s test was compare each 
condition with untreated control cells and to compare pH effect in treated cells.  
To quantify the pH dependency of magnetic cell labeling, ICP-AES characterization of 
cell-associated iron was performed after incubating cells with the nanoparticles (Figure 5.8 B). 
As observed in the Prussian blue staining images (Figure 5.6), all nanoparticles were taken up 
by cells in the tested conditions, but the higher content of cell-bound iron was registered for 
MNP-DMSA-PLLib-Nav-bPEG(B) (P<0.0001, at pH 6.5 and P<0.005 at pH 7.4, relative to 
untreated cells). Cell-associated iron is mainly due to internalized nanoparticles but there is also 
a proportion of nanoparticles adsorbed onto the cell surface (Figure 5.9). 
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Figure 5.9. Contribution of internalized and adsorbed nanoparticles for the proportion of cellular iron found 
in cells after labeling. 
Both MNP-DMSA-PLLib-Nav-bPEG types showed higher cellular uptake at acidic than 
at physiological conditions, as evidenced in Figure 5.8 B and Figure 5.9. However, while only a 
subtle difference was registered for MNP-DMSA-PLLib-Nav-bPEG(A) (2.52 ± 0.5 pg Fe/cell at 
pH 6.5 and 1.89 ± 0.57 pg Fe/cell at pH 7.4), a significantly higher uptake of MNP-DMSA-PLLib-
Nav-bPEG(B) was observed at pH 6.5 (22.82 ± 8.15 pg Fe/cell) than at pH 7.4 (11.79 ± 3.22 pg 
Fe/cell). Approximately a 2-fold increase in Fe uptake was promoted by MNP-DMSA-PLLib-
Nav-bPEG(B) in acidic compared to physiological conditions, which supports our strategy for 
preferential interaction with cells in the acidic environment characteristic of tumor tissues. The 
uptake of Fe observed at pH 6.5 in our study (~23 pg Fe/cell after incubation with 10 µg Fe/ml 
for 5 h) is ~5 times higher than the one reported by other authors for a pH-dependent MNP 
system that used chlorotoxin (CTX) as active targeting agent for glioma cells (~ 2 pg Fe /cell 
after incubating with 4 µg Fe/mL for 6 h).
11
 
Despite the less cationic character of MNP-DMSA-PLLib-Nav-bPEG(B) compared with 
MNP-DMSA-PLLib (Figure 5.4 A), the cellular uptake is higher, leading to more effective 
labelling, as seen in Figures 5.6 D and 5.6 d. In fact, there are several factors that influence the 
uptake of nanoparticles by cells and surface charge cannot be taken in consideration alone. In 
particular size and surface chemistry are also important parameters that influence the way 
nanoparticles interact with cells,
39,40
 as discussed previously. Our measurements in 150 mM salt 
showed that both MMP-DMSA-PLLib and MNP-DMSA-PLLib-Nav-bPEG(B) are polydisperse at 
pH 6.5 while at pH 7.4 Nav-bPEG(B)-coated nanoparticles form smaller aggregates and are 
less polydisperse, but have neutral charge (Figure 5.4). Charge reversal due to Nav-bPEG(B) 
dissociation at pH 6.5, aggregation and advantageous interaction with cell culture components 
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might be responsible for the differential uptake of MNP-DMSA-PLLib-Nav-bPEG(B) in acidic 
medium compared to physiological medium.  
Superparamagnetic iron oxide nanoparticles with core sizes between 6 and 20 nm are 
negative MRI contrast agents,
1
 i.e., have the ability to shorten the transversal relaxation time 
(T2) of water protons in their vicinity, which translates in a darkening effect of MR images in the 
areas were the nanoprobes are present. The MNP-DMSA that are the basis of this multilayer 
system were previously shown to possess superparamagnetic and T2 MRI contrast agent 
properties.
23,41
 To evaluate the multilayer nanoprobes regarding their efficacy as MRI contrast 
agents and the ability to distinguish the cells according to their culture pH, T2-weighted MR 
images of agarose dispersions of 90 000 cells incubated with the multilayer MNPs in acidic and 
physiological conditions were produced. For cells incubated with MNP-DMSA-PLLib-Nav-
bPEG(A), the level of cellular uptake was not sufficient to render the cells visible by MRI 
compared to unlabeled cells nor to provide differential contrast for the different incubation 
conditions (Figure 5.8 C). On the other hand, for cells incubated with MNP-DMSA-PLLib-Nav-
bPEG(B), the MR images show a clear contrast difference relative to unlabeled cells and, more 
importantly, show preferential labeling of cells in acidic conditions compared to those in 
physiological medium (Figure 5.8 C). Labeled cells are detectable as hypointense regions in the 
images, which are more intense in the acidic than in the physiological sample due to the higher 
content of MNPs in those cell samples. Correspondingly, T2 of cells in acidic medium (T2 = 
56.75 ± 0.48 ms) is shorter than in physiological medium (T2 = 63.90 ± 5.48 ms) (Figure 5.8 D). 
Similar results were reported by Crayton et al.,
10
 which showed that cells incubated with glycol-
chitosan-coated MNPs exhibited pH-dependence to their T2 relaxation times and caused 
increasingly higher signal losses in MR images from pH 7.65 to pH 5.9.  
Given the overall results of this study, MNP-DMSA-PLLib-Nav-bPEG(B) multilayer 
system is a potential effective pH-sensitive nanoprobe for MRI cell labeling. It is interesting to 
note that the cell phantoms presented in this work contained a relatively small amount of cells 
compared to other authors’ studies
10
 and compared to our previous studies (300 000 cells of the 
same HCT116 cell line).
26,41
 Although the coating materials used were different, better contrast 
was achieved in the present study for cells at acidic conditions, even with a lower administered 
dose of iron, which also supports the high labelling efficacy of this system.  
The multilayer pH-sensitive magnetic nanoprobe MNP-DMSA-PLLib-Nav-bPEG(B) 
overall presented better performance in vitro than MNP-DMSA-PLLib-Nav-bPEG(A), despite its 
higher polydispersity and size. The observed selectivity for labeling HCT116 cells in acidic 
compared to physiological medium confirms that the ib-Nav pH-dependent and biologically 
derived affinity pair is suited to confer pH-sensitivity in the range of values that we tested and 
that immobilization within the multilayered architecture system does not affect its robustness. 
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Compared to a similar architecture system,
20
 our magnetic nanoprobe presents the advantage 
of allowing imaging by MRI, which is well established for human-scale diagnosis in the clinic 
unlike other imaging modalities such as fluorescence. Moreover, it offers the possibility (not 
explored in this work) of magnetic targeting using an external magnet to direct the nanoprobe to 
desired areas after systemic injection. 
Given the availability of free amine groups in the PLLib layer, a more complex 
nanoprobe could be engineered using the developed system as template. For example, reporter 
and/or specific targeting molecules could be attached to create a combined targeting strategy 
for a pH-sensitive multimodal drug delivery and imaging system. 
5.4. Conclusions 
In this work, a proof-of-concept of an affinity triggered T2 MRI contrast agent for cancer 
cell labeling was presented. The developed nanoprobe is activated by the typically acidic pH 
found in cancer tissues so that preferential interaction with cells is promoted under those 
conditions, leading to higher contrast in MRI. While most strategies to produce iron oxide MNP 
sensitive to pH rely on the use of chemically engineered polymers with pH-sensitive bonds or 
chemical groups, this work has demonstrated the feasibility of a biologicaly-derived affinity 
interaction (iminobiotin/neutravidin) to achieve pH activation of such nanoprobes. The MNP-
DMSA-PLLib-Nav-bPEG(B) multilayer nanoprobe provideD pH dependent MRI contrast in cell 
phantoms of HCT116 colorectal carcinoma cells due to its pH-removable PEG shell. Indeed, we 
have shown that the PEGylated outer layer of MNP-DMSA-PLLib-Nav-bPEG(B) is able to shield 
the cationic charges of the underlying PLLib layer at physiological pH (pH 7.4) and expose it at 
acidic pH by means of the neutravidin linker between both layers. The weaker strength of Nav-ib 
affinity interaction at acidic pH triggers the release of Nav-bPEG from the nanoparticles in acidic 
environment, which leads to enhanced nanoparticle uptake by HCT116 cells in acidic conditions 
(22.82 ± 8.15 pg Fe/cell) compared to the observed in physiological pH conditions (11.79 ± 3.22 
pg Fe/cell). For cells cultured at pH 7.4, PEG shell also contributes to decrease the cytotoxicity 
of the nanoprobes. The difference in nanoparticle uptake resulted in clear hypointensity 
differences between cells cultured in acidic medium (T2 = 56.75 ± 0.48 ms) and cells cultured in 
physiological medium (T2 = 63.90 ± 5.48 ms). As acidity is a characteristic of most of cancer 
tissues, the presented tumor-targeted nanoprobe architecture allows a general tumor targeting 
approach and is expected to provide specific MR labeling of tumoral tissues disregarding the 
type of cancer. We suggest that the iminobiotin/neutravidin based MNP multilayer architecture  
could contribute to surpass some of the issues associated with ligand/receptor mediated tumor 
targeting strategies in vivo; for example, the heterogeneity among cancer cell populations and 
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the heterogeneous expression of receptors or antigens on cancer cell membranes,
8
 which limit 
the efficacy of nanoprobes decorated with specific ligands targeting for one biomarker. Also, 
given the availability of free amine groups in PLLib layer, a more complex nanoprobe could be 
engineered using the present system as a template. For example, drugs, reporter and/or 
specific targeting molecules could be attached to produce a pH-sensitive multimodal drug 
delivery and imaging system. 
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The project presented in this thesis aimed at designing iron oxide MNP–based T2 MRI 
nanoprobes using natural and synthetic polymers as particle coating and functionalization 
materials. The major contributions of this project were in the development of magnetic 
nanoprobes bearing a novel biopolymer produced by a biotechnological process, as well as the 
design of an affinity triggered magnetic nanoprobe for selective targeting of tumor environments 
using a biologically-derived affinity pair.  
The thermal decomposition method was employed to synthesize monodisperse 
magnetic cores with controlled size and magnetic properties, important for biomedical 
applications. The hydrophobic MNP that resulted from the synthesis were stabilized in aqueous 
medium by replacing the hydrophobic ligands by hydrophilic small molecules such as citric acid 
or meso-2,3-dimercaptosuccinic acid (DMSA) through a ligand exchange reaction. After a 
comprehensive characterization of the physiochemical properties of the hydrophilic MNP, it was 
concluded that the ligand-exchange protocol with DMSA, besides being more straightforward, 
provided particles with better magnetization and chemically more versatile for further 
functionalization.
1
 MNP-DMSA with optimal hydrodynamic size distribution and colloidal stability 
were then used towards the development of MRI nanoprobes with natural/synthetic polymer 
coatings. A summary of the physiochemical properties and nanoprobe-cell interactions for the 
developed nanoprobes is found in Table 6.1, Table 6.2 and Figure 6.1. 
Most natural polymer-coated MNP described in the literature are produced by 
adsorption of the polymer onto the MNP surface. However, in order to increase the stability of 
the coating, permanent conjugation strategies are preferred. Since MNP-DMSA have both thiol 
and carboxylic acid groups at the surface, the reactivity of these groups was explored to 
covalently couple the biopolymer gum Arabic (GA), derived from Acacia senegal and Acacia 
seyal trees. The use of EDC/NHS chemistry for the establishment of amide bonds between the 
carboxylic acid groups from MNP-DMSA and the free amine groups in gum Arabic proved to be 
an efficient strategy to produce a nanoprobe with excellent MRI T2 contrast enhancement 
properties (r2/r1 = 350) which provided approximately a 20-fold enhancement of relative cellular 
uptake in human colorectal carcinoma cells (HCT116 cell line) compared to uncoated MNP-
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DMSA. Contrast enhancement was clearly visible as dose-dependent hypointensity in in vitro 
MRI phantoms of HCT116 cells incubated with MNP-DMSA-GA.
2
 The protocols defined in this 
work served as the inspiration to explore the feasibility of a new biopolymer, the 
exopolysaccharide (EPS) Fucopol,
3
 as a coating agent for MNP-DMSA to produce cell labelling 
agents. Since EPS possesses an associated residual protein fraction, the covalent coupling 
strategy firstly devised to conjugate GA onto MNP-DMSA was optimized and employed to 
produce MNP-DMSA-EPS with covalently coupled EPS.
4
 Like GA, EPS coating led to the 
formation of aggregates of magnetic cores entrapped in the polymer network which have 
enhanced relaxometric properties compared to MNP-DMSA (r2/r1=148 for MNP-DMSA-EPS vs. 
r2/r1=2.3 for MNP-DMSA) (Table 6.1). These nanoprobes were shown to be particularly efficient 
T2-contrast agents for in vitro cell labeling of human neural progenitor/stem cells (ReNcell VM 
cell line), promoting a 10-fold increase in the relative uptake of iron per cell compared to MNP-
DMSA without affecting the viability and multipotency of the cells. Dose-dependent MRI contrast 
enhancement was obtained in agarose dispersions of these cells, contrary to in vitro MRI of 
HCT116 cells labeled with the same nanoprobe (Table 6.2 and Figure 6.1). 
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) 110.0 314.7 361.0 n.d. 182 
r2/r1 42.3 349.7 148.0 n.d. 82.7 
(a)
intensities distribution; n.d. = not determined. Zeta potential measured at pH 7 in 10 mM KNO3. 
A combination of synthetic and biological coating layers was also explored in this thesis, 
showing for the first time, the addition of pH sensitive properties to iron oxide MNPs through the 
use of a biologically-derived affinity interaction. In order to engineer a dynamic nanoprobe 
activated by the acidic tumor microenvironment, a pH removable PEG shield was bound to 
positively charged MNPs. The biologically derived and pH-sensitive affinity pair composed by 
the protein neutravidin and the ligand iminobiotin was used as a linker between a poly-l-lysine 
(PLL) inner layer and a biotinylated poly(ethyleneglycol) (bPEG) outer layer on the MNPs. This 
system was built over the initial MNP-DMSA monodisperse particles taking advantage of the 
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strong electrostatic interactions between the negatively charged MNP-DMSA surface and the 
positively charged PLL. Layering conditions were optimized towards differential cellular uptake 
at tumor and physiological pH. The nanoprobes’ uptake by HCT116 cells in vitro was shown to 
be enhanced under acidic pH conditions as a 2-fold increase in iron uptake per cell was 
observed at acidic pH compared to physiological pH. Increased cellular uptake of the 
nanoprobes in acidic pH resulted in enhanced contrast in T2-weighted MR images, which 
allowed cells cultured in physiological medium to be distinguished from others cultured in 
acidified medium (Table 6.2 and Figure 6.1). 
 
Figure 6.1. Summary of the average relative iron uptake per cell upon incubation with the MNPs 
developed in the context of this thesis. See incubation conditions in Table 6.2 
While biopolymers have intrinsic biocompatibility and biodegradability properties and 
are greener products, synthetic polymers offer engineering versatility and possibility of being 
tailor-made with specific properties. The work described in this thesis took advantage of these 
features to create new polymer-coated MRI nanoprobes with differing architectures and cell 
interaction abilities. The nature of the polymeric coating, as well as its relative amount in the 
nanoprobe composition were shown to influence the size, colloidal properties and relaxivities of 
the nanoprobes, which was particularly observed for biopolymer-coated nanoprobes (Table 6.1). 
Importantly, the effect of polymers nature and coating architecture was noticeable in the 
interactions of the nanoprobes with in vitro cell cultures (Figure 6.1 and Table 6.2). 
Independently of the incubation time and cell type, the presence of a polymeric coating on the 
nanoprobes contributed to an increase in the fraction of cell-associated iron compared to 
uncoated MNP-DMSA. Then, different cellular uptake levels were observed depending on the 
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 polymer, different uptake was observed depending on the cell type (Figure 6.1). Several 
factors influence interactions of MNP with cells.
6
 With this work it can be concluded that a 
balance between MNPs intrinsic physiochemical characteristics (such as particle size, shape, 
charge and surface chemistry) and incubation conditions (incubation time, iron concentration 
administered, constitution of the culture medium) might be optimized towards efficient and safe 
magnetic labeling of a determined cell type.  
GA and EPS-coated MNPs were shown to be biocompatible in the range of 
concentrations tested and taken up by cells non-specifically without the need for transfection 
agents. These hybrid magnetic-biopolymeric nanoplatforms are therefore suggested as potential 
nanoprobes for in vitro cell labeling and in vivo cell tracking by MRI, for example in the context 
of cell transplantation applications, such as stem cell therapy. On the other hand, through the 
combination of the synthetic polymers PLL and PEG with the biologically derived affinity pair 
neutravidin/iminobiotin, a multilayer pH-dependent cell labeling nanoprobe was engineered. A 
known affinity pair found in Nature was employed to render pH-responsive properties to the 
active layers of the nanoprobe. However, other tailor-made affinity pairs can be optimized or 
developed to specifically target the needs for tumor cell labelling, for instance by presenting a 
sharper dissociation behavior at tumoral pH conditions. Considering the scenario of in vivo 
nanoprobe administration, different behaviors would be expected as a consequence of the 
particles differing architectures. While biopolymer-coated MNP would be expected to passively 
accumulate in tumor tissue via EPR and internalized non-specifically, multilayer MNP 
internalization after EPR-mediated accumulation would be enhanced in response to tumor 
acidic environment.  
More than static systems, the nanoparticles developed in the scope of this thesis, are 
versatile nanoplatforms for further functionalization. Given the availability of chemical functional 
groups on the polymeric coatings (carboxylic acid and hydroxyl groups in GA and EPS, and 
amine in PLL), more complex nanoprobes could be engineered. Targeting ligands, therapeutic 
moieties and/or reporter molecules could be conjugated to produce multimodal and theranostic 
nanodevices with tissue-specific uptake, which ultimately would contribute to the improvement 




























Table 6.2. Overall summary of the interactions between the different MNP produced in this thesis and in vitro cell cultures. 
MNP type Cell line Incubation time 
Relative IC50 
(µg Fe/ml) 







In vitro MRI T2-weighted 
contrast enhancement 
MNP-DMSA 
HCT116 48 h 55 54 1.3 No efficient contrast enhancement 
ReNcell VM 4h + 24 h recovery n. d. 57 1.1 n.d. 
MNP-DMSA-GA HCT116 48 h 43 31 17.3 
Fe dose-dependent hypointensity  
I.D.=-18.1[Fe]+1994.8 (r
2
 = 0.995) 
MNP-DMSA-EPS 
HCT116 48 h 82 46 8.4 
Modest hypointensity compared 
with untreated cells. No linear 
variation. 
ReNcell VM 4h + 24 h recovery n. d. 16 4.8 
Fe dose-dependent  hypointensity 
I.D.=-81.6[Fe]+2428 (r
2





5 h n. d. 10 
22.8 Increased hypointensity in acidic 
cell samples (T2=56.8 ms) 





Iron concentration in the culture medium as determined by ICP-AES; average values of Fe uptake are presented. I.D.=integrated density; n.d. = not determined. 
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